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ABSTRACT 
Improving the solubility, stability and bioaccessibility of lipophilic 
nutraceutical, Curcumin, using colloidal delivery systems 
MAY 2021
 BINGJING ZHENG
B.A., University of Massachusetts Amherst
 Ph.D., University of Massachusetts Amherst 
Directed by: Professor David Julian McClements 
Curcumin is a yellow-orange crystalline substance found in certain foods (turmeric) that is 
claimed to exhibit a broad range of biological activities.  Its application as a nutraceutical in 
functional foods and beverages is often limited by its relatively low solubility in aqueous media, 
its chemical instability, and its low bioavailability. Recent research suggests that colloidal 
delivery systems can overcome these hurdles and improve the efficacy and commercial value of 
curcumin in the food, supplement, and pharmaceutical fields. The purpose of this research was to 
develop colloidal delivery systems to improve the application of curcumin as a nutraceutical in 
foods.   
First, the chemical degradation of curcumin in oil-in-water emulsions and filled hydrogel 
beads (alginate and chitosan beads) was initially compared to that of curcumin in aqueous 
solutions (dimethyl sulfoxide, DMSO). The same amount of curcumin was encapsulated in all 
the delivery systems, and the emulsion and aqueous solution form of curcumin exhibited higher 
color intensity than the hydrogel beads. After being incubated in the samples under both acidic 
and neutral conditions for 15-days at 55 ºC in the dark, it was found that curcumin was more 
stable under acidic than neutral conditions. Interestingly, the encapsulation of curcumin in 
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alginate beads actually promoted its degradation at both acidic and neutral pH, but encapsulation 
in chitosan beads enhanced its stability at pH 7 but reduced it at pH 3. The curcumin degradation 
rate increased in the following order: at pH 7, chitosan beads < emulsion < alginate beads < 
aqueous solution; at pH 3, emulsion < aqueous solutions < chitosan beads < alginate beads.  
Second, an innovative pH-driven method was used to load curcumin into emulsions and 
its efficacy was compared to other loading methods: oil-solubilization and heat-driven methods. 
The aim of using the pH-driven method was to improve the encapsulation efficiency. The oil-
solubilization method involved dissolving powdered curcumin in the oil phase (60 oC, 2 h) and 
then forming a nanoemulsion.  The heat-driven method involved forming a nanoemulsion and 
then adding powdered curcumin and incubating at an elevated temperature (100 oC, 15 
min).  The pH-driven method involved dissolving curcumin in an alkaline solution (pH 12.5) and 
then adding this solution to an acidified nanoemulsion (pH 6.0). Initially, the encapsulation 
efficiency of the curcumin in the three nanoemulsions was determined: pH-driven (93%) > heat-
driven (76%) > conventional method (56%). The bioaccessibility of the colloidal delivery 
systems created using the pH-driven method was then compared to that in three commercial 
supplements that use different encapsulation technologies: Nature Made, Full Spectrum, and 
CurcuWin. The curcumin concentration in the mixed micelles decreased in the following 
order: CurcuWin ≈ pH-driven nanoemulsions > heat-driven nanoemulsions > conventional 
nanoemulsions >> Full spectrum > Nature Made. This result indicated our natural emulsion-
based system was suitable for encapsulating and increasing the bioaccessibility of curcumin.  
Third, we compared the efficacy of three different colloidal delivery systems produced 
using the pH-driven method: curcumin nanocrystals; curcumin-loaded nanoemulsions; and 
curcumin-loaded soy oil bodies.  A control was also used that consisted of curcumin powder 
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dispersed in water.  The nanoemulsions and oil bodies formed yellowish creamy dispersions that 
were stable to creaming, whereas the nanocrystals formed a cloudy yellow-orange suspension 
that was prone to sedimentation.  The potential fate of the different delivery systems after 
ingestion was assessed using a gastrointestinal tract (GIT) model that consisted of mouth, 
stomach, and small intestine phases.  The nanoemulsions and oil bodies were rapidly and fully 
digested, while the nanocrystals were not.  All three systems were relatively stable to chemical 
transformation in the in vitro digestion model, but the nanocrystals gave a low bioaccessibility, 
whereas the other two systems had a high bioaccessibility, which was attributed to their ability to 
form mixed micelles that solubilized the curcumin.  
Fourth, we examined the physical and chemical stability of curcumin-loaded soybean oil 
bodies prepared using the pH-driven method. First, the impact of pH (from 6.5 to 8) on the 
stability of curcumin-loaded soymilk during storage was investigated at 4 ºC for 36 days.  At this 
low storage temperature, more than 85% of the alkaline-sensitive curcumin was retained at all 
three pH values, without any evidence of color fading.  The impact of holding temperature (4, 
20, 37, and 55 ºC) on the physicochemical stability of the curcumin-loaded soymilks was then 
measured during storage at pH 7 for 14 days.  At 4 and 20 ºC, the emulsions remained physically 
stable, most of the curcumin (> 90%) was retained, and there was no evidence of color fading.  
At the higher temperatures, however, the rate of curcumin degradation increased. For instance, 
around 30% and 70% of curcumin was lost when the soymilks were stored at 37 and 55 ºC, 
respectively.  On the other hand, the soymilks remained physically stable throughout this period.  
Finally, we showed that curcumin can be successfully loaded into dairy milk using this 
approach, without adversely affecting milk fat globule stability.  The physical and chemical 
stability of curcumin-loaded milk stored under different pH and temperature conditions was 
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assessed. The impact of pH on the stability of the curcumin-loaded milk was investigated by 
storing the samples at 4 ºC for 60 days at pH 6.5, 7.0 and or 8.0.  At this low storage temperature, 
all milk samples were stable to fat globule aggregation, creaming, curcumin degradation (<13% 
loss), and color fading. The impact of temperature on the stability of the curcumin-loaded milk 
was investigated by storing samples at pH 7 for 15 days at 4, 20, 37, or 55 ºC.  As expected, the 
extent of curcumin degradation decreased with decreasing storage temperature: 55 ºC (43%) > 37 
ºC (21%) > 20 ºC (10%) > 4 ºC (5%). Interestingly, the color of the samples stored at 4, 20 and 
37 ºC remained similar to that of the initial samples, but the sample stored at 55 ºC showed 
significant color fading. The bioaccessibility of the curcumin determined using a simulated 
gastrointestinal tract model was around 40%, which was attributed to some chemical degradation 
and binding of the curcumin reducing its stability and solubilization.  
Overall, the results of this research provide valuable information that will facilitate the 
design and formulation of curcumin-fortified functional foods with potential health benefits. 
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Curcumin is a photochemical derived from turmeric, which is a perennial herb belonging to the 
Zingiberaceae family (Fig.1). Colloquially, turmeric is referred to as the “golden spice” because 
of its unique golden yellow color and earthy pungent flavor 1, 2.  In south and southeast Asian 
countries, turmeric has been used as a spice and pigment in food preparations for thousands of 
years.  In addition, it has been widely used as an herbal medicine due to its perceived therapeutic 
benefits.  Chemically, there are three major polyphenol substances that belong to the 
“curcuminoid” family: curcumin (diferuloylmethane); demethoxycurcumin; and 
bisdemethoxycurcumin. Of these, the curcumin form is the most biologically active and so has 
been the focus in the development of pharmaceutical, supplement, and food products 3, 4.  
In functional food applications, curcumin can be considered as a natural ingredient that provides 
a distinctive color and flavor profile, as well as having potential health benefits 1, 2, 4. Research in 
various fields has shown that ingestion of curcumin may be beneficial to health due to its wide 
range of biological activities, including anti-inflammatory 5, 6, antioxidant 6, 7, antibacterial, 
antiviral, anti-fungal 8, 9, antidiabetic, anti-tumor, and anti-cancer 3, 10, 11 activities. In cases where 
it is efficacious, curcumin may have advantages for the prevention or treatment of diseases 
because of its low cost, good safety profile, and lack of side effects.  The research highlighting 
the potential benefits of curcumin has led to it being applied in a variety of commercial food and 
non-food products, including energy drinks, supplements, ointments, soaps, and cosmetics12. 
Pure curcumin is an orangey-yellow colored crystalline material, which normally comes in a 
powdered form. Moreover, it is a chemically-labile hydrophobic substance that has a low water-
solubility (particularly under acidic or neutral conditions where it is fully protonated), poor 
chemical stability (especially under alkaline conditions), and low bioavailability (mainly due to 
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low bioaccessibility and chemical transformation due to metabolic enzymes in the 
gastrointestinal tract).  In addition, curcumin is susceptible to chemical degradation during 
storage, particularly when exposed to light, high temperatures, and alkaline conditions 13. 
Although curcumin is relatively stable to chemical degradation under acidic conditions, it has a 
very low water-solubility under these conditions, which can promote crystallization and 
sedimentation in aqueous delivery systems 14.  For this reason, it is important to develop 
effective approaches to overcome these hurdles so that curcumin can be successfully 
incorporated into pharmaceuticals, supplements, and functional food products.  
One of the most effective means of protecting curcumin against chemical degradation, 
increasing its water dispersibility, and improving its bioavailability is to use modern 
encapsulation technologies 15, 16.  These technologies involve incorporating the curcumin into 
edible nanoparticles or microparticles that can then be introduced into food or supplement 
products 17.  These colloidal particles are assembled from food-grade ingredients, such as 
surfactants, phospholipids, lipids, proteins, polysaccharides, and minerals, using either 
spontaneous or directed processes.  Numerous kinds of colloidal particles can be employed for 
this purpose, including micellar aggregates, liposomes, emulsion droplets, solid lipid particles, 
















2. Literature Review 
 
 
2.1 Chemistry of curcumin 
  
Curcumin (C21H20O6) is an asymmetric molecule with a molar mass of 368.38 g/mol (Fig. 1). 
Structurally, it contains three main functional groups: two aromatic ring systems containing o-
methoxy phenolic groups, and one alpha, beta-unsaturated beta-diketone moiety. In aqueous 
solutions, curcumin undergoes keto-enol tautomerism with its conformation depending on pH: 
the keto form dominates under acidic and/or neutral conditions, while the enol form dominates 
under alkaline pH conditions (Fig. 2)19-21.  The enol form is more chemically labile than the keto 
form, accounting for the poor chemical stability of curcumin in basic solutions21.  
  
 
Fig.1 Chemical structure of curcumin 
 
2.2. Biological activities of curcumin  
2.2.1 Antioxidant activity 
One of the main reasons that curcumin is used in many food formulations is due to its relatively 
strong antioxidant activity, which is believed to increase the shelf life of food products and 
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protect cells from free-radical induced damage.  Reactive oxygen species (ROS) generated inside 
the human body can promote the oxidation of lipids, proteins, and DNA molecules that place 
critical roles in normal cellular function.  A number of chronic diseases have been linked to this 
phenomenon, including inflammation, cardiovascular disease, diabetes, and cancer 6, 22 23. 
Curcumin exhibits its antioxidant activity by acting as a free radical scavenger, singlet oxygen 
quencher, and chelating agent. For instance, it can donate a hydrogen atom from its -diketone 
moiety to lipid alkyl or lipid peroxyl radicals, thereby reducing their activity 24, 25.  In addition, it 
can chelate ferric (Fe2+) and ferrous (Fe2+) ions, which are known to be potent pro-oxidants. 
Some studies have also shown that it is highly effective at inhibiting the oxidation of emulsified 
lipids.  For instance, in linoleic acid emulsions a lower dose of curcumin (20 mM) was required 
to inhibit lipid oxidation than butylated hydroxyanisole (123 mM), butylated hydroxytoluene 
(102 mM), tocopherol (51 mM), and trolox (90 mM)7.  
2.2.2 Anti-inflammatory activity 
Curcumin is also widely used as a nutraceutical in functional foods because of its relatively 
strong anti-inflammatory activities.  In particular, it has been reported that curcumin can 
suppress inflammatory response enzymes and transcription factors, such as TNF-a, IL-1, IL-6, 
IL8, IL12, monocyte chemoattractant protein (MCP)-1, cyclooxygenase-2 (COX 2) and 
inducible nitric oxide synthase (iNOS), lipoxygenase, thereby inhibiting the production of 
inflammatory cytokines26, 27.  The efficacy of curcumin for treating rheumatoid arthritis (a 
disease linked to inflammation of the joints) was compared to that of a widely used drug for this 
purpose (diclofenac sodium). After eight weeks, patients reported that curcumin formulation was 
more effective at reducing pain, swelling, and tenderness then the drug and that it exhibited less 
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side effects. Moreover, the patients receiving the drug reported itching and swelling around their 
eyes, as well as dimness of vision28.  Animal studies have also reported that curcumin reduced 
inflammation and bone erosion of collagen-induced arthritis (CIA) in rats after eight weeks of 
treatment (110 mg/kg)29. Other researchers have also claimed that the anti-inflammatory activity 
of curcumin is responsible for its ability to inhibit tumor formation and cancer. 
 
2.2.3 Antimicrobial effects  
The antimicrobial activity of curcumin means that it has potential to inhibit food spoilage thereby 
prolonging shelf life, as well as deactivating pathogenic organisms thereby increasing food 
safety 30. Moreover, ingestion of curcumin-rich foods has the potential to treat or prevent some 
infectious diseases 31. Several mechanisms of action have been proposed for the antimicrobial 
activity of curcumin, including its ability to increase the permeability of bacterial cell walls, 
inhibit microtubule formation, impair bacterial virulence factors and interfere with key 
biochemical pathways 32. For instance, studies have shown that there is an increase in cell 
membrane leakage for both gram-negative (S. aureus and E. faecalis) and gram-positive (E.coli 
and P. aeruginosa) bacteria after being treated with curcumin 33.  
 
2.2.4 Anticancer 
Curcumin has also been reported to have the ability to inhibit the growth of cancer cells by 
suppression of angiogenesis and induction of apoptosis 34, 35.  In vitro and in vivo studies suggest 
that curcumin may be able to downregulate cell growth and proliferation in various types of 
cancer cells, including prostate, breast, and colon cancers34. In the case of prostate cancer, 
curcumin downregulated cancer cell proliferation by attacking epidermal growth factor receptors 
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(EGFR) that normally down-regulate EGFT expression36. Curcumin has also been shown to 
suppress cell motility and metastasis by inhibition of bone metastatic LNCaP-derivative C4-2B 
prostate cancer cells36, 37. In the case of breast cancer, curcumin has been reported to mediate 
breast cancer cell apoptosis via suppression of NFκB, cyclinD, and MMP-1 experssion38. In the 
case of colon cancer, curcumin had been reported to reduce miR-21 promoter activity and 
expression by inhibiting HCT116 cells and Pko cells in the G2/M phase, which regulates 
progression and metastasis of cancer cells 39, 40.  
2.3. Potential Toxicity 
The potential toxicity and side effects of ingesting curcumin have been investigated for decades 
using both animal and human models. A human feeding study reported no toxicity when up to 8 
g of curcumin were ingested every day for three months, however, some of the test subjects did 
report minor side effects, such as diarrhea or nausea 41. Another human study reported only 
minor side effects (diarrhea, rash, headache, and yellow stool) in one subject when they were fed 
relatively high levels (1 – 12 g per day) of curcumin for prolonged periods 42. After reviewing 
the available evidence, the United States Food and Drug Admission (FDA) considers curcumin 
to be generally regarded as safe (GRAS)43. The United Nations and World Health Organization 
Expert Committee on Food Additives, as well as the European Food Safety Authority, allow a 
relatively high daily intake of curcumin: 0 to 3 mg/kg body weight/day 44, 45, which corresponds 
to up to about 210 mg day for an average person.  This level is well above that reported to have 
beneficial health effects in human feeding studies46. 
2.4. Factors affecting curcumin’s application  
In this section, some of the main challenges that need to be addressed when formulating 
curcumin-based functional foods are discussed. 
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2.4.1 Solubility  
At room temperature, pure curcumin is a crystalline material with a melting point around 183 ºC.  
In addition, it is a predominantly hydrophobic substance due to the non-polar regions in the 
aliphatic bridge, aromatic rings, and methyl groups (Figure 1) 47. Nevertheless, it does have three 
hydroxyl groups, which become deprotonated at sufficiently high pH values, thereby giving it a 
negative charge (Figure 2).  Consequently, curcumin is a predominantly hydrophobic molecule 
with low water-solubility under acidic and neutral conditions (where the hydroxyl groups are 
protonated), but a hydrophilic molecule with a relatively high water-solubility under alkaline 
conditions (where the hydroxyl groups are de-protonated) 48. In particular, the solubility of 
curcumin increases as the solution pH is raised around and above the pKa values of the three 
hydroxyl groups (7.5, 8.5 and, 9), which are located in the enolic and phenolic regions of the 
molecule (Figure 1 & 2).  As an example, at pH  7.5, the net charge = 0, the log D = 4.1, and 
the water-solubility is very low (around 24 mg mL-1 or 0.0024%).  Conversely, at pH  12.0, the 
net charge = -3, the log D = -2.0, and the water-solubility is very high (> 3 g mL-1).  As well as 
leading to an increase in water-solubility under alkaline conditions, deprotonation of these 
hydroxyl groups also promotes a color change and an increase in chemical instability (see the 
following sections). In most foods, the pH is in the range from about 2 to 8, so that the curcumin 
is a predominantly hydrophobic molecule with low-water solubility.  As a result, it typically 
needs to be dissolved in some form of hydrophobic substance before it can be incorporated into 
aqueous-based foods, otherwise, it will be in a crystalline form.  Having said that, the pH-
dependence of the water-solubility of curcumin can be utilized in the formation of colloidal 
forms of curcumin, e.g., in the pH-shift method (see later).   
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2.4.2 pH-induced color changes 
The color of curcumin solutions depends on the protonation state of the three hydroxyl groups 
and therefore changes with pH (Figure 2).  From pH 2 to 7, all of the hydroxyl groups are 
protonated and the curcumin appears golden yellow, which is the case in most foods.  From pH 7 
to 8.5, the enolic hydroxyl group becomes progressively deprotonated, causing the curcumin to 
change to a more orangey color. At still higher pH values, the other two phenolic hydroxyl 
groups become deprotonated causing the curcumin to have a more reddish color 4, 13, 49. The 
chemical state of curcumin under specific solution conditions can therefore be elucidated by 
measuring the UV-visible absorption spectrum 4. It should be noted that curcumin chemically 
degrades under alkaline conditions, which causes changes in its color.  
2.4.3. Chemical degradation  
2.4.3.1 Alkaline degradation 
As mentioned earlier, the water-solubility of curcumin increases under alkaline conditions, 
which contributes to an increased rate of chemical decomposition. At pH values around and 
above the pKa values of its hydroxyl groups, curcumin undergoes rapid hydrolytic degradation, 
which has been attributed to cleavage of the 𝜶, 𝜷-unsaturated 𝜷-diketone moiety. As a result, the 
original curcumin molecule is transformed into trans-6-(4´-hydroxy-3´-methoxyphenyl)-2,4-
dioxo-5-hexanal, which itself undergoes cleavage reactions to form ferulic acid, 
feruloylmethane, and vanillin4, 13, 49, 50 (Fig. 2). The color of curcumin fades due to this alkaline 
degradation reaction. In phosphate buffer solutions, it has been reported that around 90% of 
curcumin degraded within 15 minutes of incubation at neutral or alkali conditions, but the 
molecule was relatively resistant to degradation under acidic conditions14, 51. The possible 
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degradation of curcumin under neutral and alkaline conditions must therefore be considered 
when developing curcumin-enriched functional foods.  
2.4.3.2 Photodegradation  
Curcumin (crystalline or solubilized) also undergoes chemical degradation when exposed to 
light, which promotes color fading 52, 53. The photodegradation of curcumin is also initiated at the 
𝜶, 𝜷-unsaturated 𝜷-diketone moiety and leads to a variety of reaction products, including p-
hydroxybenzaldehyde, vanillin, vanilic acid, ferulic aldehyde, and ferulic acid (Figure 2)52. 
Typically, the crystalline form of curcumin is more stable to photodegradation than the 
solubilized form, which may be because a higher fraction of the light waves is able to penetrate 
into a clear solution. Certain reaction products (e.g., vanillin and ferulic acid) have been reported 
to have some antioxidant and anticancer activities, but they are less potent than the curcumin 
molecule itself 54-56 .  
2.4.3.3 Autoxidation   
Curcumin may also chemically degrade due to autoxidation reactions that occur spontaneously in 
aqueous solutions via a radical chain reaction57, 58.  Initially, free radicals in the surrounding 
solution initiate autoxidation of the phenolic hydroxyls on the curcumin molecule, which results 
in the formation of an unstable intermediate that breaks down through a series of reactions to 
form bicyclopentadione57, 59. This reaction product has been shown to exhibit some anticancer 










Fig. 2 the pH effects the color, hydrophobicity and molecular change in curcumin structure. It also demonstrates the 




2.4.4 Bioavailability   
In this section, some of the main factors limiting the bioavailability of curcumin are highlighted 
(Fig. 3).  
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2.4.4.1 Bioaccessibility, Chemical Transformation, and Absorption 
The high melting point and low water-solubility of curcumin under acidic and neutral conditions 
mean that pure curcumin crystals typically have a low bioaccessibility.  In other words, the 
crystals do not readily dissolve in the aqueous gastrointestinal fluids, which reduces their ability 
to be transported through the mucus layer and be absorbed by the epithelium cells 34, 61. The 
bioavailability of curcumin may also be limited due to chemical transformation within the 
gastrointestinal tract.  Curcumin is resistant to degradation under acidic environments, and 
should therefore remain stable in the stomach.  Conversely, it is prone to alkaline degradation 
under neutral or basic conditions and so may be unstable in the small intestine and colon.  Some 
studies have shown that curcumin may also undergo autoxidation under physiological pH 
conditions 3.  Despite these potential degradation mechanisms, a rat study reported that around 
90% of ingested curcumin remained in the GIT after exposure to the stomach and small intestine 
conditions for 30 mins, suggesting that its degradation was relatively slow within the gut 62. The 
bioaccessibility and chemical stability of curcumin can be increased by encapsulating it within a 
lipid phase, such as a bulk or emulsified oil 47, 63.  Trapping the curcumin within a lipid phase 
protects it from chemical degradation by physically isolating it from reactants in the aqueous 
gastrointestinal fluids.  Moreover, the utilization of a digestible lipid phase (such as a 
triglyceride) leads to the production of lipid digestion products (fatty acids and monoglycerides) 
that are incorporated into mixed micelles.  These mixed micelles can then solubilize the 
curcumin within their hydrophobic interiors, thereby enhancing its bioaccessibility.  Moreover, 
they can transport the hydrophobic curcumin molecules to the epithelium cells where they can be 
absorbed.  After absorption, the curcumin may be metabolized within the epithelium cells and/or 
expelled back into the intestinal lumen due to the presence of efflux transporters within the cell 
 12 
membranes 64, 65.  Some substances within foods, such as piperine in black pepper and certain 
catechins in green tea, are able to inhibit these efflux transporters, therefore increasing the 
amount of curcumin remaining in the body 66, 67.  This gives food formulators an approach to 
increase the potential bioactivity of curcumin using common food ingredients that act as efflux 
inhibitors 68.    
 
 
Fig 3. Proposed anticancer signaling pathways that curcumin can modulate.Key: AP-1, activating protein-1; EGR-1, 
early growth response protein-1; ERE, estrogen response element; HIF-1, hypoxia-in- ducible factor-1; mTOR, 
mammalian target of rapamycin; ncRNAs, non-coding RNAs; Nrf2:,NF-E2-related factor 2; PI3K/AKT, 
phosphatidyli- nositide 3-kinases/protein kinase B; STAT3, signal transducer and activator of transcription 3; WT1: 




One of the main reasons for the poor oral bioavailability of curcumin is its rapid metabolism by 
metabolic enzymes inside the gut, as well as after absorption (particularly in the liver), leading to 
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the formation of a variety of metabolites with different biological activities to the parent 
molecule 61. The human intestine and liver contain phenol sulfotransferase isoenzymes that 
convert curcumin into curcumin sulfates, as well as glucuronidases that convert curcumin into 
curcumin glucuronides 69. In addition, a number of other metabolites may be formed, including 
bicyclopentadione, dihydrocurcumin, tetrahydrocurcumin (THC), hexahydrocurcumin (HHC), 
octahydrocurcumin (OHC), hexahydrocurcuminol, dihydroferulic acid, and ferulic acid 68, 70. The 
majority of the curcumin glucuronides, curcumin sulfates, and other metabolites are fairly water-
soluble and so are quickly excreted from the body via urine and feces71, 72 
 A number of the metabolites of curcumin have been found to exhibit some biological activity. 
THC has been reported to have stronger anti-inflammatory, antidiabetic, and antihyperlipidemic 
activity than curcumin, as well as a similar antioxidant activity54, 73 22.  HHC has been reported to 
have similar or better antioxidant, anti-inflammatory, anticancer, and cardiovascular protective 
activities as curcumin 74-76. OHC has also been reported to have superior anticancer properties 
than curcumin, by being more effective at suppressing tumor growth and inducing cancer cell 
apoptosis 77, 78.  In contrast, curcumin glucuronide has been reported to have a lower absorption 
and anticancer activity than curcumin 79. Curcumin glucuronides and curcumin sulfates have also 
been reported to be less bioactive than other metabolites, as well as the parent molecule 80.  
2.4.4.3 Tissue distribution 
After absorption, curcumin enters the bloodstream and is rapidly distributed throughout the body, 
resulting in it being located in many tissues at detectable levels, including the liver, kidney, 
colon, brain, heart, lung, and spleen 62, 68, 81-83.  For instance, a rat study reported that a small 
amount of curcumin was found in the liver and kidney soon after oral administration, while about 
38% was present in the large intestine after 24 hours 62. The maximum curcumin concentration 
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was detected in the liver (around 45 ug/ whole tissue) and kidney (6 ug/whole tissue) after 3 
hours. The amount of curcumin in the kidney has been reported to decline after about 24 hours, 
while that in the liver remains fairly constant for up to 4 days 82. A rat feeding study reported that 
different levels of curcumin were detected in different tissues after oral administration: liver (70 
nmol/mL), kidney (78 umol/mL), brain (3 nmol/mL), lungs (15 nmol/mL), heart (9 nmol/mL), 
and muscle tissue (8 nmol/mL)81. These results suggest that curcumin has the potential to work 
in various tissues within the human body, which means that it may be able to treat a variety of 
different disease conditions.  
2.4.4.4 Elimination  
Curcumin is eliminated from the body more through the feces than through the urine, which may 
be due to its relatively low water-solubility 83. An animal study suggested that about 34% of 
curcumin was excreted through the feces, while less than 0.2% was secreted in the urine 82. 
Nevertheless, curcumin metabolites (such as glucuronides and sulfates), which are much more 
water-soluble than the parent molecule, tend to be excreted through both the urine and feces71, 72.  
2.4.4.5. Pharmacokinetics 
Pharmacokinetic studies have been used to study the levels of curcumin in the bloodstream of 
animals and humans after oral ingestion.  These studies typically show that the fraction of 
curcumin reaching the bloodstream in an intact form is very low.  For instance, in an animal 
study, it was reported that there was only about 0.22 ug/mL of curcumin in blood samples taken 
an hour after oral administration of 1.0 g curcumin per kg body weight, with this concentration 
declining over the following 6 hours84. In a human trial, only around 11 nmol/L curcumin was 
detected in blood plasma collected an hour after oral administration of 3.6 g of curcumin72. In 
human feeding studies, even a relatively high intake of curcumin (8 g per day) led to a relatively 
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low serum level (2 um/mL) in blood samples collected an hour or two after consumption41. 
These studies indicate that only a very small fraction of ingested curcumin actually gets into the 
systemic circulation in humans, which may limit its potential biological activity. 
 
 
Fig.4 curcumin undergoes chemical degradation due to metabolism as it passes through the human gut and body. 




2.5. Strategies to overcome the challenges of curcumin 
Potential strategies to improve the solubility/dispersibility, stability and bioavailability of 
curcumin are highlighted in this section.  
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2.5.1 Methods to enhance solubility/dispersibility of curcumin 
The solubility of curcumin in both oil and water phases is important when developing effective 
formulations to encapsulate and deliver it.  At room temperature, pure curcumin is typically in a 
powdered crystalline form.  Consequently, it must be dissolved or dispersed within an 
appropriate solvent before it can be incorporated into a suitable food format.  In this section, a 
number of approaches for introducing curcumin into solvents are highlighted.  
2.5.1.1. Direct dissolution  
Curcumin has a relatively low water-solubility (under neutral or acidic conditions), but it can be 
directly dissolved within oils and some organic solvents due to its lipophilic nature. Other than 
curcumin in water exhibits in the keto-form, the curcumin within the organic solvent solution has 
enolic form in nature (Figure 2). Some of the most common organic solvents used to directly 
solubilize curcumin are ethanol, methanol, chloroform, acetone, and dimethoxy sulfoxide 
(DMSO) 4. These solvents are often used to dissolve curcumin prior to creating colloidal delivery 
systems.  For instance, ethanol is often used to solubilize both curcumin and particle-forming 
materials, such as surfactants, phospholipids, hydrophobic proteins, or hydrophobic 
polysaccharides.  Colloidal particles are then formed using an antisolvent precipitation method 
by injecting the ethanol mixture into water 85 86. When the hydrophobic curcumin and particle-
forming materials come into contact with water, curcumin-loaded particles are spontaneously 
formed.  Curcumin has been loaded into zein nanoparticles using this method 87.  One 
disadvantage of using organic solvents for this purpose is that they may be environmentally 
unfriendly and additional costs are associated with removing and analyzing them in the final 
formulation 88, 89.  This problem can be overcome by using supercritical fluids (such as 
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supercritical carbon dioxide) to dissolve the curcumin90, 91. Alternatively, alkaline water can be 
used as a solvent, rather than an organic fluid. 
As mentioned earlier, the solubility of curcumin increases substantially when the solution is 
raised above about pH 9 because the molecule changes from hydrophobic to hydrophilic (Figure 
2).  Consequently, curcumin can be solubilized in highly alkaline solutions.  Curcumin-loaded 
colloidal particles can then be formed using a pH-shift method that involves injecting the 
alkaline curcumin solution into an acidified aqueous colloidal suspension.  The pH decreases 
when these two systems are mixed together, which causes the curcumin to become more 
hydrophobic and move into the non-polar regions within the colloidal particles.  This approach 
has been used to encapsulate curcumin into surface micelles 92, solid lipid particles, liposomes 93, 
emulsions, protein nanoparticles94, 95,  and oil bodies 95, 96.  The curcumin should only be kept for 
a relatively short time under highly alkaline conditions to avoid its degradation.   
2.5.1.2. Mechanical action 
The dissolution of crystalline curcumin in solvents can be increased by applying mechanical 
forces, such as stirring and sonication. Sonication is particularly suitable for this purpose because 
it generates intense fluctuating pressure waves that induce acoustic cavitation, leading to 
efficient mixing and dissolution 97, 98.  
2.5.1.3. Heating 
The solubility of crystalline materials in solvents usually increases as the temperature is raised.  
Consequently, it is possible to solubilize a higher concentration of curcumin by heating the 
system. This approach has been used to facilitate the dissolution of powdered curcumin into bulk 
oils, prior to emulsion formation 99. It has also been used to increase the dissolution of powdered 
curcumin into pre-existing emulsions 100.  
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2.5.1.4. Encapsulation technologies 
One of the most common approaches to improve the water-dispersibility of curcumin is to 
incorporate it within colloidal particles that have a hydrophobic interior but a hydrophilic 
exterior, such as micelles, microemulsions, emulsions, or hydrophobic biopolymer particles.  
Numerous kinds of colloidal particles that can be used for this purpose are covered in more detail 
in Section 6.3. 
2.5.2. Methods to enhance stability of curcumin 
As mentioned earlier, curcumin is susceptible to chemical transformation when exposed to 
certain conditions, such as alkaline pH, light, elevated temperatures, transition metals, and 
metabolic enzymes.  For this reason, it is necessary to develop effective strategies to protect it 
from chemical degradation so that it can reach the target organs in an active state. 
2.5.2.1. Antioxidant technologies 
The rate of chemical degradation of curcumin can be inhibited by adding synthetic or natural 
antioxidants 101.  These authors reported that co-administration of curcumin with certain 
antioxidants decreased the degradation rate and increased the amount absorbed after oral 
administration to rats.  Specifically, a number of food-grade redox active antioxidants were 
shown to greatly improve curcumin stability, including ascorbic acid, gallic acid, caffeic acid, 
rosmarinic acid, tert-butylhydroquinone (TBHQ), and Trolox.  The addition of antioxidants has 
also been shown to enhance the stability of curcumin encapsulated within oil-in-water emulsions 
102.  Hydrophilic and amphiphilic antioxidants were found to be more effective than lipophilic 
ones in this study, which may be because the chemical degradation of curcumin occurs more 
rapidly in the water phase.  Overall, the authors reported the following order of efficacy for 
different antioxidants: Trolox  ascorbic acid > ascorbyl palmitate >> control > alpha-
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tocopherol. These results suggest that the stability of curcumin in food formulations can be 
improved by adding appropriate antioxidants.   
2.5.2.2. Encapsulation technologies 
The chemical degradation of curcumin occurs faster when it is surrounded by water than oil, 
because substances that accelerate the degradation reaction (such as hydroxyl ions) are mainly 
located within the aqueous phase 14.  Consequently, the stability of curcumin to chemical 
degradation can be improved by encapsulating it within a hydrophobic phase, which may be a 
bulk phase (such as oil) or colloidal particles (such as oil droplets, solid fat particles, or 
hydrophobic protein particles) 14, 103, 104.  Interestingly, the chemical stability of curcumin 
increases as the size of these hydrophobic colloidal particles increases, because then there is a 
slower exchange of curcumin molecules between the particles and the surrounding aqueous 
phase 105.  Various kinds of encapsulation technologies that may improve the chemical stability 
of curcumin in aqueous-based systems are discussed in Section 6.3. 
2.5.2.3. Controlling environmental conditions 
  Curcumin is known to degrade faster when exposed to light 106, high temperatures 14, high 
oxygen levels 107, and alkaline environments 14.  It is therefore possible to improve its stability by 
controlling solution, environmental, and/or packaging conditions.  For instance, the chemical 
stability of curcumin can be improved by incorporating it into acidic products (pH < 7) that are 
stored at low temperatures in the dark.  Alternatively, it may be possible to exclude light and 
oxygen by using appropriate packaging procedures and materials, thereby further enhancing the 
stability of curcumin-based products.   
 20 
2.5.3. Methods to enhance the bioavailability of curcumin 
The bioavailability of curcumin can be enhanced by retarding its metabolism, increasing its 
bioaccessibility, and/or promoting its absorption. The enzymes that metabolize curcumin are 
located within the aqueous phase or within the cell membranes inside the human body.  
Consequently, the metabolism of curcumin can therefore be inhibited by trapping it inside 
hydrophobic phases that isolate it from the enzymes, such as those inside micellar, liposomal, 
microemulsion, emulsion, solid fat, or biopolymer particles.  The bioaccessibility of curcumin 
can be increased by enhancing the amount that is solubilized within the mixed micelles present 
in the small intestine.  This may be achieved by including surfactants, phospholipids, fatty acids, 
or monoglycerides within the curcumin-loaded carrier particles, as these surface-active 
substances, can become incorporated into the mixed micelles and increase their solubilization 
capacity.  Alternatively, this can be achieved by including digestible lipids within the curcumin-
loaded carrier particles, such as triglycerides or diglycerides.  These lipids are then converted 
into monoglycerides and fatty acids by lipase in the human gut, thereby generating surface-active 
materials that can be incorporated into the mixed micelles and enhance their solubilization 
capacity.  Finally, substances that increase the permeability of the epithelium cell membranes or 
that block efflux transporters can be incorporated into the curcumin-loaded carrier particles.  For 
instance, some surfactants, fatty acids, biopolymers, and phytochemicals have been shown to 
increase the permeability of epithelium cells, thereby leading to enhanced absorption of 
hydrophobic bioactives 108-110.  As mentioned previously, certain kinds of food components, 
including piperine in black pepper and some catechins in green tea, can inhibit efflux 
transporters, thereby increasing the amount of curcumin absorbed by the body 66, 67.   
2.6. Colloidal Delivery Systems 
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Colloidal delivery systems have been widely explored for their ability to increase the 
bioavailability of polyphenols, like curcumin18. Numerous kinds of colloidal delivery systems 
have been shown to be suitable for this purpose, including micelles, microemulsions, emulsions, 
solid lipid nanoparticles, protein nanoparticles, and biopolymer microgels. The curcumin-loaded 
colloidal particles can then be incorporated into functional food and beverage systems, or 
converted into a powdered form and used in supplements.  An alternative strategy is to use 
excipient foods to enhance the bioavailability of curcumin. An excipient is a food that contains 
no bioactive components itself but breaks down in the human gut to form an environment that 
enhances the bioaccessibility, stability, or absorption of any curcumin co-ingested with it.  
Emulsified foods containing digestible lipids are particularly suitable for this purpose, including 
milk, creams, dressings, sauces, or yogurts111.  
 
 
Fig. 5. Different kinds of colloidal delivery system can be used to encapsulate curcumin, thereby improving its 





Micelles have been widely used to improve the solubility and bioavailability of hydrophobic 
drug and nutraceuticals 112, 113. They are spontaneously formed when surfactants are dispersed in 
water above their critical micelle concentrations.  Consequently, they can often be fabricated 
using very simple processing methods, such as heating and/or mixing of the bioactive, surfactant, 
and water together.  After assembly, the hydrophobic tails congregate together in the interior of 
the micelles, while the hydrophilic head groups point outwards towards the water.  Micelles are 
typically formed from synthetic surfactants, but they can also be formed from certain kinds of 
natural surfactants, such as casein 114, 115.  Curcumin can be solubilized within the hydrophobic 
interior of the micelles by adding it before or after micelle formation.  Typically, micelles are 
relatively thermodynamically stable colloidal dispersions containing relatively small (typically 5 
to 20 nm) particles.  As a result, they tend to be optically transparent because the particles are so 
small that they do not scatter light waves strongly. The viscosities of micellar systems depend on 
the surfactant concentration and micelle structure. At low concentrations, they tend to be fluids 
with low viscosities, whereas at higher concentrations, they tend to be semi-solids with high 
viscosities or gel-like textures. Micelles enhance the bioavailability of hydrophobic compounds 
(like curcumin) by increasing their bioaccessibility in the gastrointestinal fluids, as well as 
possibly increasing the permeability of the epithelium cells116.   
Synthetic food-grade surfactants, such as Tweens, have been widely used to solubilize curcumin 
117.  The solubilization of curcumin has been reported to increase with increasing chain length 
and decreasing the unsaturation of the surfactant tail groups 117.  Natural surfactants, such as 
casein, have also been used to solubilize curcumin within aqueous solutions 118, which may be 
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more suitable for certain food applications.  The pharmacokinetics of curcumin-fortified Tween 
80 micelles and have been tested in a human feeding study. The curcumin-micelle formulation 
was found to have a 185-fold higher area under the curve (AUC) than free curcumin, without 
exhibiting any adverse side-effects 119.  
2.6.2. Liposomes 
Liposomes are self-assembled spherical particles consisting of one or more phospholipid bilayers 
89, 120.  They therefore have a structure that is somewhat similar to biological cell wall 
membranes. A phospholipid molecule consists of a hydrophilic head group and a hydrophobic 
tail group consisting of two fatty acid chains.  In a single bilayer, the phospholipid molecules are 
organized tail-to-tail therefore forming a thin hydrophobic domain, while the polar head groups 
face outwards.  Liposomes containing multiple bilayers often have an onion-like structure with 
concentric rings of individual bilayers.  Liposomes therefore have polar, non-polar, and 
amphiphilic regions inside the same colloidal particle, which can be useful for encapsulating one 
or more bioactive agents with different polarities within a single delivery system.  Liposomes 
vary greatly in dimensions, ranging from around 25 nm to 25 um depending on the formulation 
and fabrication method used.  Curcumin-loaded liposome typically has an orangey-yellow clear 
or slightly turbid look depending on the particle size 87.  
Liposomes can be prepared using various methods, including passive-loading, active-loading, 
mechanical-dispersion, solvent-dispersion, and detergent-removal methods 120. The preparation 
method used affects the nature of the liposomes formed, as well as the loading capacity of the 
curcumin. The characteristics of curcumin-loaded liposomes prepared using three different 
methods have been compared: thin film, ethanol injection, and pH-driven methods 93.  The initial 
diameters of the liposomes decreased in the following trend: thin film (452 nm) > pH-driven 
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(217 nm) > ethanol injection (115 nm).   The initial encapsulation efficiency of the liposomes for 
curcumin decreased as follows: thin film (78%) > pH-driven (66%) > ethanol injection (39%). 
The physical and chemical stability of the curcumin-loaded liposomes also depended on the 
fabrication methods.  After 30-days storage in the dark (4°C), the mean particle diameters 
increased to 1650, 234, and 153 nm for the thin film, pH-driven, and ethanol injection methods, 
while the curcumin concentration decreased by 50%, 2%, and 2%, respectively.  The effect of 
ionic strength (0.1 to 1 M NaCl) on the stability of the liposomes was also assessed. Overall, the 
salt-stability of the emulsions decreased as their initial particle size increased.  In particular, the 
liposomes prepared by ethanol-injection (which had the smallest initial size) were stable to salt 
addition, with little change in their appearance at any salt level after storage. Conversely, an 
increase in turbidity and precipitation were observed in the other liposome suspensions at high 
salt levels.  Overall, the suggest that controlling the liposome size is important for maintaining 
good product stability93. In another study, it was shown that curcumin-loaded liposomes could 
inhibit the chemical degradation of curcumin, especially when exposed to transition metal ions 
(Fe3+, Fe2+ Al3+, and Cu2+) 121.  
The phospholipid source may also influence the physicochemical characteristic of curcumin-
loaded liposomes. One study compared the properties of curcumin-loaded liposomes produced 
using a thin film/ultrasonic dispersion method that were fabricated from either milk fat globule 
membrane (MFGM) or soybean lecithin122. There were differences in the encapsulation 
efficiency, mean particle diameter, and -potential of the liposomes depending on lecithin type: 
EE = 74%, d = 212 nm ζ = +7.6 mV for MFGM; EE = 63%, d = 471 nm and ζ = -48.6 mV for 
soybean lecithin. Encapsulation of the curcumin was also shown to protect it from degradation 
when exposed to alkaline conditions, Fe3+, light, heating, oxygen, and relative humidity, with the 
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MFGM liposomes giving slightly better protection than the soybean lecithin ones 122. Other 
studies have also shown that lecithin type influences the encapsulation efficiency and stability of 
curcumin in liposomes 123.  
The impact of liposome encapsulation on the bioavailability of curcumin has been studied using 
both in vitro and in vivo experiences. Interestingly, an in vitro gastrointestinal tract study showed 
that curcumin in larger liposomes (200 or 450 nm) had a higher bioaccessibility than that in 
smaller ones (114 nm)93. An animal feeding study has been used to investigate the oral 
bioavailability of the two curcumin-loaded liposome formulations: flexible liposomes (FL) and 
silica-coated flexible liposomes (SL) 124.  Pure curcumin suspended in water was used as a 
control.  The curcumin concentrations within the blood plasma of the animals were measured up 
to 12 hours after oral administration. The maximum curcumin concentration occurred after 45 
min for both the FL formulation and the control, with values of 129 and 71 ng/ L, respectively. 
Conversely, the maximum curcumin concentration occurred after 3 hours for the SL formulation 
with a value of 447 ng/L.  Moreover, no curcumin was detected in the plasma of the animals 
after 4 hours for the control, while around 20 ng/L still remained after 12 hours for the 
encapsulated curcumin. Overall, both the SL (7.8-fold) and FL (2.4-fold) formulations gave a 
higher total amount of curcumin within the blood compared to free curcumin124. Thus, both 
liposome formulations were effective at increasing curcumin bioavailability.   
Other researchers have also used an animal model (mice) to study the impact of liposomal 
encapsulation of curcumin on its bioavailability123.  The maximum plasma concentration and 
time-to-reach this value depended on the formulation used: free curcumin (Cmax =64 µg/L; Tmax = 
120 min); curcumin-loaded liposomes (Cmax = 319 µg/L; Tmax = 30 min); and, free curcumin + 
liposomes (Cmax = 78 µg/L; Tmax= 120 min).  These results show that the bioavailability can 
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again be increased by delivering curcumin in the form of liposomes.  Importantly, liposomal 
curcumin also exhibited a higher plasma antioxidation activity than the other two curcumin 
formulations 123, which can be attributed to its higher plasma level.  Curcumin-loaded liposomes 
have been shown to exhibit the same cellular antioxidant activity as free curcumin when exposed 
to Caco-2 cells for 2 hours 121, which shows that encapsulation did not reduce the bioactivity of 
this nutraceutical. 
2.6.3. Microemulsions 
In general, microemulsions are thermodynamically stable isotropic colloidal dispersions formed 
from oil, water, and surfactant. Oil-in-water microemulsions contain small colloidal particles 
(typically 5 to 50 nm) comprised of oil and surfactant, which have a hydrophobic core and a 
hydrophilic shell.  Any hydrophobic or amphiphilic bioactive substances can be incorporated 
into these colloidal particles.  The fact that the colloidal particles in microemulsions are much 
smaller than the wavelength of light means that they are typically optically clear or only slightly 
turbid. Because they are thermodynamically stable systems, microemulsions should form 
spontaneously when the different components are mixed together but some mechanical mixing 
and/or heating may be required to facilitate this process.  This is because there may be a kinetic 
energy barrier between the separated substances and the final microemulsion system that must be 
overcome. 
Researchers have tried to optimize the formulation of curcumin-loaded microemulsions by 
varying the type and level of different substances used to fabricate them.  For instance, one study 
reported that an optimum formulation consisted of DL- -tocopherol (3.3 wt%), Tween 20 (53.8 
wt%), and ethanol (6.6 wt%) 125. This curcumin-loaded microemulsion had a clear yellow 
appearance, due to its small particle diameter (5 nm) and high curcumin level (14.6 mg/mL). 
 27 
These curcumin-loaded microemulsions remained stable when stored under refrigerator 
conditions (4 oC) for a month, with no significant change in particle size or curcumin 
concentration. This study also showed that the encapsulated curcumin had a relatively high 
permeability (around 70%) when tested using an in vitro method 125.  
Another study showed that self-micro-emulsifying drug delivery systems (SMEDDS) fabricated 
from oils and surfactants could be used to encapsulate and release curcumin 126. In this case, the 
curcumin, oil, and surfactant are mixed together and then incorporated into capsules or pellets.  
This mixture spontaneously forms a microemulsion when it comes into contact with aqueous 
gastrointestinal fluids. These formulations exhibited excellent physical and chemical stability 
during storage, as well as leading to a 17-fold increase in the oral bioavailability of the curcumin 
(compared to the non-encapsulated form) using animal feeding studies 126. Similar findings have 
been reported in other animal feeding studies using SMEDDS 127.  Overall, these results suggest 
that microemulsions can be designed to encapsulate curcumin, improve its stability, and enhance 
its bioavailability.  For food applications, however, the potential limitations of this approach are 
the high levels of synthetic surfactant required, which can cause problems with cost, taste, and 
toxicity.  
2.6.4. Nanoemulsions & emulsions  
Nanoemulsions and emulsions typically consist of two immiscible liquids stabilized by an 
emulsifier, and perhaps other ingredients, such as thickening agents, gelling agents, ripening 
inhibitors, or weighting agents 128.  Nanoemulsions typically contain droplets with a mean 
diameter between about 20 to 200 nm, whereas emulsions contain droplets with mean diameters 
greater than 200 nm 129.  As a result, nanoemulsions may appear clear to opaque, whereas 
emulsions nearly always appear opaque, due to differences in light scattering.  Because 
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nanoemulsions have a greater specific surface area (AS), they need more emulsifier to stabilize 
them, since AS is proportional to the reciprocal of the mean particle diameter (d32).  The 
physicochemical principles underlying the formation and stability of emulsions and 
nanoemulsions are the same, and so we will simply refer to them as “emulsions” in the 
remainder of this section.   
For encapsulation purposes, oil-in-water (O/W) emulsions are typically used because 
hydrophobic substances can be encapsulated inside the droplets and then introduced into 
aqueous-based food and beverage products.  The small droplets found in emulsions can be 
produced using two different approaches: high- or low-intensity methods 129. High-intensity 
methods employ mechanical devices that apply intense disruptive stresses to fluids, which cause 
large droplets to breakdown into smaller ones, and include high-shearing, colloid mills, high-
pressure homogenization, microfluidization, and sonication devices. Low-intensity methods rely 
on spontaneous droplet formation when oil-water-surfactant mixtures are exposed to particular 
conditions (compositions/temperatures), which includes phase inversion temperature and 
spontaneous emulsification methods 128, 129. 
Emulsion-based systems have been widely used for the encapsulation, stabilization, and delivery 
of curcumin.  Curcumin-loaded emulsions have a yellow-orange clear to milky appearance, 
depending on droplet concentration, droplet size, curcumin concentration, and solution pH 96. As 
mentioned earlier, the emulsions look clear when the droplets are very small (< 40 nm) but milky 
when they are larger.  The color of the emulsions depends on pH because of changes in the 
molecular conformation of the curcumin molecules discussed earlier 130.  
Researchers have examined the impact of formulation parameters on the formation and 
functionality of curcumin-loaded emulsions, including oil type, emulsifier type, and curcumin-
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solubilization method 131. In particular, five oils (canola, corn, linseed, MCT, and sunflower, oil), 
four emulsifiers (lecithin, Tween 80, gum acacia, and whey protein), and three solubilization 
methods (heating, sonication, and microwaving) were investigated. Overall, heating was the 
most efficient method of dissolving curcumin in the oil phase, while MCT led to the highest 
curcumin content in the oil phase.  The synthetic surfactant (Tween 80) produced curcumin-
loaded MCT emulsions with relatively high curcumin contents, small particle diameters, high 
surface potentials, and good physical and chemical stabilities 131.  The natural emulsifiers could 
also produce curcumin-loaded emulsions, but they were not as stable as the ones produced by the 
synthetic surfactant.  
Another study compared three methods of producing curcumin-loaded emulsions from all-
natural ingredients (corn oil and quillaja saponin): conventional, heat-driven, and pH-driven 
methods. The conventional method involved dissolving powdered curcumin in an oil phase and 
then forming an emulsion by high-pressure homogenization.  The heat-driven method involved 
preparing an emulsion first, and then heating it in the presence of powdered curcumin (100 C for 
15 min). The pH-driven method involved mixing an acidified emulsion with an alkaline 
curcumin solution. The encapsulation efficiency was higher for the pH-driven method (93%) 
than the heat-driven method (76.2%) or conventional method (55.5%). The oil droplets in the 
curcumin-loaded emulsions produced using the pH-driven method had a high negative charge (-
45 mV) and small particle diameter (180 nm). The bioaccessibility of the curcumin in the 
emulsions was determined using an in vitro model, and shown to be higher than non-
encapsulated curcumin, as well as commercial curcumin supplements 51.   
The physical and chemical stability of curcumin-loaded oil droplets has been shown to depend 
on their mean diameter (0.17, 0.52, or 14 µm) 132.  As expected, the rate of droplet creaming 
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increased with increasing droplet size because of the increase in gravitational forces.  
Conversely, the chemical instability of the curcumin decreased with increasing droplet size, 
which was attributed to the reduction in the contact area between the oil and water phases.  
Overall, curcumin bioaccessibility did not depend strongly on droplet size because of the 
competing effects of increased solubilization but decreased chemical stability of curcumin in 
smaller droplets.   
An animal (mouse) study examined the impact of oil droplet size (50,100 and 200 nm) on 
curcumin bioavailability, anti-inflammatory activity, and anti-allergic effects 133.  Interestingly, a 
higher curcumin concentration was found in the blood for the 100 nm droplets (Cmax ≈ 11 ng/mL, 
Tmax = 2hr) than for the 50 nm or 200 nm ones (Cmax ≈ 5 ng/mL, Tmax = 2-hour). The 100 nm 
droplets also exhibited higher anti-inflammatory and anti-allergic effects133.  Again, these effects 
may be due to conflicting influences of particle size on bioaccessibility, stability, and absorption. 
2.6.5. Solid lipid particles 
Solid lipid nanoparticles (SLNs) are similar in composition and structure to oil-in-water 
emulsions, except that the lipid phase is crystalline at the application temperature 134, 135. The size 
of the lipid particles in the SLN suspensions vary from around 20 to 1000 nm depending on the 
formulation and preparation method used.  Suspensions in the lower particle size range (< 50 
nm) appear transparent, whereas those containing larger particles appear cloudy or opaque 136. 
SLNs are typically prepared using the same methods as emulsions (high-pressure 
homogenization, sonication, or microfluidization), except homogenization is usually carried out 
at a temperature appreciably above the melting point of the lipid phase. In principle, a solidified 
lipid core is more effective at retaining and stabilizing curcumin than a liquified one.  However, 
the system must be carefully designed to inhibit particle aggregation and curcumin expulsion 
 31 
when the lipid phase crystallizes134, 135.  In addition, solidified lipid phases are typically digested 
more slowly than liquid ones, which may lead to prolonged release of any encapsulated 
substances.  
Curcumin has been successfully encapsulated within SLNs coated by biopolymers (caseinate or 
caseinate/pectin) 137.  The size, charge, and stability of these SLNs could be controlled by 
optimizing the formulation and preparation methods used.  Curcumin has also been encapsulated 
within SLNs coated by soy lecithin and Tween 80 138.  Initially, the SLNs had a relatively small 
diameter (134 nm) and a high encapsulation efficiency for curcumin (92%). After incubation for 
12 months at a refrigerated temperature (5 °C), the particle size only increased slightly (160 nm) 
and the curcumin content only decreased slightly (3%).  These results suggest that the SLNs 
were suitable for curcumin encapsulation under low-temperature storage conditions. The 
researchers also investigated the pharmacokinetics of curcumin after oral administration to rats.  
Encapsulation of curcumin within the SLNs led to a 48-fold increase in plasma concentration and 
a 39-fold increase in the area under the curve compared to a control (powdered curcumin in 
water), leading to an appreciable increase in oral bioavailability.  
The efficacy of Curcumin-loaded solid lipid nanoparticles (Cur-SLNs) and nanostructured lipid 
carriers (Cur-NLCs) has been compared using in vitro and in vivo studies 139.  Cur-SLNs were 
prepared using cetyl palmitate as a lipid source leading to a highly regular crystalline structure, 
whereas Cur-NLCs were formulated using oleic acid and cholesterol as a lipid source leading to 
a more irregular solid structure.  The storage stability, antioxidant activity, pharmacokinetics, 
and cytotoxicity of the Cur-SLNs and Cur-NLCs were then compared.  The entrapment 
efficiency and storage stability of the Cur-NLCs were higher than that of the Cur-SLNs, but their 
antioxidant activities were similar. In an animal (rat) pharmacokinetic study, the area under the 
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curve (AUC) in the plasma was 5-fold and 2-fold higher for Cur-NLCs and Cur-SLNs than the 
control, indicating that both delivery systems increased the bioavailability. Thus, NLCs appeared 
to be more effective at increasing the efficacy of curcumin than SLNs. In vivo studies with 
humans have shown that curcumin-loaded SLNs can appreciably increase the bioavailability of 
curcumin 140. 
2.6.6. Biopolymer particles 
Biopolymer particles are typically assembled from proteins and/or polysaccharides using an 
appropriate method. The method employed depends on the nature of the biopolymers 
themselves, as well as the required characteristics of the colloidal particles formed (such as 
composition, size, shape, charge, and stability).  The final particles usually contain biopolymer 
molecules held together by attractive forces, such as hydrophobic, electrostatic, or hydrogen 
bonding interactions.   The most common methods of inducing the assembly of biopolymer 
molecules are ionotropic, cold-set, heat-set, or enzymatic gelation. The most common particle-
forming methods include injection, emulsion templating, electrostatic complexation, antisolvent 
precipitation, and thermodynamic incompatibility methods 141. Biopolymer particles can be 
prepared with mean diameters ranging from around 100 nm to 1 mm depending on the 
fabrication method used. 
Biopolymer particles can be formed from proteins or polysaccharides that have antioxidant 
properties, thereby protecting labile nutraceuticals from chemical degradation 94. They can also 
be designed to retain nutraceuticals under one set of environmental conditions, but then release 
them under another set 141.  For example, biopolymer particles could be designed to retain 
curcumin during storage, mouth, and stomach conditions, but then release it in under small 
intestinal conditions.  
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Curcumin-loaded lipid droplets have been encapsulated within hydrogel beads made from either 
alginate (370 µm) or chitosan (255 µm) using an injection-gelation method 142. The anionic 
alginate was cross-linked with cationic calcium ions, whereas the cationic chitosan was cross-
linked with anionic tripolyphosphate ions.   Interestingly, encapsulating the curcumin-loaded 
lipid droplets within the hydrogel beads actually reduced its chemical stability.  Moreover, there 
were some swelling and shape changes in the beads during storage.  Curcumin has also been 
encapsulated within wheat protein microgels (510 nm) formed by heating the system at a 
controlled pH 143.  The protein microgels had a relatively high encapsulation efficiency (90%), 
good sedimentation stability, and high antioxidant activity, which may be important for 
commercial applications. 
Encapsulating curcumin within biopolymer microgels may be an advantage in applications 
where sustained or triggered release is required. An in vitro study showed a faster and higher 
release of curcumin from free oil droplets than from oil droplets trapped in either carrageenan 
beads or alginate beads 144. Similarly, the release of curcumin under simulated gastrointestinal 
conditions has been shown to be reduced when it is encapsulated within whey protein microgels 
143 or pectin microgels 145. These results suggest that biopolymer microgels may be useful for 
prolonging the release of curcumin, rather than increasing its bioavailability.  
The water-dispersibility and antioxidant activity of curcumin have been increased by 
incorporating it within the hydrophobic cores of casein-micelles 146. In a human study, it was 
shown that the oral bioavailability of curcumin could be increased substantially by loading it into 
γ-cyclodextrin complexes 147.  
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2.6.7. Nature-derived colloidal particles 
The growing interest in developing more sustainable and healthy food products has led many 
food scientists to explore the possibility of using nature-derived colloidal particles to encapsulate 
curcumin.  Recently, it was shown that curcumin could be encapsulated within the milk fat 
globules in bovine milk130 and the oil bodies in plant-based milks 148.  The curcumin was loaded 
into these nature-derived colloidal particles using the pH-shift method.  First, curcumin is 
dissolved in a highly alkaline aqueous solution (pH 12), which is then mixed with an acidified 
milk product.  The final pH of the mixed system is designed to be neutral or below, leading to a 
decrease in the water-solubility of the curcumin, which causes it to move into the hydrophobic 
core of the colloidal particles (milk fat globules or oil bodies).  The authors showed that the 
curcumin-loaded milks had good storage stability and a high curcumin bioaccessibility, as 
determined by an in vitro digestion method 130, 148.   
2.7. Conclusion  
Curcumin has been used as an edible health-promoting substance for thousands of years as part 
of traditional medicinal practices in Asia. More recently, modern scientific methods have 
demonstrated that curcumin exhibits a broad spectrum of biological activities that may be 
beneficial to human health, including antioxidant, antimicrobial, anti-inflammatory, and 
antitumor activities. Even so, there are a number of challenges that have to be addressed when 
formulating curcumin-based functional foods or therapeutics, including its low water solubility, 
chemical stability, and bioavailability. In this article, we highlighted some of the methods that 
can be used to overcome these problems, including antioxidant, encapsulation, and storage 
strategies.  In particular, we focused on the utilization of colloidal delivery systems, such as 
micelles, liposomes, microemulsions, emulsions, solid lipid nanoparticles, biopolymer particles, 
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and nature-derived colloidal particles. Each of these delivery systems has its own advantages and 
disadvantages for specific applications and it is important to select the most appropriate 
formulation.  For instance, there are differences in the appearances, textures, mouthfeels, flavors, 
shelf-lives, and environmental histories of different curcumin-fortified functional food products 
(such as soft drinks, milky drinks, sauces, dressings, and bakery goods), which require different 
kinds of encapsulation technologies.  In the future, it will be important to compare different 
formulations in terms of their cost, ease-of-manufacture, robustness, pharmacokinetics, 
bioavailability, bioactivity, sustainability, and environmental impact.  The most suitable 





























3. Impact of delivery system type on curcumin stability: Comparison of 
curcumin degradation in aqueous solutions, emulsions, and hydrogel 
beads 
3.1.  Introduction 
 Turmeric, a member of the ginger family, has been used as a dietary spice, yellow dye, 
preservative and traditional medicine in the south and southeast of Asia for thousands of years 31. 
Turmeric consists of three major curcuminoids: curcumin; demethoxycurcumin; and, 
bisdemethoxycurcumin 3. Curcumin is the most bioactive constituent within turmeric and has 
been reported to have various pharmaceutical functions, including antioxidant, antibacterial, anti-
inflammatory, anti-tumor and anti-cancer activities 3, 149, 150.  Curcumin is generally regarded as 
safe (GRAS) by the United States Food and Drug Administration (FDA) due to its low toxicity 
even when ingested at relatively high levels 41.  For these reasons, curcumin has been widely 
investigated for its potential application as a bioactive agent in functional foods, supplements, 
and pharmaceuticals 151, 152.  Curcumin has a desirable yellowish color that also makes it suitable 
for use as a natural colorant in some food products 1.   
 The effectiveness of curcumin as a nutraceutical or natural colorant in food applications 
depends on its ease of use, chemical stability, and bioavailability.  Curcumin is a hydrophobic 
substance that has low water-solubility, poor chemical stability (especially in alkaline solutions), 
and low bioavailability 3.  Under alkaline conditions, hydroxyl ions convert curcumin 
(diferuloylmethane) into trans-6-(4′-hydroxy-3′-methoxyphenyl)-2,4-dioxo-5-hexanal, ferulic 
acid, feruloylmethane, and vanillin, which leads to a reduction in its desirable yellow color 13, 49. 
Therefore, there is a need for delivery systems to improve the water-dispersibility, chemical 
stability and bioavailability of curcumin 153-155. 
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 Previous studies have demonstrated that the functional attributes of curcumin can be 
improved by encapsulating it within emulsion-based delivery systems, such as emulsions (d > 
200 nm) or nanoemulsions (d < 200 nm) 103, 156-159. Encapsulation of the hydrophobic curcumin 
molecules within lipid droplets improves their dispersion in aqueous solutions, and helps protect 
them from chemical degradation by limiting their interactions with reactive substances in the 
aqueous phase (such as hydroxyl ions).  Moreover, the presence of a digestible lipid within the 
delivery system can increase curcumin bioavailability by forming mixed micelles in the 
gastrointestinal fluids that solubilize and transport the curcumin to the epithelium cells 132, 160.  
An advantage to using nanoemulsions rather than emulsions for curcumin encapsulation is that 
they have better physical stability and a higher bioavailability 160.  Conversely, an important 
limitation of using nanoemulsions is that they have a large specific surface area, and so curcumin 
is more exposed to reactive substances in the aqueous phase that may promote their degradation 
132.  This problem may be overcome by encapsulating curcumin-loaded lipid droplets inside 
hydrogel beads 160-163.  The hydrogel beads should be designed to protect the curcumin from 
degradation in foods and the gastrointestinal tract, but then release it at an appropriate location 
where it can be absorbed and exhibit its bioactive effects.  A number of previous studies have 
examined the impact of curcumin encapsulation on its bioavailability and bioactivity 3, 132, but 
there have been few studies on the impact of encapsulation on its storage stability.  
 The objective of the current study was to determine the impact of delivery system type on 
the chemical stability of curcumin when stored under either neutral or acidic conditions. Two 
different types of food-grade delivery system were investigated: emulsions (curcumin-loaded 
lipid droplets) and filled hydrogel beads (curcumin-loaded lipid droplets trapped in microgels). 
The efficacy of these delivery systems was established by comparing them to a system consisting 
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of curcumin dispersed in an aqueous solution.  Hydrogel beads with different characteristics 
were fabricated using two different types of ionic polysaccharide: alginate and chitosan;  These 
two polysaccharides were selected because they have opposite charges 164. Alginate is an anionic 
polysaccharide composed of 1,4′-linked β-D-mannuronic acid and α-L-guluronic acid units, 
whose negative charge comes from de-protonated carboxylic groups 165, 166. Chitosan is a 
cationic polysaccharide that consists of D-glucosamine and N-acetyl glucosamine units, whose 
positive charge comes from protonated amino groups 167. The results of this study may be useful 
for the rational formulation of foods, supplements, and other products containing curcumin. 
3.2. Materials and methods  
3.2.1. Materials  
 Corn oil was purchased from a local supermarket (Mazola, ACH Foods, Cordova, TN). 
The following chemicals were purchased from the Sigma-Aldrich Chemical Company (St. Louis, 
MO): curcumin powder (C 1386, purity 76% assayed by HPLC); alginic acid (A2033) (sodium 
salt extracted from brown algae, medium viscosity, viscosity of 1% dissolved in water = 15-20 
mPa s); chitosan (448877, medium molecular weight, viscosity of 1 wt. % dissolved in 1% acetic 
acid = 200-800 mPa s); Tween 80 (P1754); Nile Red (N3013). All other chemicals were of 
analytical grade and were purchased from the Fisher Chemical Company (Thermo Fisher 
Scientific). Double distilled water, obtained from a water purification system (Nanopure Infinity, 
Barnstead International, Dubuque, IA), was used to prepare all solutions, emulsions, and 
hydrogels.  
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3.2.2. Preparation of curcumin in different delivery matrices 
3.2.2.1. Aqueous solutions 
 Curcumin powder (9 mg) was dissolved in 30 ml dimethyl sulfoxide (DMSO) solution. 
Aqueous solutions of curcumin with different pH values were prepared by pouring 90% (v/v) 
phosphate buffer solution (5 mM, pH 3.0 or 7.0) into 10% curcumin solution.  The final systems 
contained 3 mg of curcumin per 100 mL of 10% DMSO solution. 
3.2.2.2. Emulsions 
  A stock emulsion was prepared from 10% (w/w) oil phase (corn oil) and 90% (w/w) 
aqueous phase (1% w/w Tween 80, 10 mM Phosphate Buffer, pH 6.5).  Initially, the oil and 
aqueous phases were blended together for 2 min using a high shear mixer to form a coarse 
emulsion (M133/1281-0, Biospec Product, Inc., ESGC, Switzerland), and then they were passed 
five times through a high-pressure homogenizer at an operating pressure of 12,000 psi 
(Microfluidizer M-110Y, Microfluidics, Newton, MA USA). The resulting emulsions were 
stored at 4 C before being used. 
 Curcumin powder (0.3 mg/ml) was added to the stock 10% w/w oil-in-water emulsion 
and the resulting system was stirred for 2 hours at 85 C to fully dissolve the curcumin (SWB-
10L-2, Major Science, Inc., CA, USA).  This emulsion was then diluted 10-fold using either pH 
3 or pH 7 phosphate buffer solution (5 mM), and the resulting systems were adjusted back to the 
required pH.  The final systems therefore contained 1% w/w oil phase and 3 mg of curcumin per 
100 mL of emulsion.  
3.2.2.3. Curcumin-loaded filled alginate beads 
 An aqueous alginate solution was formed by dispersing 1.6% (w/v) alginate in double 
distilled water and then stirring overnight.  A 1% (w/w) curcumin emulsion was then mixed with 
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this alginate solution (1:1 v/v) and then stirred for 1 hour in the dark. Curcumin-loaded filled 
alginate beads were formed by injecting the mixture of curcumin-loaded lipid droplets and 
alginate into a 10% (w/v) calcium chloride solution using an encapsulation device (Encapsulator 
B-390, BUSHI, Switzerland).  This device had a vibrating nozzle with a diameter of 120 m, an 
operating frequency of 1400 Hz, and an electrode potential of 1000 V.  The beads were kept in 
the calcium chloride solution for at least half an hour with constant stirring to ensure 
crosslinking. The beads were then washed three times with double distilled water to remove any 
residual crosslinking solution, and then filtered overnight in a refrigerator. The resultant filled 
alginate beads were stored at 4 C in the dark before use.  
3.2.2.4. Curcumin-loaded filled chitosan beads 
 Chitosan powder (1.6 % w/v) was dissolved in 100 mM acetic acid and stirred overnight. 
Any insoluble matter was removed by centrifuging the chitosan solution at 2000 rpm for 5 min 
(Sorvall ST 8, Thermo Fisher Scientific, Inc., PR, China), so as to avoid blocking the nozzle of 
the encapsulation device.  The filled-chitosan beads were then prepared using similar conditions 
as the filled-alginate beads: 120 m nozzle size; operating frequency 1400 Hz; and, electrode 
potential of 900 V.  The filled chitosan beads were formed by injecting a mixture of curcumin-
loaded lipid droplets and chitosan into 100 mM sodium tripolyphosphate solution (pH 3) using 
the encapsulation device.  The resulting beads were then kept in the gelling solution and stirred 
for at least 30 min at ambient temperature to ensure crosslinking of the chitosan molecules.  The 
hardened beads were then washed with distilled water to remove excess crosslinking solution 
from their surfaces, and then filtered overnight in a refrigerator.   
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 Eventually, both types of hydrogel beads were placed in either acidic or neutral 
phosphate buffer solutions (5 mM, pH 3 or 7) to determine the impact of pH and storage time on 
curcumin stability and bead properties. 
3.2.3. Calculation of oil content in beads 
 The oil content of the filled hydrogel beads was calculated using the following 
expression:  
Oil content (g oil per g beads) = Winital  Coil / Wfinal    (1) 
Here, Winitial is the weight of the filled beads before filtration (g); Coil is the percentage of oil in 
the original mixture used to prepare the beads; and Wfinal is the weight of the filled beads after 
filtration (g).  
3.2.4. Storage study 
 Four delivery matrices were prepared to investigate their impact on the color stability of 
curcumin: (i) aqueous solutions (DMSO); (ii) emulsions; (iii) filled alginate beads; and, (iv) 
filled chitosan beads. All the samples containted the same final amount of curcumin (3 mg per 
100 mL). Each system was distributed into a number of test tubes, so that a separate sample 
could be used for analysis at each incubation time.  The samples were stored under both acid (pH 
3.0) and neutral (pH 7.0) conditions at 55 C for 14 days in the dark.  
3.2.5. Color measurement  
 The tristimulus color coordinates of the samples were determined using an instrumental 
colorimeter (ColorFlex EZ 45/0-LAV, Hunter Associates Laboratory Inc., Virginia, USA): L* 
(lightness/darkness); a* (redness/greenness); and, b* (yellowness/blueness). A test sample (10 
ml) was placed in a petri dish, and then illuminated with D65-artificial daylight (10 standard 
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angle) using a white background plat.  In this study, only the b* values were used because they 
best represented changes in the yellow color of curcumin due to chemical degradation.  
3.2.6. Particle characterization 
 The mean particle diameters and particle sizes distributions of the samples were 
measured using static light scattering (Mastersizer 2000; Malvern Instruments, Worcester- shire, 
UK). Small aliquots of sample were added to 5 mM buffer solutions (same pH as sample) placed 
in the instrument measurement cell and stirred at 1200 rpm to ensure homogeneity. The 
refractive indexes of the dispersed and continuous phases used in the calculations were 1.474 and 
1.330, respectively. The data is reported as either the full particle size distribution or the volume-
weighted mean particle diameter (d43).  The electrical charges (ζ-potentials) of the samples were 
analyzed using particle electrophoresis (Nano-ZS, Malvern Instruments, Worcestershire, UK). 
All samples were diluted with buffer solution (same pH as sample) before measurement. The 
particle sizes and electrical charges of curcumin solutions (DMSO) could not be measured 
because they did not contain colloidal particles that scattered light sufficiently strongly. 
3.2.7. Bead swelling 
 Weighed filtered wet beads were immersed in either acid (pH 3) or neutral (pH 7) 
phosphate buffer solutions at 55 °C, and then their mean particle diameters (d43) were measured 
by static light scattering at the first and last days of storage.  The percentage increase in the 
diameter of the beads due to swelling was then calculated using the following expression:  
 Swelling percentage (%) = [(dfinal – dinitial) / dinitial] 100  (2) 
3.2.8. Microstructure analysis  
 The microstructures of the samples were characterized using confocal scanning 
fluorescence microscopy (Nikon D-Eclipse C1 80i, Nikon, Melville, NY).  All images were 
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acquired using a 10 eyepiece and a 20 objective lens. Samples were stained with Nile Red 
(1%) to highlight the location of the lipid regions.  Images of the curcumin solutions were not 
measured because they were homogeneous systems that did not have any observable structure. 
3.2.9. Statistical analysis  
 All data are shown as the mean  standard deviation (SD) of measurements, were carried 
out in triplicate experiments using freshly prepared samples. The statistical comparisons were 
preformed using the student’s t-test by commercial software (SPSS 16). P-values lower than 0.05 
were considered to be significantly different.  
3.3. Results and discussion 
3.3.1 Properties of initial curcumin-loaded delivery systems  
 The different kinds of curcumin delivery system were prepared as described earlier: 
curcumin solution; curcumin emulsion; curcumin-loaded filled alginate beads; and, curcumin-
loaded filled chitosan beads. The physicochemical and structural properties of the different 
delivery systems were then measured. 
3.3.1.1. Curcumin solution 
 The overall appearance and yellowness (b* value) of aqueous solutions containing 
curcumin were measured by digital photography (Fig. 1a) and instrumental colorimetry (Table 
1).  The aqueous curcumin solutions turned a transparent orange-brown color after adjustment to 
pH 7, but remained a transparent yellow color after adjustment to pH 3 (Fig. 1a).  Despite their 
different visual appearances, the two solutions had fairly similar b*-values (Table 1). Curcumin 
is known to be more structurally stable in acidic solutions than in neutral or alkaline solutions 1. 
At relatively high level of hydroxide ions in the aqueous phase under neutral or alkaline 
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conditions rapidly degrades curcumin, which leads to a rapid color change 1, 13. The initial 
aqueous solutions containing curcumin did not contain any colloidal particles and therefore it 
was not possible to measure the particle size, charge, or microstructure. 
3.3.1.2 Curcumin emulsion 
 The 1% w/w oil-in-water emulsions containing curcumin initially had a homogeneous 
cloudy yellow appearance at both pH values (Fig. 1a). Moreover, the b*-values were very similar 
for the emulsions under both acidic and neutral conditions, being around +60.4 (Table 1).  
Notably, the curcumin-loaded emulsions did not have the orange-brown color that was observed 
in the aqueous solutions at neutral pH (Fig. 1a).  This result suggests that encapsulation of the 
curcumin within lipid droplets protected it from chemical degradation induced by hydroxyl ions 
or other constituents in the aqueous phase.  
 Static light scattering and particle electrophoresis were used to measure the initial mean 
particle diameter and surface potential of the droplets in the curcumin emulsions. The pH of the 
aqueous phase did not affect the mean droplet diameter (D43= 0.27  0.01 m) or the particle size 
distribution (Fig. 1b), but it did affect the surface potential (Table 1). The curcumin-loaded lipid 
droplets had a relatively strong negative  -potential at pH 7 ( = −20.3 mV), but a slightly 
positive  -potential at pH 3 ( = +0.2 mV). The pH dependence of the  -potential of lipid 
droplets coated by a non-ionic surfactant can be attributed to two effects.  First, there may be 
preferential adsorption of anionic hydroxyl ions to the droplet surfaces at relatively high pH 
values, and adsorption of cationic hydrogen ions at relatively low pH values 168.  Second, the oil 
or surfactant ingredients used to formulate the emulsions may contain ionic impurities, such as 
free fatty acids, that give the lipid droplets a charge 128.   
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 The microstructure of the curcumin emulsions, determined by confocal fluorescence 
microscopy, indicated that the lipid droplets were evenly distributed throughout the system at 
both pH values (Fig. 1c).  The individual lipid droplets could not be discriminated using this 
form of optical microscopy because they were below the limit of resolution. 
3.1.3 Filled alginate beads 
 The individual curcumin-loaded filled alginate beads were opaque spheres that had a 
milky yellow appearance.  After these beads were dispersed in aqueous solutions they rapidly 
moved to the bottom of the test tubes and formed cloudy yellow sediments, with the sediment 
layer being thicker at pH 7 than pH 3 (Fig. 1a).  The rapid downward movement of the beads can 
be attributed to the fact that they were relatively large and their densities were greater than that 
of the surrounding water 128.  The fact that a thicker sediment layer was formed at pH 7, suggests 
that the beads were more swollen under neutral conditions than under acidic conditions, which 
was confirmed by light scattering measurements (see later).  The alginate bead suspensions had 
similar yellow colors (b*  28) at both pH values (Table 1), but these b* values were only about 
half of those of the emulsions.  This effect may have been because the scattering of light by the 
beads decreased the color intensity 169.   
 The initial particle size distributions of the filled alginate beads in both the acidic and 
neutral solutions were monomodal (Fig. 1b), but the beads in the pH 7 solution (D43= 404 µm) 
were appreciably larger than those in the pH 3 solution (D43= 371 µm) (Table 1). This difference 
in bead dimensions can be related to changes in the electrostatic interactions in the systems 164, 
166.  At pH 7, the alginate molecules have a relatively high negative charge because this pH is 
well above the pKa value of the carboxyl groups (around pH 3.5) on the alginate chains.  
Consequently, there will be a relatively strong electrostatic repulsion between the anionic 
 46 
alginate chains that make up the hydrogel network, thereby causing the beads to swell. 
Conversely, the alginate molecules are less highly charged when the solution pH is below the 
pKa value of the carboxyl groups, and therefore there will be a weaker electrostatic repulsion 
between the alginate chains, causing the beads to be less swollen under acidic conditions 170.  As 
mentioned earlier, this effect would account for the fact that the thickness of the sediment layer 
at the bottom of the test tubes was greater at pH 7 than at pH 3 (Fig. 1a).  
 The electrical characteristics of the filled alginate beads also depended on solution pH 
(Table 1).  The surface potential of the beads was appreciably more negative at pH 7 (−17.4 mV) 
than at pH 3 (−12.7 mV), which can again be attributed to the change in the electrical charge on 
the alginate molecules when the pH is altered from above to below the pKa values of the 
carboxyl groups 166.  
 The microstructure of the filled alginate beads was characterized using confocal 
fluorescence microscopy at both pH values (Fig. 1c).  Filled alginate beads incubated in both 
acidic and neutral pH conditions had similar structures, consisting of large spheres with lipid 
droplets (stained red) distributed inside. There was no evidence of any lipid droplets in the 
aqueous phase surrounding the alginate beads, which indicated that the encapsulation efficiency 
was high.  
3.3.1.4. Filled chitosan beads 
 The individual filled chitosan beads also had a milky yellow appearance when observed 
by eye, which can be attributed to selective absorption of light waves by the encapsulated 
curcumin molecules.  When the filled chitosan beads were suspended in aqueous buffer solutions 
they rapidly moved downwards and formed a sediment at the bottom of the test tubes.  However, 
in this case the sediment layer was thicker at pH 3 than at pH 7 (opposite to the alginate beads), 
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and the sediment layer formed was thinner than for the alginate beads.  Again, the rapid 
sedimentation of the chitosan beads can be attributed to their relatively large size and high 
density.   The fact that a thinner sediment layer was formed for the chitosan beads than for the 
alginate beads can be attributed to the fact that the latter beads were more swollen (trap more 
water).  Moreover, the thicker sediment layer formed under acidic conditions can be attributed to 
the fact that the chitosan beads were more swollen at pH 3 than at pH 7.  Indeed, the light 
scattering measurements confirmed that the mean particle diameter of the chitosan beads 
incubated at pH 3 (D43= 255 µm) were larger than those incubated at pH 7 (D43= 239 µm) (Table 
1).  This effect can again be attributed to the impact of electrostatic interactions on the swelling 
behavior of the beads 171, 172.  At a pH well below the pKa value of the amino groups ( 6.5), the 
chitosan chains have a high positive charge, and so there is a strong electrostatic repulsion 
between them, which leads to swelling of the beads.  Conversely, at a pH above the pKa value, 
the chitosan chains have a lower positive charge, and so there is a weaker electrostatic repulsion 
between them, leading to less swelling.  The instrumentally determined yellow color (b* value) 
of the chitosan bead suspensions was fairly similar at both pH values, and was appreciably less 
than that measured in the emulsions (Table 1).  As discussed earlier, this latter effect may have 
been because the hydrogel beads scattered light, thereby leading to some color fading.   
 The surface potential (ζ-potential) of the chitosan beads was highly dependent on the pH 
of the buffer solution in which they were incubated (Table 1). The chitosan beads initially had a 
relatively high negative charge at pH 7 (-22.7 mV), but a small positive charge at pH 3 (+0.8 
mV).  The electrical charge on the chitosan molecules in solution is known to change from 
highly positive at acidic pH to slightly positive at neutral pH 173.  The fact that the chitosan beads 
had a strong negative charge at pH 7 in our study may therefore have been due to the fact that the 
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chitosan molecules were cross-linked with tripolyphosphate ions (P3O10
5-), and so the net charge 
was dominated by the strongly anionic multivalent ions rather than by the weakly cationic 
chitosan molecules.  
 The particle size distributions (Fig. 1b) of the chitosan beads were monomodal at both pH 
3 and 7, but as mentioned earlier, the beads were slightly larger under acidic than under neutral 
conditions (Table 1), which was attributed to a greater degree of electrostatic repulsion between 
the chitosan chains.  The morphology of the chitosan beads was observed by confocal 
fluorescence microscopy, which indicated that they had a more irregular shape and were smaller 
than the alginate beads (Figure 1c).  The smaller dimensions of the chitosan beads suggest that 
the polysaccharide molecules were more densely packed within the hydrogel matrix, which may 
account for the thinner sediment layer formed by these systems than for the alginate beads (Fig. 
1a). The lipid droplets (stained red) appeared to be exclusively located inside the chitosan beads, 
which suggested that they had a high encapsulation efficiency.   
3.3.1.5 Comparison of delivery systems 
  Our results indicate that encapsulation of curcumin within the lipid droplets inhibited the 
color change from yellow to brown-orange that was observed at pH 7 in the aqueous solutions.  
This effect was observed in both the emulsions and in the filled hydrogel beads.  The origin of 
this effect can be attributed to differences in the molecular environment of the curcumin in the 
different delivery systems.  In the aqueous solutions, the curcumin is exposed to relatively high 
levels of hydroxyl ions at neutral pH, which promotes its chemical degradation.  In the lipid 
droplets, the curcumin is surrounded by oil molecules, and is therefore more protected from 
direct contact with the hydroxyl ions. 
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 The different characteristics of the various delivery systems will determine the type of 
products that they can be utilized in.  Aqueous solutions could be used in optically transparent 
products, whereas emulsions could be used in optically opaque products.  The fact that the 
emulsions had good creaming stability means that that could be used in either low or high 
viscosity products.  Conversely, the filled hydrogel beads could only be used in optically opaque 
high viscosity products, otherwise they would rapidly sediment.  Alternatively, the delivery 
systems could be converted into a powdered form (e.g., by spray or freeze drying), and then 













Fig. 1 a) Appearances, b) Particle size distributions c) microstructure of different curcumin-loaded delivery systems 
before and after being storage under acidic or neutral conditions at 55C for 14 days. The delivery systems consisted 
of curcumin dispersed in aqueous solutions, emulsions or filled hydrogel beads. a) The picture on the right shows 
the presence of sediments at the bottom of the test tubes containing the aqueous solutions. C)The microstructures 
were obtained using confocal fluorescence microscopy, and the lipid phase appeared red due to the presence of Nile 





Table.1 The impact of pH on the initial yellow color (b*), mean particle diameter (D43) and electrical characteristics 
(-potential) of curcumin-loaded delivery systems: aqueous solutions; emulsions; filled alginate beads; and, filled 




















































3.3.2. Influence of delivery system type on storage stability of encapsulated curcumin  
 The impact of delivery system type on the chemical stability of curcumin was 
investigated by incubating the samples in acidic (pH 3) and neutral (pH 7) conditions at 55 C 
for 14 days and then measuring the change in color (Fig. 2).  The initial rate of color degradation 
was estimated by calculating the slope of the lines in the initial region where the plots were 
approximately linear (Fig. 3).  In addition, the changes in the physicochemical and structural 
properties of the particles in the delivery systems were measured throughout storage.     
3.2.1. Curcumin solution  
  Visual observation of the aqueous solutions containing curcumin after 14-days storage 
indicated that a noticeable color change occurred at both pH values, with much more extensive 
color fading at pH 7 than pH 3 (Fig. 1a).  There was also an appreciable decrease in the 
yellowness of the curcumin solutions measured using a colorimeter, with the b* value decreasing 
to 17% of its original value at pH 3 and to 73% of its original value at pH 7 (Fig. 2).  Moreover, 
the initial rate of color fading was appreciably higher at neutral conditions than at acidic 
conditions (Fig. 3).  These results are in agreement with previous studies that have reported that 
curcumin is much more unstable to chemical degradation at neutral or alkaline conditions, than 
at acidic conditions 19.  Curcumin may be more stable in acidic solutions because the phenolic 
group is protonated, which stabilizes its conjugated diene structure, whereas it is de-protonated at 
  Aqueous Solution Emulsion Filled Alginate Beads Filled Chitosan Beads 
  pH 7 pH 3 pH 7 pH 3 pH 7 pH 3 pH 7 pH 3 
b* 65.5±2.8 a 67.5±3.1 a 60.4±3.1 b 60.4±3.5 b 26.5±4.6 d 28.6±2.1 d 34.3±1.5 c 33.1±2.9 c 
D43 (m)   0.27±0.03 
d 0.27± 0.04 d 404±15 a 371±10 b 239±21 c 255±19 c 
ζ (mV)   −20.3±0.7 
b 0.28±0.55 e −17.4±2.1 c −12.7±1.0 d −22.7±1.9 a 0.74±0.58 e 
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pH 7, which destabilizes it 49, 50, 174.  The curcumin solutions did not become completely colorless 
at the end of the storage period, which suggests that some of the reaction products formed during 
their chemical degradation were colored.  Moreover, there was evidence of some curcumin 
precipitation in the aqueous solutions during storage, with a thin layer of sediment being 
observed at the bottom of the test tubes (Fig. 1a). 
3.3.2.2. Curcumin emulsions 
 Visual observation of the curcumin emulsions indicated that appreciable color fading 
occurred when they were stored at pH 7, but there was little change when they were stored at pH 
3 (Fig. 1a).  Instrumental color measurements also showed that there was much more color 
fading at neutral conditions than at acidic conditions, with the b*-value decreasing to 33% of its 
original value at pH 7 but to 93% of its original value at pH 3 (Fig. 2).  In addition, the initial 
rate of color fading was much faster at pH 7 than pH 3 (Fig. 3).  The rate and extent of color 
fading was considerably less in the emulsions than in the aqueous solutions at both pH values, 
which suggested that encapsulation of curcumin within the hydrophobic interior of lipid droplets 
protected it from chemical degradation. No sediments were observed at the bottom of the test 
tubes containing the curcumin-loaded emulsions, which suggests that the presence of the lipid 
droplets also prevented curcumin precipitation.  
 The mean particle diameter of the lipid droplets in the emulsions was similar at both pH 
values, and did not change appreciably during the 14-day storage period, remaining around D43= 
0.27 ± 0.01 m (data not shown).  The confocal fluorescence microscopy images of the 
emulsions taken after 14-days storage also indicated that they were stable to aggregation, with 
small droplets being evenly distributed throughout the images (Fig. 1c). The surface potential of 
the lipid droplets also did not change appreciably during storage, with the ζ-potential remaining 
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around -0.4 ± 0.5 mV at pH 3 and around -21.2 ± 1.0 mV at pH 7 (data not shown).  Overall, 
these results indicate that the emulsions were stable to droplet aggregation under the 
experimental storage conditions used.  It should be noted that a small amount of creaming was 
observed in the emulsions after 14-days storage (Fig. 1a), which may have been because there 
was a small population of relatively large droplets that moved upwards due to gravity.   
 
Table 2. Influence of acidic and neutral incubation on the diameters of hydrogel beads. Samples designated with 
different letters (a, b, c) were significantly different (Duncan, p<0.05).  
 
  Initial Bead Diameter (m) Final Bead Diameter (m) % of Swelling 
Alginate beads (pH 7) 404±15 a 480±7 A +19.3±3.7 
Alginate beads (pH 3) 371±10 b 331±9 C −10.8±3.8 
Chitosan beads (pH 7) 239±21 cD 245±26 cD −1.9±5.0 
Chitosan beads (pH 3) 255±19 cD 436±18 B +72±11 
 
3.3.2.3. Filled alginate beads 
 The curcumin encapsulated in the alginate beads was highly unstable to chemical 
degradation when stored at both acidic and neutral conditions, with the degradation rate being 
faster at pH 7 than at pH 3 (Fig. 2).   The initial rate of color degradation was actually much 
higher in the filled alginate beads than in either the aqueous solutions or the emulsions at pH 3 
(Fig. 3), which suggests that the local molecular environment inside the alginate beads actually 
promoted curcumin degradation under acidic conditions.  Conversely, the initial rate of curcumin 
degradation was much less in the alginate beads than in the aqueous solutions at pH 7, but 
considerably higher than in the emulsions (Fig. 2).  Since both the emulsions and filled alginate 
beads contained curcumin-loaded lipid droplets, this result suggests that the microenvironment 
inside the alginate beads also promoted curcumin degradation at neutral conditions.   The local 
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pH inside a hydrogel can be appreciably different from the pH in the surrounding aqueous phase 
175, which may have altered the stability of the curcumin to degradation.  However, further 
studies are needed to identify the precise molecular origin of this interesting finding. 
 The impact of pH on the physicochemical and structural properties of the filled alginate 
beads during storage was also measured (Fig. 4). As mentioned earlier, the initial diameter of the 
alginate beads was higher at pH 7 than at pH 3 because of the stronger electrostatic repulsion 
between the alginate chains within the hydrogel matrix 164, 166. At pH 7, the mean particle 
diameter of the alginate beads increased appreciably during storage, from around 404 µm 
initially to 482 um after 14-days storage, which corresponds to a 19% increase in dimensions.  
Conversely, at pH 3, the mean particle diameter increased slightly during the first three days of 
storage, but then decreased appreciably at longer storage times.  Overall, the mean particle 
diameter of the alginate beads incubated under acidic conditions decreased from around 371µm 
initially to 331 µm after two-weeks storage, which corresponds to a 11% decrease in size.  The 
swelling of the alginate beads under neutral conditions and shrinkage under acidic conditions 
was also observed in the confocal fluorescence microscopy images (Fig. 1c).  These images also 
showed that the beads remained spherical throughout storage, and that the lipid droplets 
remained trapped inside them. 
 The swelling of the beads at pH 7 may have occurred because of slow molecular 
rearrangements of the alginate chains within the hydrogel matrix during storage as they tried to 
increase the distance between their neighbors driven by the strong electrostatic repulsion 
between them.  Alternatively, swelling may have occurred at neutral pH because some of the 
calcium ions leached out of the hydrogel matrix into the surrounding aqueous phase due to ion 
exchange with sodium ions from the phosphate buffer, thereby allowing the alginate chains to 
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move further apart from each other 170.  The shrinkage of the alginate beads at pH 3 may have 
occurred because the alginate molecules underwent molecular rearrangements during storage that 
allowed them to adopt a more compact structure, since there would be less electrostatic repulsion 
between them at this pH.  Alternatively, some of the alginate molecules at the surfaces of the 
hydrogel beads may have degraded or dissociated under acidic conditions, and then moved into 
the surrounding aqueous phase i.e., surface erosion 170.    
  At pH 3, the surface potential (ζ -potential) of the alginate beads remained relatively 
constant throughout storage (Fig. 5), which suggested that there was little change in the 
composition or structure of the bead surfaces.  Conversely, at pH 7, the ζ -potential of the 
alginate beads became more negative during storage (Fig. 5), which suggested that there was 
some change in their surface composition or structure.  This increase in negative charge supports 
the hypothesis that some of the cationic calcium ions may have leached out of the hydrogel beads 
during storage.     
3.2.4. Filled chitosan beads 
 The chemical stability of curcumin was appreciably different when it was encapsulated in 
chitosan beads than in alginate beads (Fig. 2).  At pH 7, encapsulation of curcumin in the filled 
chitosan beads greatly retarded the rate and extent of color degradation compared to the aqueous 
solution and emulsion.  Moreover, the chemical degradation rate was much slower in the 
chitosan beads than in the alginate beads (Fig. 3).  These results clearly show that the molecular 
environment of curcumin plays a key role in determining its chemical stability.  At pH 7, the 
biopolymer network within the chitosan beads would be expected to be relatively compact, as 
highlighted by the small particle size (Fig. 1b), thin sediment layer formed (Fig. 1a), and high 
packing density of the lipid droplets within the beads observed by confocal microscopy (Fig. 1c).  
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Consequently, one would expect the pore size of the biopolymer network inside the beads to be 
relatively small under these conditions, which may have inhibited the ability of aqueous phase 
components to interact with the curcumin-loaded lipid droplets.  Alternatively, the high level of 
amino-groups associated with the chitosan chains may have enhanced the chemical stability of 
the encapsulated curcumin, since recent studies suggest that the interaction of curcumin with 
amino groups may inhibit its degradation around neutral pH 176.  At pH 3, the color loss occurred 
more rapidly when the curcumin-loaded lipid droplets were encapsulated within chitosan beads 
rather than being freely dispersed within the aqueous phase (Figs. 2 and 3), which suggests that 
the presence of the chitosan network actually promoted curcumin degradation.  On the other 
hand, the stability of the curcumin was appreciably higher in the chitosan beads than in the 
alginate beads. The origin of these effects is currently unknown, but again highlights the 
importance of the molecular environment of the chitosan on its stability. 
 The physicochemical and structural properties of the chitosan beads were also measured 
during storage.  At pH 7, the mean particle diameter of the beads remained relatively constant 
throughout storage (Fig. 4), which was supported by the confocal microscopy images taken after 
14-days storage (Fig. 1c).  Moreover, the thickness of the sediment formed at the bottom of the 
test tubes was fairly similar at the beginning and end of storage (Fig. 1a).  Taken together, these 
results suggest that the chitosan beads did not swell, shrink, or dissociate when stored under 
neutral conditions.   Conversely, there was a progressive increase in the mean particle diameter 
of the chitosan beads during the first 10 days of storage at pH 7 (Fig. 2).  Indeed, the mean 
particle diameter of the beads increased from around 255 µm initially to 436 µm after 14-days, 
which corresponds to an increase in diameter of about 72% (Table 1).  Interestingly, the confocal 
microscopy images indicated that the chitosan beads changed from relatively small irregular 
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particles at the beginning of the storage period to large spheres at the end (Fig. 1c).  However, 
the lipid droplets still remained trapped within the chitosan beads at the end of the incubation 
period.  The swelling of the chitosan beads under acidic conditions was also demonstrated by the 
large increase in the thickness of the sediment layer at the bottom of the test tubes after 2-weeks 
storage (Fig. 1a).  The high degree of swelling observed in the chitosan beads at pH 3 may have 
been because of the strong electrostatic repulsion between the strongly cationic chitosan 
molecules.  Consequently, the structural organization of the chitosan chains within the hydrogel 
beads changed over time so that they could get further apart 177. Alternatively, some of the 
tripolyphosphate molecules may have diffused out of the beads during storage, thereby 
decreasing the number of cross-links between the chitosan molecules. 
 The electrical characteristics of the chitosan beads changed appreciably during storage at 
both pH values, which suggested that their surface composition or structure changed.  At pH 3, 
the ζ -potential of the chitosan beads became progressively more positive during storage (Fig. 5), 
which may have occurred because some of the negatively charged tripolyphosphate ions diffused 
out of the beads.  At pH 7, the ζ -potential of the chitosan beads became less negative during 
storage (Fig. 5), which again may be indicative of the loss of tripolyphosphate ions.  The 
leaching out of these ions during storage would therefore account for the observed increase in 
bead dimensions during storage, since there would be fewer cross-links between the chitosan 
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Fig.2. Influence of acidic and neutral pH conditions on yellow color (b*) degradation in different types of curcumin-
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Fig.3. Influence of acidic and neutral pH conditions on the initial rate of color degradation in different types of 
curcumin-loaded delivery systems during storage at 55 C. 
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Fig. 4. Influence of storage pH on the mean particle diameter of curcumin-loaded filled alginate or chitosan beads 
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Fig. 5.     Influence of storage pH on the surface potential (-potential) of curcumin-loaded filled alginate or chitosan 




3.3.2.5 Comparison of delivery systems 
 Our results indicate that there were major differences in the chemical and physical 
stability of the different delivery systems during storage.  The aqueous curcumin solutions were 
highly unstable to color fading and precipitation, and would therefore be unsuitable as delivery 
systems for commercial applications.  The curcumin-loaded emulsions had good physical 
stability at both pH values, and provided the best protection against chemical degradation at pH 7 
of all the systems studied.  Consequently, they would be the most suitable delivery systems for 
application in commercial products with pH values around neutral.  However, the curcumin-
loaded emulsions were prone to rapid color fading at pH 7, and would therefore not be suitable 
















































 Compared to the emulsions, the alginate beads appeared to accelerate curcumin 
degradation at both pH values, and would therefore be unsuitable as delivery systems.  
Moreover, there were appreciable changes in the dimensions of the alginate beads during 
storage, which might also be undesirable for many commercial applications (see below). The 
chitosan beads also appeared to be less suitable than the emulsions for encapsulation of curcumin 
under acidic conditions, since there was a more rapid degradation rate (Fig. 3).  On the other 
hand, the rate of color loss was appreciably lower in the filled chitosan-beads than in the 
emulsions at pH 7, which suggested that this type of bead may be more suitable for application in 
commercial products with pH values around neutral.  However, appreciable swelling of the 
chitosan beads occurred during storage at pH 3.  Changes in the dimensions of hydrogel beads 
during storage may have a number of important implications for their practical applications as 
delivery systems.  Typically, the apparent shear viscosity or elastic modulus of hydrogel 
suspensions increases/decreases when they swell/shrink because this increases/decreases the 
disperse phase volume fraction 178, 179. The optical properties and stability to gravitational 
separation of hydrogel beads may also be altered appreciably when their particle dimensions 
change 180.  The pore size of the hydrogel matrix within the beads will increase/decrease when 
they swell/shrink, which may impact the retention and release of any encapsulated components 
164, 166.  The pH dependent changes in the dimensions of the hydrogel beads may be particularly 
important when they are used to control the delivery of bioactive components within the human 
gastrointestinal tract, where the pH changes appreciably as one moves through the mouth, 
stomach, small intestine and colon 170.  Consequently, there may be undesirable alterations in the 




 This study has provided some valuable insights into the design and development of 
curcumin delivery systems.  It is often assumed that encapsulation of a bioactive component 
within a delivery system will improve its chemical stability, but as shown in this study, this is not 
always the case.  For instance, encapsulation of curcumin-loaded lipid droplets within alginate 
beads actually decreased their chemical stability under both acidic and neutral conditions.  
Consequently, it is important to carefully select the most appropriate delivery system for each 
application.  In this study, it was shown that oil-in-water emulsions were the most effective 
delivery systems for curcumin at pH 3, since they gave the best protection against chemical 
degradation and remained physically stable.  Moreover, they are simpler, quicker and cheaper to 
fabricate that filled hydrogel beads, which would be an advantage for many commercial 
applications.  On the other hand, filled chitosan beads appeared to give the best protection 
against curcumin degradation at pH 7.  However, these beads were prone to substantial swelling 
during storage, which would limit their application in some products. In future studies, it would 
be interesting to identify the molecular basis for differences in the stability of curcumin in 


















4. Impact of delivery system type on curcumin bioaccessibility: comparison of 
curcumin-loaded nanoemulsions with commercial curcumin supplements 
4.1. Introduction 
 Curcumin, a bioactive constituent found in turmeric, has been shown to have anti-
oxidative and anti-inflammatory properties that provide the basis for its application as a 
nutraceutical or pharmaceutical to inhibit or treat certain diseases, such as rheumatoid arthritis, 
cystic fibrosis, inflammatory bowel disease, and colon cancer 3, 150, 181. In foods, curcumin can 
also be used as a natural pigment because it has a desirable yellow-orange color.  Curcumin has a 
relatively low toxicity and is generally regarded as safe (GRAS) by the United States Food and 
Drug Administration (FDA).  The potentially beneficial biological activities exhibited by 
curcumin has led the pharmaceutical, supplement, and food industries to develop forms suitable 
for oral ingestion, such as pills, capsules, powders, foods, and drinks 1, 13, 132, 182. However, there 
are a number of hurdles that have to be overcome before curcumin can be utilized in these 
products, including its high melting point, low water-solubility, alkaline degradation, and low 
oral bioavailability 183.  
 The oral bioavailability and bioactivity of curcumin is known to depend on the physical 
form that it is delivered in. Studies have reported that encapsulation of curcumin within colloidal 
particles enhances its bioavailability 132, 146, 183-186. Many of the conventional technologies used to 
incorporate curcumin into colloid dispersions utilize either heating or organic solvents, which 
both have technical challenges 13, 187, 188. The main disadvantage of using heating methods is that 
curcumin chemically degrades at high temperatures, which leads to a loss of its biological 
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activity 13, 184.  On the other hand, the main disadvantage of using organic solvent methods is that 
they are environmentally unfriendly and costly 88, 189.  Consequently, there is interest in 
developing alternative approaches for incorporating curcumin into colloidal delivery systems. 
 Recently, a novel pH-driven method has been developed to incorporate hydrophobic 
molecules, such as curcumin, into colloid delivery systems without using heating or organic 
solvents 92-94, 190.  This method is based on the fact that the water-solubility of curcumin is highly 
dependent on solution pH.  Curcumin is practically insoluble in water under acidic and neutral 
conditions, but highly soluble under alkaline conditions because it is a weak Brønsted acid with 
three labile protons at high pH values (pKa = 7.5, 8.5, and 9.5) 
4, 13, 191. Consequently, the water-
solubility of curcumin increases when the pH increases above neutral because the molecules 
becomes progressively more negatively charged.  Conversely, when the pH of an alkaline 
curcumin solution is reduced, the negative charge on the curcumin is reduced and it becomes 
insoluble. The pH-driven method utilizes this phenomenon to load curcumin into oil-in-water 
emulsions.  The curcumin is first dissolved in an alkaline solution, which is then mixed with an 
acidified emulsion.   When the pH of the entire system decreases the curcumin becomes 
insoluble and is driven into the interior of the oil droplets. 
 The main objective of the current study was to compare the pH-driven method of loading 
nanoemulsions with curcumin with two more commonly used methods: the conventional method 
and the heat-driven method.  The conventional method involved dissolving powdered curcumin 
in an oil phase and then blending this with an aqueous phase to form a curcumin-loaded 
nanoemulsion.  The heat-driven method involved forming a nanoemulsion first, then adding 
powdered curcumin, and then incubating the mixed system at an elevated temperature to cause 
the curcumin crystals to dissolve and move into the oil droplets.  The loading capacity and 
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bioaccessibility of curcumin in nanoemulsions prepared using the three different loading 
methods was compared. In addition, the efficacy of the nanoemulsion-based delivery systems 
prepared in this study were compared to those of three commercial formulations in terms of their 
ability to increase curcumin bioaccessibility.  Due to the increasing trend towards clean-labels in 
the food industry, all-natural ingredients were utilized to fabricate the curcumin-loaded 
nanoemulsions.  The results of this study should have important implications for the design and 
formulation of more efficacious nutraceutical delivery systems. 
4.2. Material & Methods 
4.2.1 Materials 
 Corn oil was purchased from a local supermarket and used without further purification 
(Mazola, ACH Foods, Cordova, TN). Curcumin supplements produced by Nature Made (Nature 
Made Nutritional Products, Mission Hills, CA), Full Spectrum (Solgar, Inc., Leonia, NJ), and 
CurcuWin (Relentless Improvement® LLC, Reno, NV) were also purchased from an on-line 
supplier (Amazon.com). The following chemicals were purchased from the Sigma-Aldrich 
Chemical Company (St. Louis, MO): curcumin (C1386-10G, purity  65%); mucin from porcine 
stomach (M2378-100G); pepsin from porcine gastric mucosa (P7000-25G); lipase from porcine 
gastric mucosa (L3126-100G); porcine bile extract (B8831-100G); sodium hydroxide (SS266-
4L), and Nile Red (N3013-100MG). Quillaja saponin (Q-Naturale® 200) was provided by 
Ingredion Inc. (Westchester, IL).  
 The three commercial curcumin supplements had different physical forms.  The Nature 
Made (NM) and CurcuWin (Win) products were powders, whereas the Full Spectrum (FS) 
products was a liquid.  The NM product appeared to be prepared by directly adding powdered 
curcumin into capsules with other inactive ingredients.  However, the Win product appeared to 
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be prepared using a patented technology (UltraSol®) from Omniactive Healthy Technologies 
(Canada), which involves incorporating curcumin into food-grade nanoparticles with 
antioxidants. The FS product was a water-soluble form containing curcumin stabilized by a 
synthetic surfactant (Polysorbate 80). 
4.2.2 Preparation protocol 
 The curcumin nanoemulsions were prepared using three different approaches: the 
conventional method; heat-driven method; and, pH-driven method. 
4.2.2.1. Conventional method  
 Curcumin-loaded nanoemulsions were produced using the conventional method by 
dispersing powdered curcumin into an oil phase (corn oil) prior to homogenization. A weighed 
amount of curcumin powder was added to the oil phase (3 mg/g) and then the mixture was 
incubated at 60 C for 2 hours to ensure fully dissolution. The aqueous phase was prepared by 
mixing Quillaja saponin (2% w/w) with phosphate buffer solution (10 mM, pH 6) for 5 min. A 
coarse emulsion was then formed by blending 10% (w/w) of curcumin-loaded oil with 90% 
(w/w) of aqueous phase for 2 min using a high-speed blender (M122.1281-0, Biospec Products, 
Inc., ESGC, Switzerland). A nanoemulsion was then formed by passing the coarse emulsion five 
times through a high-pressure homogenizer (Microfluidizer M-110Y, Microfluidics, Newton, 
MA USA) with a 75-m interaction chamber (F20Y) at an operating pressure of 12,000 psi. The 
resulting curcumin nanoemulsion was stored at 4 C in the dark before being used. The 
nanoemulsions were then diluted 1:1 (w/w) using double distilled water so that the final system 
contained 0.15 mg curcumin per g emulsion for the in vitro studies. 
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4.2.2.2. Heat-driven method 
 Curcumin-loaded nanoemulsions were prepared using the heat-driven method by mixing 
powdered curcumin with heated nanoemulsions. The stock nanoemulsions were fabricated by 
homogenizing 10% (w/w) oil phase (corn oil) and 90% (w/w) aqueous phase (2 % w/w Q-
naturale, 10 mM phosphate buffer, pH 6) using the same approach as described for the 
conventional method. Powdered curcumin (0.3 mg/g) was then added to the stock nanoemulsion 
and the resulting mixture was incubated at 100 C for 15 min in the dark with constant stirring.  
This system was then diluted 1:1 (w/w) with double distilled water to obtain a final system 
containing 5% oil and 0.15 mg curcumin /g emulsion. 
4.2.2.3 pH-driven method 
 The curcumin-loaded nanoemulsions fabricated using the pH-driven method were 
prepared by mixing an alkaline solution of dissolved curcumin with a stock nanoemulsion, which 
was slightly acidic (pH 6). An alkaline curcumin solution (6 mg/g, pH 12.5) was prepared by 
adding powdered curcumin into an alkaline solution (0.1N sodium hydroxide) and then stirring 
for 2 min in the dark at ambient temperature. The alkaline curcumin solution was then added to a 
stock nanoemulsion (prepared using the same method as for the heat-driven method) to reach a 
final concentration of 0.3 mg curcumin per g emulsion. The mixed nanoemulsion formed has 
immediately adjusted back to pH 6 and then stirred for 30 min in the dark at ambient 
temperature. Again, the samples were diluted with double distilled water to obtain a final system 
containing 5% oil and 0.15 mg curcumin per g emulsion. 
4.2.2.4 Commercial curcumin supplements  
 Initially, the curcumin concentration of each product was determined based on a standard 
curve prepared using pure curcumin. The curcumin was extracted from each sample using 
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chloroform. The samples were diluted with double distilled water to obtain final systems 
containing 0.15 mg of curcumin per g sample.  
4.2.3 Optical properties 
 The optical properties of curcumin dispersions prepared using different fabrication 
methods was characterized by measuring their color coordinates. An instrumental colorimeter 
(ColorFlex EZ 45/0-LAV, Hunter Associates Laboratory Inc., Virginia, USA) was used to 
determine the color coordinates: L* (lightness/darkness); a* (redness/greenness); and b* 
(yellowness/blueness). An aliquot of sample (10 mL) was placed in a Petri dish, and then 
illuminated using D65-artificial daylight (10 standard angle) with a black background. Three 
replicate measurements were taken and averaged to represent the final results. Only the b* and 
L* values are reported here because they best represent the yellow color and lightness of the 
curcumin-loaded systems.  
4.2.4 simulated gastrointestinal digestion 
4.2.4.1 General  
 A gastrointestinal tract (GIT) model was used to analyze the effect of delivery system 
type on the potential gastrointestinal fate of curcumin. The model mimicked the mouth, stomach, 
and small intestine stages of the GIT.  An equal amount of each sample (30 mL) was transferred 
into a glass beaker and then incubated at 37 C in a shaking incubator (Innova Incubator Shaker, 
Model 4080, New Brunswick Scientific, New Jersey, USA). Each sample contained 0.15 mg 
curcumin per g sample, while all the emulsions containing the same level of oil (5% w/w).  
2.4.2 Oral phase 
 An artificial saliva stock solution (ASSS) was prepared and used within 2 days of the 
study. The ASSS was fabricated by mixing sodium chloride (1.594 g/L), ammonium nitrate 
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(0.328 g/L), potassium phosphate (0.636 g/L), potassium chloride (0.202 g/L), potassium citrate 
(0.308 g/L), uric acid sodium salt (0.021 g/L), urea (0.198 g/L), lactic acid sodium salt (0.146 
g/L) with double distilled water (1 L) and storing at 4C overnight. Then, a stock simulated 
saliva fluid (SSF) was prepared by adding 90 mg mucin into 30 g ASSS and stirred overnight at 
4 C before the digestion study.  
 For the oral phase study, the initial sample (30 mL) and SSF (30 mL) were heated to 37 
C for 10 min prior to starting. The two samples were then transferred into a glass beaker after 
incubation and the pH was adjusted to 6.8. The resulting mixture was then placed into a shaking 
incubator operating at 100 rpm and 37 C for 2 min to mimic oral conditions.   
4.2.4.3 Stomach phase 
 Initially, a simulated gastric fluid work solution (SGFWS) was prepared by adding pepsin 
(3.2 mg/g) into stimulated gastric fluid (SGF) and then stirring for 40 min at room temperature. 
The SGF was produced by fully dissolving sodium chloride (2 g/L) and hydrochloric acid (83.3 
mM/L or 7 mL/L) into double distilled water at room temperature. The remaining SGF solution 
was placed into the refrigerator (4C) before experiments.  The sample and SGF were preheated 
to 37 C for 10 min before each study.  Samples (40 g) collected from the mouth phase were 
mixed with SGF (40 g) and then adjusted to pH 2.5. The samples were then continuously 
agitated for 2 hours using an incubator shaker set at 100 rpm and 37 C.  
4.2.4.4 Small Intestine phase 
 Initially, three solutions containing intestinal constituents were prepared and incubated in 
a water bath (37C): stock simulated intestinal fluids (SIF); bile salt solution; and, lipase 
solution. The stock SIF was prepared by fully dissolving calcium chloride (5.5 g) and sodium 
chloride (32.87 g) in 150 ml double distilled water. The bile salt solution was prepared by mixing 
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porcine bile extract (53.57 mg/mL) with phosphate buffer (5 mM, pH 7) overnight at room 
temperature with continuous stirring. The lipase solution (24 mg/ mL) was prepared 30 min 
before utilization by mixing powdered lipase with phosphate buffer (5 mM, pH 7).  
 Samples collected from the stomach phase (60 g) were transferred into a water bath at a 
temperature of 37 C. An automatic titration unit (Metrohm, USA Inc.) was used to monitor and 
maintain a neutral pH in the sample. First, the sample was adjusted to pH 7, subsequently, 3 mL 
SIF containing (0.5 M CaCl2 and 7.5 M NaCl) and 7 mL bile salt solution (containing 375 mg 
bile extract) was added to the sample, which was then adjusted back to pH 7. Finally, 5 mL of 
lipase solution (containing 120 mg lipase) was added to this mixture and the automatic titration 
device was started.  The volume of alkaline solution (0.25 M NaOH solution) required to 
maintain a neutral pH was recorded throughout the digestion period. All solutions were 
preheated to 37 oC for 5 min before being used. 
 The amount of NaOH solution required to neutralize the free fatty acids (FFA) released 
was recorded and used to estimate the fraction of FFA released 192: 





Here, FFA (%) is the percentage of released FFAs; VNaOH is the volume of titrant required to 
neutralize the FFA; mNaOH is the molarity of sodium hydroxide; Mlipid is the molecular weight of 
the oil used (grams per mole); and the “2” represents the fact that two FFAs are released from a 
triglyceride, and Wlipid is the mass (gram) of the oil in the digestion system. 
4.2.5 Particle characterization 
 A laser light scattering instrument (Mastersizer 2000, Malvern Instruments Ltd., Malvern, 
Worcestershire, U.K.) was used to measure the particle diameter and particle size distribution of 
the samples. A particle electrophoresis device (Zetasizer Nano, Malvern Instruments, Worcester- 
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shire, U.K.) was used to determine the ζ-potential values of the particles. The initial, mouth and 
small intestine samples were diluted with phosphate buffer (5 mM, pH 7), while the stomach 
samples were adjusted with acidified double distilled water (pH 2.5) to avoid multiple scattering 
effects. 
4.2.6 Microstructure analysis 
 A confocal scanning laser microscope (Nikon D-Eclipse C1 80i, Nikon, Melville, NY) 
was used to characterized the microstructure of the samples with a 200 magnification (20 
objective lens 10 eyepiece). The oil regions in the samples were stained by adding a 
hydrophobic fluorescence dye in the form of Nile red solution (1 mg/mL ethanol).  
4.2.7 Curcumin concentration determination 
 The level of curcumin in the initial samples, mixed micelle fraction, and total digest 
fraction were measured.  The curcumin concentration in the samples was quantified using an 
UV-visible spectrophotometer at a wavelength of 419 nm (Cary 100 UV−vis, Agilent 
Technologies, Santa Clara, CA, USA). Samples were collected after the small intestine phase 
and split into two portions: the mixed micelle fraction and the total digest fraction.  The mixed 
micelle fraction was transferred into a centrifuge tube and centrifuged (18,000 rpm, 25 C) for 50 
min (Thermo Scientific, Waltham, MA). The clear top layer of these samples was collected to 
represent the “mixed micelle fraction” where the curcumin was solubilized. The total digest 
fraction was used directly without any centrifugation. The concentration of curcumin in each 
fraction was determined by adding chloroform and then then centrifuging at 3000 rpm for 10 
min.  The hydrophobic curcumin moved into the chloroform layer.  The concentration of the 
curcumin in the separated chloroform layers was then determined using a standard curve 
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prepared by measuring the absorbance of known curcumin samples (Supplementary information 
Fig. 1). 
 The bioaccessibility of curcumin, which is the fraction in the small intestine that was 
solubilized in the mixed micelle phase (and therefore potentially available for absorption), was 
calculated using the following equation: 





 The stability of curcumin, which is the fraction remaining in the original state in the small 
intestine phase, was calculated using the following equation: 





Here, Cmicelle is the concentration of curcumin in the mixed micelle faction; Cdigest is the 
concentration of curcumin in the total digest; and, Cinitial is the curcumin concentration in the 
initial sample.  
4.2.8 Statistical analysis 
 All experiments were performed on at least three freshly prepared samples. The resulting 
data are measured as the mean ± standard deviation calculated from this data. Statistical 
differences among samples were determined using statistical analysis software (SPSS, IBM 
Corporation, Armonk, NY, USA), with p< 0.05 being considered as a significant difference.   
 
4.3. Results & discussion  
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4.3.1 Influence of curcumin loading method 
 Initially, the impact of the three different loading methods on the formation and 
properties of the curcumin-loaded nanoemulsions was investigated: the conventional; heat-
driven; and, pH-driven.   
4.3.1.1 Influence of loading method on encapsulation efficiency 
 An equal amount of curcumin powder (150 g/mL) was used to prepare each 
nanoemulsion. However, the total amount of curcumin encapsulated within the nanoemulsions 
after fabrication was different: 140 μg/mL for the pH-driven method; 114 μg/mL for the heat-
driven method; and, 83 μg/mL for the conventional method (Table 1). Consequently, the 
encapsulation efficiency of the pH-driven method (93%) was considerably higher than that of the 
heat-driven (76%) or conventional (56%) methods.  There are a number of potential reasons for 
these differences.  First, the pH-driven method is carried out at ambient temperature and so there 
is little thermal degradation of the curcumin.  In contrast, both the heat-driven (100 C for 15 
min) and conventional (60C for 2 h) methods required a thermal processing step that could 
damage the curcumin. The fact that the amount of curcumin was lower in the nanoemulsions 
prepared using the conventional method suggests that the prolonged heating time used caused 
more extensive thermal degradation.  Second, the different loading methods may have resulted in 
different amounts of curcumin crystallization during the nanoemulsion preparation procedure. 
Previous studies have shown that curcumin dissolved at high temperatures may crystallize when 
the system is cooled 5, 187. In our study, we observed an orange precipitate at the bottom of the 
nanoemulsions prepared using the conventional method, which was presumably due to the 
formation and sedimentation of curcumin crystals (Fig 1a).  In contrast, no orange precipitate 
was observed for the heat-driven and pH-driven methods, which suggests that loading the 
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curcumin after the nanoemulsions have been formed inhibited crystallization, possibly because 
the lipid droplets always had small dimensions.  The solubility of substances is known to 
increase as the size of the particles they are contained within decreases due to a thermodynamic 
effect related to increased specific surface area 193.    
 The colorimetry measurements of the nanoemulsions supported the loading 
measurements. All samples had positive b-values and high L-values corresponding to materials 
with a yellowish color and strong lightness. As expected, the intensity of the yellow color of the 
nanoemulsions decreased with decreasing encapsulation efficiency: b* = 93, 87, and 73 for the 




 Conventional Heat-Driven pH-Driven  
Initial curcumin 
concentration (g/mL) 
83.3 ± 10.8 a 114.3 ± 8.5 b 139.7 ± 3.8 c 
Loading capacity (%) 55.5 ± 7.2 a 76.2 ± 5.2 b 93.2 ± 2.3 c 
L* 121.2 ±0.5c 118.9 ± 0.2b 117.8 ± 0.3a 
b* 72.7 ± 0.5 a 87.0 ± 0.2 b 92.2 ± 1.8 c 
D32 (m) 0.17 ± 0.02 
a 0.20 ± 0.00 b 0.18 ± 0.01 ab 
ζ- potential (mV) -45.2 ± 1.3 a -44.6 ± 1.7 a -45.3 ± 1.8 a 
 
Table 1. The influence of the fabrication method on the initial curcumin concentration, loading capacity, tristimulus 
color value (b*), mean particle diameter (D32) and electrical characteristics (ζ- potential) of curcumin lipid 

















Fig. 1.  a. Appearances of curcumin-loaded lipid nanoparticles prepared using different methods. b. the percentage 
of curcumin loading capacity of different methods on lipid nanoparticle. The lowercase letter means significantly 
different (Duncan, p < 0.05) between samples.  
 
 
4.3.1.2 Influence of loading method on gastrointestinal fate of curcumin nanoemulsions 
 
 The impact of loading method on the gastrointestinal fate of the curcumin-loaded 
nanoemulsions was monitored using a simulated GIT. The particle size distribution (Fig. 2), 
mean particle diameter (Fig. 3), microstructure (Fig. 4) and  -potential (Fig. 5) of samples 
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collected from nanoemulsions exposed to mouth, stomach and intestinal phase were fairly 
similar to each other.  This similarity can be attributed to the fact that all the nanoemulsions 
initially contained similar droplet sizes, compositions, and charges.   
4.3.1.2.1 Initial  
 Initially, the particle size distributions (PSDs) of the curcumin-loaded nanoemulsions was 
monomodal and the mean particle diameters were relatively small (d32 < 200 nm) (Figures 2 and 
3). The confocal microscopy images indicated that the lipid droplets were evenly distributed 
throughout the samples, indicating they were stable to flocculation.  Interestingly, the light 
scattering data and the microscopy images indicated that the nanoemulsions prepared using the 
heat-driven method contained slightly larger droplets than the other two systems. This may have 
been because these nanoemulsions were held at a high temperature during their preparation, 
which may have caused some droplet aggregation.  Indeed, previous studies have shown that 
lipid droplets coated with quillaja saponins undergo some aggregation at elevated temperatures 
194.   
 All the curcumin-loaded lipid droplets initially had a relatively high negative surface 
potential (ζ > -40 mV) (Table 1), which can be attributed to the presence of carboxylic acid 
groups that have pKa values around pH 3.5 
194, 195.  This relatively high surface potential is 
important for nanoemulsion stability because it generates a strong electrostatic repulsion between 
the lipids droplets 128.  The fact that all the samples had similar surface potentials suggests that 
the interfacial composition was not highly dependent on the curcumin-loading method used. 
4.3.1.2.2 Oral phase  
 The PSDs of all the nanoemulsions were still monomodal after exposure to simulated oral 
conditions, but the mean particle diameter increased compared to the initial samples (Figs. 2 and 
3). Moreover, the confocal microscopy images indicated that there were some larger particles in 
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the samples (Fig. 3), which is indicative of droplet aggregation.  The magnitude of the surface 
potential on the particles in the samples changed from around -40 mV to around -30 mV after 
exposure to the simulated saliva. These effects can be attributed to the presence of mineral ions 
and mucin molecules in the saliva.  The mineral ions screen the electrostatic repulsion between 
the lipid droplets while the mucin molecules can promote depletion and/or bridging flocculation 
196-198.  
4.3.1.2.3 Stomach phase 
 The PSDs became bimodal after exposure to the stomach phase with a population of 
relatively small particles and another population of relatively large particles (Fig. 2). As 
expected, this led to an increase in the mean particle diameter of the samples compared to the 
mouth phase (Fig. 3). The confocal microscopy images indicated that many of the lipid droplets 
in these samples were clustered together (Fig 3).  Taken together, these results are characteristic 
of the lipid droplet aggregation that is often observed under simulated gastric conditions 196, 199. 
The surface potentials of the particles became slightly positive (≈ +1 mV) after exposure to the 
stomach phase due to the relatively low pH and high ionic strength of the simulated gastric fluids 
(Fig. 5). Specifically, the low pH leads to protonation of the carboxylic acid groups on the 
adsorbed surfactant molecules while the mineral ions cause electrostatic screening 132, 199.  
4.3.1.2.4 Small Intestine 
 The PSDs of all the samples were relatively broad after exposure to the simulated small 
intestinal phase (Fig. 2), which reflects the fact that there are many kinds of colloidal particles 
present after digestion, including micelles, vesicles, calcium-fatty acid soaps, and undigested 
lipid droplets 200. The mean particle diameter of the samples in the small intestine phase was 
fairly similar to that in the stomach phase (Fig. 3) but does not reflect the broad range of particle 
sizes present. The confocal microscopy images indicated that most of the lipid droplets had been 
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digested, but that there were some relatively large lipid-rich particles present.  The surface 
potential of the particles was negative (-20 mV) due to the fact that most of the constituents 
making up the colloidal particles in the neutral intestinal fluids are anionic, such as bile acids, 
free fatty acids, saponins, and peptides.  
4.3.1.3 Influence of loading method on lipid digestion profile 
 In this section, the impact of the curcumin loading method on the lipid digestion profiles 
of the nanoemulsions was investigated using an automatic titration unit. The volume of sodium 
hydroxide (NaOH) solution required to maintain neutral pH in the samples when they were 
exposed to simulated small intestinal conditions was monitored.  This volume was then used to 
calculate the fraction of FFAs released. Overall, the FFA release profiles of the three 
nanoemulsions were very similar (Fig. 6). The amount of FFAs released increased rapidly during 
the first 10 min and then gradually increased for the remainder of the digestion period. These 
results are consistent with previous studies that have also reported that the small lipid droplets in 
nanoemulsions are rapidly digested by lipase because of their high surface area 132, 160, 201.  
Overall, these results indicate that the curcumin loading method used to prepare the 
nanoemulsions did not have a major impact on lipid digestion. 
4.3.1.4 Influence of loading method on physiochemical characteristics of mixed micelles 
 The impact of the curcumin loading method on the properties of the mixed micelles 
formed at the end of the small intestine phase was also investigated.  Initially, the raw digest was 
centrifuged to remove any large particles such as insoluble calcium-fatty acid soaps and 
undigested lipid droplets. The size and electrical characteristics of the particles remaining in the 
clear mixed micelle phase were then measured.  The mean particle diameter of the mixed 
micelles collected from all three curcumin nanoemulsions was fairly similar: d32 = 146 ± 2 nm, 
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136 ± 2 nm and 158 ± 2 nm for the conventional, heat-driven, and pH-driven methods, 
respectively.  Similarly, the surface potentials of the mixed micelles from each sample were also 
relatively similar: ζ-potential = -21 ± 3 mV, -26 ± 3 mV and -21 ± 2 mV, respectively. The 
negative charges on the mixed micelles can be attributed to the fact that they were mainly 
comprised of neutral (monoacylglycerols) and anionic (bile salts and free fatty acids) molecular 
species 132, 200.  These results suggest that the loading method did not have a major impact on the 
nature of the mixed micelles formed after digestion.   
4.3.1.5 Influence of loading method on curcumin bioaccessibility and stability  
 After the small intestinal phase, the curcumin concentration in the raw digest and mixed 
micelle phases were measured to determine the impact of loading method on the bioaccessibility 
and stability of the curcumin in the nanoemulsions. The level of curcumin in the raw digest 
represents the amount of curcumin remaining in the small intestine after digestion, i.e., the 
fraction that has passed through the mouth, stomach, and small intestine without chemically 
degrading. The concentration of curcumin in the mixed micelle phase represents the curcumin 
molecules that were chemically stable and solubilized within the mixed micelles. The amount of 
curcumin in the mixed micelle phase and in the raw digest were affected by the loading method 
used: pH-driven > heat-driven > conventional method (Fig. 7a). This effect can be attributed to 
differences in the initial encapsulation efficiency of the three nanoemulsions, which decreased in 
the same order (Fig. 1a).  As would be expected, a higher level of curcumin in the initial 
nanoemulsions led to a higher level of curcumin in the small intestine. These results suggest that 
the pH-driven method is the most effective at delivering a higher absolute amount of curcumin to 
the small intestine.  However, when the curcumin concentrations are normalized to the total 
amount of curcumin in the digest, then the overall bioaccessibility was relatively independent of 
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the loading method used (Fig. 7b).  This would also be expected because there would have been 
proportionally higher levels of curcumin in both the mixed micelles and digest.    
  Another important factor that impacts the overall bioavailability of curcumin is its 
stability to degradation within the gastrointestinal tract.  The fraction of curcumin that remained 
after the small intestine phase was therefore determined relative to the initial amount in each 
system (Fig. 7b).  The fraction of curcumin remaining decreased in the following order: 
conventional > heat-driven > pH-driven method.  This suggests that the curcumin was more 
stable in the nanoemulsions prepared using the conventional method than those prepared using 
the pH-driven method.  The effect may have occurred because some of the curcumin was in a 
crystalline form in the nanoemulsion prepared using the conventional method and was therefore 
more resistant to chemical degradation by aqueous phase components.  Even so, the curcumin 
was relatively stable in all three systems, with > 80% remaining by the end of digestion.  It 
should be noted that our in vitro GIT model did not include the Phase I and Phase II metabolic 
enzymes that are present in the human gastrointestinal tract, which means that changes in 
curcumin due to metabolism were not accounted for.  Curcumin is known to undergo 
considerable metabolism in the GIT and therefore future studies should take this phenomenon 











Fig. 2. Particle size distributions of curcumin-loaded nanoparticles prepared using different fabrication methods 




Fig. 3. Influence of simulated gastrointestinal condition on the mean particle diameter (d32) of the curcumin loaded 
lipid nanoparticles. Different lowercase letters mean significant difference (Duncan, p < 0.05) of the particle charge 
in samples within the same digestion phases; Different capital letters mean significantly different (Duncan, p < 0.05) 





















































































Fig. 4. Influence of simulated gastrointestinal condition on microstructure of the curcumin emulsion that prepared 
using different technics. The images were determined using confocal fluorescence microscopy with a scale length of 

































Fig. 5 Influence of simulated gastrointestinal condition on the particle charge of the curcumin loaded lipid 
nanoparticles. Different lowercase letters mean significant difference (Duncan, p < 0.05) of the particle charge in 
samples within the same digestion phases; Different capital letters mean significantly different (Duncan, p < 0.05) of 
a sample particle charge between digestion phase.  
 
4.3.2 Gastrointestinal fate of commercial curcumin supplements 
 Curcumin supplements are already commercially available and are sold in many 
supermarkets, pharmacies, health food shops, and on-line retailers.  These supplements come in a 
variety of physical forms, including capsules, pills, fluids, and powders.  The precise physical 
form of the curcumin within a supplement has a major impact on its bioaccessibility and 
stability.  For this reason, we measured the gastrointestinal fate of three curcumin supplements 
purchased from an on-line supplier: Nature Made (NM), Full Spectrum (FS) and Curcuwin 
(Win).  The curcumin supplements from NM and Win were in a powdered form, whereas the one 
from FS was in a liquid form (contained inside capsules).   The commercial curcumin samples 
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were removed from their capsules prior to testing and the capsules themselves were not used 
because they would interfere with the subsequent analysis.  
4.3.2.1 Initial characteristics of curcumin supplements  
 Initially, the general properties of the three curcumin supplements used were established 
based on information reported on the manufacturers label and visual observations.  The active 
ingredient in the NM supplement were reported to be a turmeric blend containing curcuminoids 
(47.5 mg), while the inactive ingredients were cellulose gel, gelatin, water, stearic acid, 
magnesium stearate, and silicon dioxide (in descending weight). These inactive ingredients have 
been reported to have a variety of functions in supplements, including acting as lubricants, 
suspending agents, stabilizers, and flow enhancers 203-206. In addition, other functions have been 
reported for specific types of these inactive ingredients.  Cellulose prolongs the shelf life of 
supplements by protecting powdered curcumin from oxygen, humidity, and enzymatic 
degradation 206.  Stearic acid and magnesium stearate act as emulsifying and solubilizing agents 
that can improve the water-dispersion and oral bioavailability of hydrophobic substances 204. 
 The active ingredient in the fluid FS supplement was reported to be curcuminoids, while 
the inactive ingredients were polysorbate 80, gelatin, and vegetable glycerin. Polysorbate 80, 
also known as Tween 80, is a synthetic non-ionic surfactant that can improve the water-
dispersibility of curcumin by spontaneously forming nanoemulsions or microemulsions in 
aqueous gastrointestinal fluids 207. Gelatin is a gel-forming protein used to form soft gel capsules 
that protect curcumin during storage and within the mouth, but then dissociate and release it 
within the stomach 208. Glycerin acts as a cosolvent that facilitates the spontaneous formation of 
microemulsions and emulsions in gastrointestinal fluids 209.  
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 The active ingredient in the Win supplement was reported to be curcuminoids, while the 
inactive ingredients were reported to be polyvinylpyrrolidone (PVP), cellulose, and mixed 
tocopherols. PVP is a synthetic water-soluble amphiphilic polymer that increases the water-
dispersibility of curcumin by encapsulating it within small colloidal particles 210-212. Cellulose 
functions as a stabilizer and lubricant that enhances bioactive stability and powder flowability 205, 
206. Mixed tocopherols are a natural antioxidant that inhibit the chemical degradation of active 
ingredients such as curcumin 7. 
4.3.2.2 Digestibility on curcumin supplements 
 Each commercial curcumin formulation was passed through the same simulated GIT used 
to test the nanoemulsions and then the concentrations of curcumin in the mixed micelles and raw 
digest were measured.  The bioaccessibility and stability of the curcumin in the commercial 
formulations was then calculated from this data.  The initial amount of curcumin in each of the 
original commercial products was different: 8.8, 6.6 and 21.8% for NM, FS, and Win, 
respectively.  For this reason, the samples were mixed with different levels of distilled water 
prior to being exposed to the simulated GIT so that each one contained the same final amount of 
curcumin (150 µg /g water) as in the nanoemulsions.    
 Analysis of the amount of digestible materials in the commercial supplements was carried 
out using the pH stat method.  However, only a small volume of 0.25 M NaOH solution had to 
be added to maintain the samples at neutral pH throughout the small intestine phase (< 0.6 mL), 
which suggested that there was little or no digestible material present (data not shown).  This 
would be expected because most of the inactive ingredients present in the supplements were 
indigestible. Presumably, the proteins in those samples that contained gelatin (NM and FS) had 
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already been digested by pepsin in the stomach phase before they reached the small intestine 
phase.        
4.3.2.3 Properties mixed micelles and digest of commercial curcumin  
 The absolute amount of curcumin solubilized in the mixed micelles by the end of the 
small intestine phase decreased in the following order for the different supplements: Win >> 
FS > NM (Fig. 7).  This effect can mainly be attributed to differences in the initial water-
dispersibility of the products.  A large amount of sediment was observed at the bottom of the test 
tubes containing the NM supplements throughout the in vitro study, whereas, no precipitate was 
observed for the FS and Win supplements (Fig. 8).  This result suggests that the majority of 
curcumin from the NM supplements remained in the sediment and was not solubilized in the 
mixed micelles. The FS supplement had a significantly higher curcumin concentration in the 
mixed micelle phase than the NM supplement. This suggests that the presence of the non-ionic 
surfactant (polysorbate 80) increased the solubility of curcumin in the mixed micelles. The 
curcumin in the Win sample gave the highest curcumin concentration in the mixed micelles, 
which could be due to multiple reasons.  First, PVP forms polymeric micelles that can 
encapsulate hydrophobic curcumin molecules and enhance their solubility in the mixed micelle 
phase 210, 212. Second, mixed tocopherols act as an antioxidant that protects curcumin from 
chemical degradation within the intestinal environment 7.  Other studies have also reported that 
the stability and bioaccessibility of curcumin can be improved by co-encapsulating it with 
antioxidants in colloidal delivery systems 184, 211-213.  
 Interestingly, the total concentration of curcumin in the overall digest followed an 
opposite trend to that observed for the mixed micelles: NM > FS ≈ Win (Fig. 7). Initially, all the 
samples had the same initial curcumin concentration (150 µg/g), which suggests that some of the 
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curcumin had chemically degraded after exposure to the mouth, stomach, and small intestine 
phases.  The relatively high concentration of curcumin in the digest for the NM sample may have 
been because it was insoluble and therefore more stable to chemical degradation (Fig. 8).  
Conversely, the curcumin in the FS and Win samples was trapped inside small colloidal particles 
with a relatively high specific surface area and therefore were more susceptible to chemical 
degradation due to the presence of reactive substances in the surrounding aqueous phase.  It is 
known that curcumin is chemically unstable under neutral pH conditions, such as those found in 
the mouth and intestinal phases 3.  
4.3.2.3 Bioaccessibility and Stability 
 The bioaccessibility and stability of the curcumin in the commercial products was 
calculated based on the curcumin concentrations in the initial, raw digest, and mixed micelle 
phases.  The bioaccessibility of the curcumin from the Win (74%) sample was significantly 
higher than that from the FS (32%) and NM (10%) samples (Fig. 7).  Again, this can be 
attributed to the ability of the amphiphilic polymer (PVP) used in this product to facilitate the 
formation of micelles that enhance the solubility of curcumin in the GIT.  Conversely, the 
bioaccessibility of curcumin was lowest in the NM sample because it contained crystals that 
were difficult to solubilize.  The stability of the curcumin was slightly higher in the NM product 
than in the FS and Win products, which can again be attributed to the fact that some of the 
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Fig.6.  a. Influence of solid dispersion method on calculated free fatty acid release profile for curcumin-loaded lipid 
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Fig 7 a. Influence of the lipid nanoparticle and commercial non-lipid contained supplements on the curcumin 
concentration in mixed micelles and raw digesta. b. Influence of lipid nanoparticle and commercial non-lipid 
contained supplements on the bioaccessibility and remnant of curcumin. Different lowercase letters and capital 
letters both mean significant difference (Duncan, p < 0.05) of the particle charge in samples within the same 
digestion phases;  
 
4.3.4 Comparison of curcumin-loaded nanoemulsions and commercial supplements 
 Finally, the effectiveness of the curcumin-loaded nanoemulsions developed in this study 
was compared with the commercially available supplements for their ability to enhance the 
bioaccessibility and stability of curcumin.  The absolute amount of curcumin solubilized in the 
mixed micelle phase decreased in the following order: Win ≈ pH-driven > heat-driven > 
conventional >> FS > NM.  Thus, the nanoemulsions were better or similar to the commercial 
supplements at solubilizing the curcumin.  This was probably because the triacylglycerols in the 
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lipid droplets were converted into monoacylglycerols and free fatty acids that increased the 
solubilization capacity of the mixed micelles. Conversely, the total amount of curcumin present 
in the digest tended to be higher for the commercial supplements: NM > Win ≈ FS ≈ pH-driven > 
heat-driven > conventional.  This suggests that there was less chemical degradation of the 
curcumin in the commercial supplements, which may have been because the curcumin was in a 
crystalline form or because they contained antioxidants.   
 The bioaccessibility of curcumin calculated from this data decreased in the following 
order: pH-driven ≈ heat-driven ≈ conventional ≈ Win >> FS > NM.  These results suggest that all 
the nanoemulsions gave bioaccessibilities that were as good as the best commercial formulation 
and better than the other two.  The stability of the curcumin was fairly similar in both the 









4.4. Conclusion  
 In summary, this study demonstrated that curcumin nanoemulsions could be prepared 
using three different loading methods: conventional, heat-driven, or pH-driven.  The pH-driven 
method was the simplest to implement and gave the highest encapsulation efficiency.  This was 
because it did not involve any heating step, whereas the other two methods involved a step where 
the curcumin was held at an elevated temperature either in oil or an emulsion.  The curcumin 
nanoemulsion prepared by the pH-driven method gave a significantly higher curcumin 
concentration in the mixed micelles phase after exposure to a simulated GIT.  All the 
nanoemulsions developed in this study gave bioaccessibilities that were similar to those of the 
best commercial formulation tested.  However, our nanoemulsions were formulated entirely from 
natural ingredients, which may be beneficial for some consumer applications. 
 It should be noted that the different curcumin formulations were only tested using a 
relatively simple static in vitro gastrointestinal model.  This model cannot accurately simulate the 
complex events occurring within the human GIT, particularly metabolism carried out by Phase I 
and Phase II enzymes and absorption within the small intestine and colon.  Future studies should 
therefore focus on testing the different formulations using more realistic animal or human 












5. Impact of curcumin delivery system format on bioaccessibility: 
nanocrystals, nanoemulsion droplets, and natural oil bodies 
5.1. Introduction  
 Turmeric is commonly used in Asian cuisine as a natural pigment and spice due to its 
distinctive yellow-orange color and unique flavor profile 214.  It has also been utilized for 
thousands of years as a therapeutic agent in traditional Chinese and Indian medicine 215, 216.  
Curcumin is one of the principal bioactive compounds found in turmeric and is claimed to 
exhibit a range of health benefits, including the ability to prevent or treat cancer, depression, 
diabetes, obesity, pain, and stroke 150, 217.  Many researchers are now using the modern 
techniques and approaches of science and biomedicine to determine the molecular basis of its 
effects and to establish the veracity of these health claims.  The results of mechanistic studies, 
mainly carried out in laboratories, suggest that curcumin does have antioxidant, anti-
inflammatory, and antimicrobial properties, as well as modulating biochemical pathways that 
influence our health status 150, 218.  The findings from randomized clinical trials (RCTs), however, 
are inconclusive, with some suggesting that consumption of curcumin has beneficial effects and 
others not 219.   
 There are numerous challenges that food formulators face when trying to incorporate 
curcumin into functional foods and beverages, which are associated with its strong color, low 
water-solubility, poor chemical stability, and low bioavailability 220.  These same factors may 
also contribute to the inconsistent results obtained in clinical trials of curcumin’s efficacy, since 
the solubility, stability, and bioavailability of curcumin are rarely measured or controlled in these 
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studies 221.  Effective delivery systems are therefore needed to encapsulate and protect curcumin 
so that it can be successfully introduced into commercial foods and beverages in a bioactive form 
47.    
 Many different kinds of curcumin delivery system have been developed, including 
micelles, nanoemulsions, emulsions, liposomes, biopolymer nanoparticles, microgels and dietary 
fibers, which have been reviewed in detail elsewhere 47, 222-224.  Each of these systems has its own 
benefits and limitations for specific applications, which are influenced by numerous factors, 
including the ease of manufacture, cost, robustness, physicochemical properties, sensory 
attributes, loading capacity, and bioavailability 225.  Curcumin can be loaded into the colloidal 
particles used in delivery systems in a variety of ways.  For instance, in the case of emulsions, 
curcumin can be loaded into the oil phase before homogenization or incorporated into the oil 
droplets after homogenization.  Recently, a simple low-cost method has been developed to load 
curcumin into preformed colloidal particles, which is based on the pH-dependence of its water-
solubility 226.  Curcumin is non-charged at low pH values (< pH 8) and has a low water-solubility 
but it is negatively charged at higher pH values and so has a high water-solubility.  The pH-shift 
method utilizes this phenomenon to load curcumin into the hydrophobic interiors of colloidal 
particles, such as casein micelles 226, biosurfactant micelles 227, 228, and emulsions 229.  Typically, 
the curcumin is dissolved in a strongly alkaline solution which is then mixed with an acidic 
colloidal dispersion.  The reduction in the water-solubility of the curcumin at the lower pH drives 
it into the interior of the colloidal particles. 
 In the current study, we investigated the possibility of using the pH-shift method to create 
different kinds of curcumin-loaded delivery systems: curcumin nanocrystals: curcumin-loaded 
oil bodies (soy milk); and curcumin-loaded nanoemulsions.  The formation, physicochemical 
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stability, and gastrointestinal fate of these delivery systems was then measured, as well as their 
impact on the bioaccessibility of the encapsulated curcumin.  This study shows that the pH-shift 
approach is a simple and versatile method that can be used to load curcumin into a variety of 
different delivery systems, including plant-based milks and nanoemulsions.    
5.2. Material & Methods 
5.2.1 Materials 
 Corn oil (Mazola, ACH Foods, Cordova, TN) and soymilk (Dairy-free Soy Creamer, 
Silk, Broomfield, CO) were purchased from a local supermarket and used without further 
purification.  Curcumin (purity 95%) was obtained from Tokyo Chemistry Industries Company 
(Tokyo, Japan).  The following chemicals were purchased from the Sigma-Aldrich Chemical 
Company (St. Louis, MO): mucin from porcine stomach (M2378-100G); pepsin from porcine 
gastric mucosa (P7000-25G); lipase from porcine pancreas pancreatin (P8096-100G); porcine 
bile extract (B8831-100G); sodium hydroxide (SS266-4L); sodium chloride (S640-3); 
ammonium nitrate (A9642-500G); potassium phosphate (P285-500); Nile Red (N3013-100MG); 
potassium citrate in basic monohydrate (P1722-100G); uric acid sodium salt (U2875-5G); urea 
(51456-500G); lactic acid sodium salt (71718-10G); and, hydrochloric acid (A144212-2.5L). 
Potassium chloride (P217-500G) and calcium chloride (C1016-500G) were purchased from 
Fisher Scientific (Fair Lawn, NJ). Quillaja saponin (Q-Naturale® 200) was provided by 
Ingredion Inc. (Westchester, IL).  Chloroform and other reagents were all of analytical grade. 
5.2.2 Preparation protocol 
 The pH-driven method was used to produce three different kinds of colloidal delivery 
system: curcumin nanocrystals; curcumin-loaded lipid droplets; and, curcumin-loaded oil bodies.  
This method required the use of a stock alkaline curcumin solution (6 mg/g), which was prepared 
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by dissolving powdered curcumin into sodium hydroxide solution (0.1 N, pH 12.5) for 2 min in 
the dark at room temperature.  The behavior of the delivery systems was compared to that of a 
control, which consisted of curcumin powder dispersed directly into water.  All systems were 
prepared so they had the same final curcumin concentration: 0.25 mg/g.   
5.2.2.1 Control  
 The curcumin control was prepared by dispersing 7.5 mg of curcumin powder into 30 g 
of double distilled water and then stirring. 
5.2.2.2 Curcumin nanocrystals 
 Suspensions of curcumin nanocrystals in water were prepared using the pH-driven 
method.  The stock alkaline curcumin solution (6 mg/g) was diluted with double distilled water 
to reach a final concentration of 0.25 mg curcumin per g liquid. The resulting mixture was then 
immediately adjusted to pH 6.8 and stirred for 10 min in the dark at ambient temperature, which 
led to the spontaneous formation of curcumin nanocrystals.  
5.2.2.3 Curcumin-loaded lipid droplets 
 Curcumin-loaded nanoemulsions were also prepared using the pH-driven method.  The 
nanoemulsions used consisted of 10% (w/w) corn oil and 90% (w/w) aqueous emulsifier solution 
(2% Q-Naturale with 5 mM phosphate buffer solution, pH 6.8).  Initially, a coarse emulsion was 
prepared using a high-shear mixer to blend the oil and aqueous phases together for 2 min 
(M122.1281-0, Biospec Products, Inc., ESGC, Switzerland). These systems were then passed 
five times through a high-pressure homogenizer (Microfluidizer M110Y, Microfluidics, Newton, 
MA) with a 75-m interaction chamber (F20Y) at an operational pressure of 12,000 psi (83 
MPa).  The resulting nanoemulsions were then mixed with the stock alkaline curcumin solution 
and the mixture was immediately adjusted to pH 6.8 and stirred for 10 min in the dark at ambient 
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temperature.  Double distilled water was used to dilute the curcumin-loaded nanoemulsions so 
the final system contained 5% oil and 0.25 mg of curcumin per g emulsion. 
5.2.2.4 Curcumin-loaded oil bodies 
 Curcumin was loaded into commercial soymilk, which consists of soy oil bodies 
dispersed within a compositionally complex aqueous solution, using a similar protocol as used to 
load the nanoemulsions.  A known amount of stock curcumin alkaline solution (1.25g per 30 mL 
soymilk) was mixed with soymilk and then the mixture was immediately adjusted to pH 6.8. The 
resulting mixture was then stirred for 10 min in the dark at ambient temperature. The final 
system was diluted with double distilled water to reach a final concentration of 5% oil and 0.25 
mg curcumin per g soymilk.  
 The composition of the soymilk reported on its label was: soymilk (filtered water, 
soybeans), cane sugar, palm oil, maltodextrin, contains 2% or less of soy lecithin, natural flavor, 
tapioca starch, locust bean gum, dipotassium phosphate. 
5.2.3 Optical properties  
 The optical properties of the different systems were characterized using a colorimeter and 
digital camara. The instrumental colorimeter (ColorFlex EZ 45/0-LAV, Hunter Associates 
Laboratory Inc., Virginia, USA) was used to determine the color coordinates: L* (darkness / 
lightness); a* (redness / greenness); and b* (yellowness / blueness).  A test sample (10 mL) was 
placed in a petri dish and illuminated with a D65-artificial daylight (10° standard angle) with a 
black background.  The final values were obtained by averaging three replicate measurements 
per sample.  
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5.2.4 Simulated gastrointestinal tract model 
 A stimulated gastrointestinal tract (GIT), designed to mimic mouth, stomach, and small 
intestine stages of the human gut, was used to analyze the potential gastrointestinal fate of the 
curcumin-loaded delivery systems. An equal amount of each sample (30 mL), which contained 
0.25 mg of curcumin per gram of sample, was transferred into a glass beaker for analysis. The 
nanoemulsion and soymilk contained the same level of oil (5% w/w). This method was slightly 
modified from previous study 87, 192, 230 
5.2.4.1 Solution preparation 
 For the oral phase, the artificial saliva stock solution (ASSS) and the stock simulated 
saliva fluid (SSF) were prepared two days and one day before the study, respectively. The ASSS 
was produced by dispersing sodium chloride (1.594 g/L), ammonium nitrate (0.328 g/L), 
potassium phosphate (0.636 g/L), potassium chloride (0.202 g/L), potassium citrate (0.308 g/L), 
uric acid sodium salt (0.021 g/L), urea (0.198 g/L), and lactic acid sodium salt (0.146 g/L) into 
double distilled water (1 L) at 4C overnight.  A stock simulated saliva fluid (SSF) was prepared 
by mixing 90 mg of mucin into 30 g of ASSS and storing the mixture at 4C overnight before 
carrying out the digestions.  
 For the gastric phase, a simulated gastric fluid (SGF) and simulated gastric fluid work 
solution (SGFWS) were prepared. The SGF was prepared by fully dissolving sodium chloride (2 
g/L) and hydrochloric acid (83.3 mM/L) into double distilled water at ambient temperature and 
then stored at 4C overnight before being used.  The SGF was warmed to room temperature and 
then the SGFWS was prepared by adding pepsin (3.2 mg/g) into the SGF with continuous 
stirring for 30 min. 
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 For the small intestinal phase, stock simulated intestinal fluids (SIF), bile salt solution, 
and pancreatic lipase solution were prepared. The stock SIF was produced by dissolving calcium 
chloride (5.5 g) and sodium chloride (32.87 g) in 150 ml in the double distilled water.  The bile 
salt solution was prepared by continuously stirring porcine bile extract (53.57 mg/mL) with 
phosphate buffer (5 mM, pH 7) overnight at room temperature. Both stock solutions were stored 
at room temperature before being used.  The lipase solution was prepared by mixing 0.9 mg of 
pancreatic lipase into 5 ml phosphate buffer (pH 7) immediately before adding to the sample. 
5.2.4.2. GIT study  
 Curcumin-loaded samples were passed through stimulated mouth, stomach, and small 
intestine phases.  To stimulate the mouth phase, the initial sample (30 mL) and SSF (30 mL) 
were preheated to 37 C and transferred into a glass beaker.  The mixture was adjusted to pH 6.8 
and placed into a shaking incubator (Innova Incubator Shaker, Model 4080, New Brunswick 
Scientific, New Jersey, USA) with an operation of 100 rpm and 37 C for 2 min. 40 ml of the 
“bolus” sample collected from the mouth phase was then mixed with preheated SGFWS (40 mL) 
and adjusted the pH to 2.5.  The resulting mixture was agitated for 2 hours using the same 
incubator shaker.  Finally, the “chyme” (60 mL) samples collected from the stomach phase were 
transferred to a fresh beaker and incubated in a water bath set at 37 C.  The pH of the sample 
was adjusted to neutral (pH 7.0) to create a small intestinal environment.  Preheated SIF (3 mL) 
and bile salt solution (7 mL) were then added into the sample.  The pH was adjusted back to 
neutral.  Freshly prepared pancreatic lipase (5 mL) was then added to the mixture and the pH was 
again altered back to neutral.  An automatic titration unit (Metrohm, USA Inc.) was used to 
monitor and maintain the sample at pH 7.0 by addition of sodium hydroxide solution (0.25 M). 
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The volume of NaOH (VNaOH) required to neutralize the solution was used to calculate the 
percentage of free fatty acids released:  





Here, mNaOH is the molarity of sodium hydroxide solution (0.25 M); Mlipid is the molecular 
weight of the oil used; and, Wlipid is the weight of the oil used in the digestion system (gram).  
This equation assumes that two fatty acids are released per triglyceride molecule if the reaction 
goes to completion. 
5.2.5 Particle characterization  
 Two light scattering instruments were used to determine the particle characteristics 
during digestion. The mean particle diameter and particle size distribution were analyzed using a 
laser light scattering instrument (Mastersizer 2000, Malvern Instruments Ltd., Malvern, 
Worcestershire, U.K.). The ζ-potential values were determined using a particle electrophoresis 
device (Zetasizer Nano, Malvern Instruments, Worcestershire, U.K.).  pH-adjusted double 
distilled water was used to dilute the samples collected from the mouth, stomach, and small 
intestinal phases, which had the same pH as the sample. 
5.2.6 Microstructure analysis 
 The microstructure of the samples was characterized using light and confocal scanning 
fluorescence microscopy (Nikon D-Eclipse C1 80i, Nikon, Melville, NY, USA).  The properties 
of the crystalline curcumin in the initial samples was determined using light microscopy with a 
cross-polarized lens (C1 Digital Eclipse, Nikon, Tokyo, Japan).  Confocal scanning laser 
microscopy with a 200-fold magnification (20  objective lens, 10 eyepiece lens) was used to 
determine the location of the oils and proteins in the samples. Nile red (1 mg/mL ethanol) and 
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FITC (1mg/mL DMSO) dye solutions were used to stain the oils (red) and proteins (green) in the 
samples, respectively. The microstructure images were taken and analyzed using analysis 
software (NIS-Elements, Nikon, Melville, NY).  
5.2.7 Determination of curcumin concentration 
 A UV-visible spectrophotometer (Cary 100 UV−Vis, Agilent Technologies, Santa Clara, 
CA, USA) was used to determine the curcumin concentration in the initial samples, mixed 
micelle fraction, and total digest fraction.  An organic solvent, chloroform, was used to extract 
curcumin from each sample by centrifuging at 3000 rpm for 10 min.  The hydrophobic curcumin 
was transferred into the chloroform layer.  The curcumin concentration was then determined 
using the UV-Vis spectrophotometer at a wavelength of 419 nm, and calculated based on a 
standard curve prepared by measuring the absorbance of the known curcumin amounts 
(Supplementary information Fig. 1).  
5.2.7.1. Encapsulation Efficiency 
 The encapsulation efficiency of each delivery systems was determined using the 
following expression: 
 Encapsulation Efficiency = 100  Cencapsulated / Cinitial 
Here Cinitial and Cencapsulated are the concentrations of curcumin initially added to the system and 
that was encapsulated within the delivery system. 
5.2.7.2. Bioaccessibility and Stability 
 After the small intestine phase, the samples were divided into two fractions: a micelle 
sample and a total digest sample. The micelle sample was transferred into a centrifuge tube and 
centrifuged (18,000 rpm, 25 C) for 50 min (Thermo Scientific, Waltham, MA).  The resulting 
mixed micelle fraction was then collected as the clear supernatant of the samples.  The total 
 101 
digest sample and the initial sample were analyzed without any further processing.  The 
concentration of curcumin in the mixed micelle (Cmicelle) and total digest (Cdigest) samples then 
calculated using the spectrometry that described on 2.7 and were used to calculate the 
bioaccessibility and stability of the curcumin-loaded samples. Here, the concentration of 
curcumin within the mixed micelle phase was represents the amount of curcumin that has been 
solubilized with in the micelle vesicle and potential available for absorption. The concentration 
of curcumin within the digest phase means the total amount of curcumin remained after 
digestion. The bioaccessibility was taken to be the percentage of curcumin solubilized in the 
small intestine that was solubilized within the mixed micelle phase, whereas the stability was 
taken to be the percentage of total curcumin that remained in the small intestine:  










The stability therefore provides information about the potential degradation of curcumin within 
the simulated GIT. 
5.2.8 Statistical analysis  
 Each experiment was repeated on at least three freshly prepared samples and the mean 
and standard deviation were calculated from these values.  Statistical differences among samples 
were determined using statistical analysis software (SPSS, IBM Corporation, Armonk, NY, 
USA), and significant difference was considered to be p < 0.05.   
5.3. Results & Discussion  
5.3.1 properties of initial curcumin-containing food matrices 
 Initially, the pH-driven method was used to form curcumin nanocrystals, curcumin-
loaded oil droplets, and curcumin-loaded oil bodies.  
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5.3.1.1 Encapsulation efficiency  
 The initial concentrations (CI) of curcumin in the three samples produced using the pH-
driven method were fairly similar to each other (Table 1), being around 230 g/mL sample.  The 
fact that the curcumin level in the samples was slightly less than the starting value (250 g/mL) 
can be attributed to some curcumin degradation during sample preparation.  Previous studies 
have reported that a small amount of curcumin is lost when it is solubilized in the strong alkaline 
solutions used in the pH-driven method 92, 93. These values correspond to an encapsulation 
efficiency (EE) of around 93%, which is relatively high for colloidal delivery systems. In 
addition, the commercial soy milk contains lecithin and palm oil that also helped to encapsulate 
curcumin within the soymilk. Therefore, Further study could force on using pure soy oil bodies 
to investigate their encapsulation efficiency. Overall, the pH-driven method was successfully 
loaded curcumin within the oil-based emulsion system and complex-formulated commercial 




 Control Nanocrystals Nanoemulsions Oil Bodies 
CI (µg/mL) 250.00 ± 0 a 233.00± 7.16 b 233.28± 11.10 b 234.58± 9.01b 
L* 6.64 ±0.80 a 25.81 ± 0.24 b 84.41 ±0.17  c 82.41± 0.10 c 
a* 2.96 ± 0.74 c -2.62 ± 0.13 c -6.85 ± 0.06 b -8.01 ± 0.09 a 
b* 7.15 ± 1.29 a 38.80 ± 0.75 b 80.48 ± 1.12 c 80.62 ± 0.48 c 
ζ- potential (mV) - - -55.75 ± 1.46 a -30.28 ± 1.87 b 
D32 (µm) - - 0.18 ± 0.02 b 0.41 ± 0.01 a 
Table 1. The initial curcumin concentration (CI), loading capacity, tristimulus color coordinates (L*, a*, b*), mean 
particle diameter (D32) and electrical characteristics (ζ- potential) of curcumin-loaded samples.  Samples designated 
with different letters are significantly different (Duncan, p < 0.05). 
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5.3.1.2 Curcumin structure and physical stability 
 The structure and location of the curcumin within the different samples were investigated 
using optical microscopy and digital photography (Fig. 1).  The microscopy images showed that 
the control sample contained relatively large curcumin crystals (Fig. 1b), while the photographs 
showed that these crystals rapidly sediment to the bottom of the test tubes (Fig. 1a).  Presumably, 
this phenomenon occurred because the curcumin crystals were relatively large and denser than 
water.  Consequently, they were particularly prone to gravitational separation in the form of 
sedimentation.   
 As expected, the curcumin nanocrystals formed by mixing the alkaline curcumin solution 
with water were much smaller than the curcumin crystals in the control (Fig. 1b), highlighting 
the ability of the pH-driven method to generate minute nutraceutical crystals.  The nanocrystals 
appeared to have thin needle-like structures that tended to associate with each other, probably 
because of hydrophobic attraction.  The curcumin nanoparticle suspensions were relatively stable 
to gravitational separation immediately after fabrication (Fig 1a), forming a cloudy dispersion 
with a relatively uniform appearance. Even so, when they were allowed to stand for 2 hours an 
orange sediment was observed at the bottom of the test tubes (Fig. 1a), suggesting that 
sedimentation still occurred, albeit at a slower rate than for the control.  This phenomenon can be 
attributed to the weaker gravitational forces acting on the nanocrystals.     
 Both the curcumin-loaded nanoemulsion and soymilk formed creamy yellow-orange 
dispersions with a uniform appearance, indicating that the oil droplets and oil bodies were stable 
to gravitational separation. No curcumin crystals were seen at the bottom of the test tubes or in 
the optical microscopy images when these samples were observed by visual inspection and 
optical microscopy (Figs. 1a and 1b). These results suggest that the pH-driven method was 
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successful in loading the curcumin into the hydrophobic interiors of the lipid droplets and oil 
bodies.  
5.3.1.3 Color coordinates 
 The color of the samples was quantified against a black background using an 
instrumental colorimetry (Table 1).  Here, L* is the light/dark axis, which varies from pure black 
(0) to pure white (100); a* is the red-green axis, which varies from strongly red (positive) to 
strongly green (negative); and, b* is the yellow-blue axis, which varies from strongly yellow 
(positive) to strongly blue (negative).   
 After stirring, the control, which consisted of curcumin powder dispersed in water, had a 
low lightness (L*= +6.64), a moderate yellowness (b*= +7.2) and a slight redness (a*= +2.96) 
(Table 1).  These color parameters can be attributed to the yellow-orange color brought by the 
curcumin crystals.  The suspension of curcumin nanocrystals had a higher lightness (L*= +25.81) 
and yellowness (b*= +38.80) than the control, and had a slight greenness (a*= -2.62) rather than 
redness (Table 1).  This effect can be attributed to the fact that the curcumin crystals were much 
smaller in this sample and so they scattered light more strongly and at different wavelengths 231. 
As a result, more light was reflected from the surface of the samples, leading to a higher 
lightness. Moreover, the scattered light encountered a higher number of curcumin crystals and so 
there was a greater degree of selective absorption of the light waves, leading to a more intense 
yellow color and a change from reddish to greenish.  
 Interestingly, the curcumin-loaded nanoemulsions and oil bodies prepared using the pH-
driven method had very similar color coordinates (Table 1). They both had relatively high L* 
values, strongly positive b* values, and slightly negative a* values, which suggests they had a 
bright yellow color with a tinge of green. These effects can be attributed to the ability of the lipid 
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droplets and oil bodies to scatter light waves strongly, as well as to the ability of the dissolved 
curcumin molecules to selectively absorb light waves 231, 232.  
5.3.1.4 Particle characteristics 
 It was not possible to determine the characteristics of the particles in the samples 
containing curcumin crystals using light scattering because they were highly non-spherical, 
having a needle-like structure. One of the assumptions in the analysis of the data for both static 
and dynamic light scattering instruments is that the particles are spherical.  For this reason, only 
the particle characteristics of the curcumin-loaded lipid droplets and oil bodies were measured.   
 The static light scattering measurements indicated that the nanoemulsions had a 
monomodal particle size distribution (PSD) and contained small lipid droplets, i.e., d32 < 200 nm 
(Table 1 and Fig. 2).  This indicates that the combination of emulsifier and microfluidizer used to 
prepare the nanoemulsions was effective at generating small lipid droplets.  The oil bodies in the 
soymilk had a bimodal PSD and contained somewhat larger particles (d32 > 400 nm) than those 
found in the nanoemulsions. The relatively large particles found in this commercial product are 
probably because the size of the oil bodies is determined by their natural origin, rather than 
homogenization. The broad particle size distribution may also have been because the soymilk 
contains a range of different types of colloidal particles and biopolymers, which could all have 
contributed to the light scattering signal.   
 As mentioned earlier, both the lipid droplets and oil bodies exhibited good stability 
against gravitational separation during storage.  According to Stokes’s Law, the velocity that a 
spherical particle moves through a fluid decreases as the particle size decreases, the fluid 
viscosity increases, and the density contrast decreases 128, 233.  The primary reason that the 
curcumin-loaded nanoemulsions were stable to creaming is the small size of the lipid droplets 
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then contain.  Conversely, the good stability of the curcumin-loaded the soymilk may have been 
because of the fairly small size of the oil bodies, as well as the increase in viscosity associated 
with the tapioca starch and locust bean gum used as thickening agents in this product.  
 The surface potential of the lipid droplets in the nanoemulsions (ζ = -55.8 mV) and the oil 
bodies in the soymilk (ζ = -30 mV) were both strongly negative (Table 1). A high surface 
potential is important for inhibiting particle aggregation in colloidal dispersions since it leads to a 
strong electrostatic repulsion 128, 233. The high negative charge on the lipid droplets in the 
nanoemulsions was attributed to the fact that they were coated with a layer of quillaja saponins, 
which are known to be strongly anionic due to the presence of carboxylic acid groups on their 
surfaces.  The high negative charge on the oil bodies in the soymilk may have been due to the 
fact that they are naturally coated by a layer of phospholipids and proteins that are anionic at 
neutral pH 234, 235.  
 The microstructure images of the nanoemulsion and soymilk further demonstrated the 
good aggregation stability of the lipid droplets and oil bodies (Figs.1 b and 5).  Both confocal 
fluorescence and light microscopy images of the curcumin-loaded colloidal systems indicated 
that no aggregation occurred. However, the soymilk was seen to contain particles that had a 
broad range of sizes (Fig 1.b), which agrees with the PSD measurements.  The wide range of 
particles in the soymilk may have been because of the natural variation in oil body dimensions 
236 or because it contained a range of other types of colloidal particles and biopolymers, such as 























Fig. 1.  (a) Appearances and (b) light microscopy images of curcumin-containing samples. The small bars in the 
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Fig. 2 Particle size distribution of curcumin-loaded emulsion and oil-bodies prepared using pH-driven method after 





5.3 Gastrointestinal fate of delivery systems 
 The curcumin-loaded nanoemulsion and soymilk samples were sequentially passed 
through artificial mouth, stomach, and small intestinal fluids to simulate passage through the 
human gut. Changes in the structural and physical properties of the samples were measured after 
exposure to each gastrointestinal stage. The two samples containing curcumin crystals dispersed 
in water, namely the control and nanocrystal samples, were not analyzed in these experiments 
because of difficulties in reliably characterizing their properties using light scattering techniques.   
5.3.1. Influence of the GIT on particle properties   
 Oral phase: After exposure to the oral phase, there was a small but significant increase in 
the mean diameter of the particles in the nanoemulsions (Figs. 2 and 3). In addition, the 
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magnitude of their negative charged decreased appreciably (Fig. 4). On the other hand, there 
appeared to be little change in the structural organization of the lipid droplets in the confocal 
microscopy images (Fig. 5). These results suggest that there was a small amount of lipid droplet 
aggregation under simulated oral conditions, which can be attributed to depletion or bridging 
flocculation caused by the mucin in the artificial saliva 197, 198. In addition, there may have been 
some electrostatic screening of the surface charge by electrolytes in the artificial saliva. In 
contrast, there was little change in the mean particle size or surface potential of the oil bodies in 
the soymilk after exposure to the simulated oral phase (Figs. 2 to 4). This suggests that the oil 
bodies may have been more resistant to aggregation in the artificial saliva, possibly because the 
mucin interacted with their surfaces less strongly 198, 237, 238. The confocal fluorescence 
microscopy images suggest that there may have been a small amount of clumping of the oil 
bodies in the oral phase (Fig. 5), but presumably the flocs formed were so weak that they were 
easily disrupted when the samples were diluted for the light scattering measurements.    
 Stomach phase: The nanoemulsions and soymilk behaved very differently under 
simulated gastric conditions.  There was no significant change in the mean particle diameter of 
the nanoemulsions when they moved from the oral to stomach phase but a huge increase in the 
size of the particles in the soymilk (Fig. 3). The PSD measurements and confocal fluorescence 
images indicated that there was only a small amount of lipid droplet aggregation in the 
nanoemulsions but extensive clumping of the oil bodies in the soymilk (Figs. 2 and 5).   
 The surface potential of the particles in both the nanoemulsions and soymilk were close 
to zero after exposure to the small intestine conditions (Fig. 4). This effect can be attributed to a 
number of physicochemical phenomena occurring in the stomach phase. First, any carboxylic 
acid and amino groups on the saponins, phospholipids, and proteins would have become 
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protonated in the highly acidic environment of the gastric fluids, leading to a reduction in 
negative charge and increase in positive charge.  Second, the electrolytes in the gastric fluids 
would have reduced the magnitude of the surface potential by screening the electrostatic 
interactions.  Third, the anionic mucin molecules arising from the artificial saliva may have 
bound to cationic patches on the surfaces of the particles.   
 The extensive aggregation of the oil bodies in the soymilk observed under gastric 
conditions may have been because the soy proteins on their surfaces became positively charged, 
thereby promoting bridging flocculation by anionic mucin molecules in the surrounding aqueous 
fluids.  Moreover, there would have been little electrostatic repulsion between the oil bodies 
because of their very low surface charge.  Hence, the oil bodies may also have aggregated due to 
the van der Waals and hydrophobic attraction between them 239, 240. In addition, the proteases 
(pepsin) in the gastric fluids may have hydrolyzed the proteins at the surfaces of the oil bodies, 
thereby reducing their aggregation stability 87.  Interestingly, the saponin-coated lipid droplets in 
the nanoemulsions were relatively stable to aggregation in the gastric fluids (Figs. 2, 3 and 5) 
even though they only had a very low surface potential (Fig. 4). This suggests that the saponin 
molecules formed a coating around the lipid droplets that was resistant to disruption in the 
gastric fluids.  Furthermore, this coating may have inhibited extensive aggregation because it 
generated a strong steric repulsion between the droplets. The good gastric stability of saponin-
coated lipid droplets has also been reported in previous studies 241, 242. 
 Small intestine phase: After incubation in the artificial intestinal fluids, the particles in 
the nanoemulsions remained relatively small (Figs. 2, 3 and 5).  On the other hand, most of the 
large aggregates observed in the stomach phase broke down when the soymilk was incubated in 
the intestinal fluids. After exposure to lipase, there is likely to be many different kinds of 
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colloidal particles present in the digest, including micelles, vesicles, calcium soaps, and 
undigested macronutrients, which all contribute to the light scattering signals used to measure the 
particle size and charge.  The confocal microscopy images also showed that both samples 
contained a wide range of different sized particles.  
 The particles in the digests arising from the nanoemulsions (-68 mV) and the soymilk (-
49 mV) had a strong negative charge.  This effect can be attributed to the fact that many of the 
constituents in the digestion are anionic at neutral pH, including the bile acids, free fatty acids, 
saponins, and peptides. 
Fig. 3 
 
Fig.3 The Mean particle diameter (d32) of the curcumin-loaded emulsion and oil-bodies under exposure to the 
simulated gastrointestinal tract model. Both Different lowercase and capital letters represent significant different 













Fig. 4 influence of stimulated gastrointestinal tract models on the surface charge of the curcumin loaded 
nanoemulsion and oil-bodies. Both Different capital and lowercase letters mean significant difference (Duncan, p < 







Fig. 5.  The microstructure of the curcumin-loaded nanoemulsion and oil bodies under exposure to gastrointestinal 
condition. the confocal microscope was used to obtain the photo with fluorescent dye and a scale length of 10 m. 
The red regions represent lipid and green means the protein  
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5.3.2. Lipid digestion profiles 
 The digestion of the components in the different delivery systems was measured during 
incubation in the small intestine phase using a pH-stat automatic titration unit (Fig. 6).  The 
volume of NaOH solution that had to be added to maintain a neutral pH within the reaction 
chamber was highly dependent on sample type.  There was little change for both samples 
containing only curcumin crystals dispersed in water (control and nanocrystals), which should be 
expected because they did not contain any digestible materials.  Conversely, there was a rapid 
increase in the volume of NaOH solution added to the nanoemulsion and soymilk samples during 
digestion, which suggests that the lipids in these samples had been easily digested by the lipase. 
Presumably, the lipase molecules adsorbed to the surfaces of the lipids droplets or oil bodies and 
hydrolyzed the triglycerides inside.  
 The percentage of free fatty acids (FFAs) released from these systems was calculated 
from the titration data (Fig. 6). These results show that the lipid phase was rapidly digested 
within the first 20 minutes of incubation in the small intestine phase, with slower digestion 
occurring at later times.  By the end of the small intestine phase, most of the lipids in the 
nanoemulsions (> 86%) and soymilk (> 84%) had been digested. This fact can be contributed on 
the relatively small particle diameter increased the surface area for the digest enzymes to 
approach 201, 243. These results suggest that the small triglyceride particles in both the 






























Fig. 6 a. The Calculated free fatty acid release profile for curcumin-loaded emulsion and oil bodies; b. influence of 




5.3.3. Properties mixed micelles and digest of curcumin delivery systems   
 Finally, the curcumin concentration in the mixed micelles and in the total digest collected 
at the end of the small intestine phase was measured for the various samples, and then the 
stability and bioaccessibility of the curcumin was determined (Fig. 7). This information is 
important because curcumin in a hydrophobic nutraceutical with a low water-solubility and poor 
chemical stability.  The concentration of curcumin in the total digest represents the fraction that 
survived throughout the entire simulated GIT model. The concentration of curcumin in the mixed 
micelles provides an indication of the fraction available for uptake by the epithelium cells.   
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 The level of curcumin in the total digest was significantly lower for the control samples 
than for any of the other samples (Fig 7a).  This was probably because some of the large crystals 
in the curcumin did not make it to the reaction chamber because they stuck to the side of the 
containers or remained at the bottom of the samples.  One would have expected the curcumin to 
be most chemically stable in the large crystals in the control sample because they have the lowest 
surface area exposed to water. There was no significant difference in the levels of curcumin in 
the total digest for the nanocrystals, nanoemulsions, or soymilk (Fig. 7a), suggesting they all had 
a similar effectiveness at protecting curcumin from chemical degradation.  Nevertheless, there 
was still a reduction in the total level of curcumin present in these samples compared to the 
amount added initially, with only about 71%-75% remaining (Fig. 7b). This suggests that there 
may have been some chemical degradation of the curcumin during its passage through the 
simulated human gut.  Curcumin is known to be highly unstable to degradation under neutral and 
basic conditions, so it is possible that some transformation of the curcumin molecules occurred 
during incubation in the simulated mouth and small intestine conditions.      
 The bioaccessibility was calculated from the ratio of curcumin in the mixed micelle phase 
to the total digest (Fig. 7b). The bioaccessibility of the curcumin was much higher in the 
nanoemulsions and soymilk than in the nanocrystal dispersions. This effect can be partly 
attributed to the fact that the free fatty acids and monoglycerides generated during lipid digestion 
combined with the phospholipids and bile salts in the small intestinal fluids to form mixed 
micelles with a higher solubilization capacity for curcumin. Moreover, the transfer of curcumin 
molecules from the colloidal particles into the micelles may have been easier when they were 
solubilized in the hydrophobic interiors of the lipid droplets and oil bodies than when they were 
present in a crystalline form. Interestingly, the bioaccessibility of the curcumin was slightly 
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higher in the soymilk than in the nanoemulsions (Fig. 7b). This suggests that the transfer of the 
curcumin molecules from the oil bodies to the mixed micelles may have been easier than from 
the saponin-coated oil droplets. It can be contributed on the additional lecithin and protein 
content within the soymilk product that helped to solubilize more curcumin. 
Fig. 7 
a                                                                         b 
˙  
Fig 7 a. influence of curcumin-loaded water, emulsion and oil bodies on curcumin concentration in mixed micelles 
and raw digest; b. and bioaccessibility and stability of curcumin. Different lowercase letters and capital letters both 
mean significant difference (Duncan, p < 0.05) of the particle charge in samples within the same digestion phases 
 
5.4. Conclusions  
 In conclusion, this study demonstrated the effectiveness of the pH-driven method to load 
curcumin into the lipid droplets in nanoemulsions, as well as the oil bodies in commercial 
soymilks. Moreover, it showed that the pH-driven method could also be used to form curcumin 
nanocrystals dispersed in water.  The pH-driven method there appears to be a versatile tool for 
creating different kinds of curcumin delivery systems.   
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 The curcumin-loaded nanoemulsion and soymilk had a homogeneous appearance and 
good stability to aggregation, which was attributed to the strong negative charge on the lipid 
droplets and oil bodies. Moreover, the curcumin appeared to remain solubilized within the 
hydrophobic domains of the lipid droplets and oil bodies, without any evidence of curcumin 
crystals being formed. There were appreciable differences in the behavior of the nanoemulsions 
and soymilk in the simulated GIT. In particular, the nanoemulsions appeared to be more 
susceptible to aggregation in the mouth phase, whereas the soymilk was much more susceptible 
to aggregation in the stomach phase.  Nevertheless, both systems led to a relatively high stability 
and bioaccessibility of the curcumin at the end of the small GIT model. In contrast, the curcumin 
nanocrystals had a relatively low bioaccessibility because there were fewer mixed micelles to 
solubilize the curcumin molecules.   
 Overall, our results show that curcumin can be loaded into different kinds of colloidal 
delivery system using the pH-driven method and that these systems can have a high 
bioaccessibility.  Consequently, the nanoemulsions and plant-based milk used in this system may 
be effective delivery systems for curcumin in functional food and beverage applications.  It 
should be noted that there are a number of limitations of the current study.  We did not include 
Phase I and II enzymes in our simulated gastrointestinal model, yet these are known to cause 
extensive metabolism of curcumin within the human gut.  In future studies, it will be important 
to test the curcumin-loaded delivery systems using more realistic in vitro models or, better still, 
using in vivo animal or human feeding studies.  It will also be important to ensure that the 
delivery systems can survive the harsh conditions that commercial foods and beverages 




6. Loading natural emulsions with nutraceuticals using the pH-driven 
method: Formation & stability of curcumin-loaded soybean oils bodies 
 
6.1 Introduction 
 Recently, there has been increasing interest in replacing animal-based and artificial 
ingredients in foods and beverages with plant-based alternatives 144.  This movement has largely 
been driven by the perceived benefits of plant-based foods on the health of both humans and the 
environment 244-246.  For this reason, the food industry is reformulating many of its existing 
products, as well as developing innovative new products, using plant-based components.  One 
category of product that has been particularly successful is plant-based milks and creams, such as 
those based on soybean, cashew, coconut, almond, hemp, and oat 247.  These products are often 
designed to have a similar appearance, texture, and flavor as their dairy-based counterparts.   
 Many plant-based milks and creams are formed by breaking down plant structures to 
release oil storage bodies, such as soybeans, almonds or cashews 247.  These oil bodies are a 
natural form of colloidal particle that consists of a triglyceride core surrounded by a layer of 
phospholipids and proteins 235, 248.  These oil bodies contribute many of the desirable 
physicochemical attributes to plant-based milks, including their opacity, mouthfeel, and flavor 
profile.  Like other types of colloidal particles, the aggregation stability of oil bodies is 
determined by the nature of the attractive and repulsive interactions acting between them, which 
depends on their surface chemistry and the prevailing environmental conditions, such as pH, 
ionic strength, and temperature 249, 250.  The formulation of stable plant-based milks and creams, 
therefore, depends on understanding the nature of the colloidal interactions acting between the 
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oil bodies.  In principle, the hydrophobic core of oil bodies can be used to solubilize and 
transport non-polar bioactive agents, such as oil-soluble vitamins and nutraceuticals, which could 
be used to fortify plant-based milks and creams with health promoting-components.  The 
challenge, however, is to load the hydrophobic bioactive into pre-existing oil bodies.   
 Previous researchers have loaded curcumin into artificial seed oil bodies formed by 
homogenization of an oil and aqueous phase together in the presence of seed proteins and 
phospholipids 251.  In the present study, however, we focused on loading curcumin into the 
natural oil bodies present in soymilk.  Our method, therefore, has the advantage that it leaves the 
oil bodies in natural plant-based sources intact.  Curcumin is the main bioactive component 
found in turmeric, which is used as a coloring and flavoring agent in foods, as well as a 
nutraceutical 47, 222, 252. Previous studies have shown that curcumin can be loaded into pre-
existing colloidal particles, such as lipid droplets, using a variety of strategies.  Crystalline 
curcumin in powdered form has been mixed with an oil-in-water emulsion and then the resulting 
mixture has been heated, which causes the curcumin to dissolve and move into the hydrophobic 
interior of the lipid droplets 105, 253.   However, holding the emulsions at elevated temperatures 
can promote droplet aggregation and curcumin degradation.  Alternatively, curcumin can be 
dissolved within an organic solvent (such as ethanol) and then mixed with pre-existing colloidal 
particles, which should also cause the curcumin to move into the particles.  But the utilization of 
organic solvents in the fabrication process is often undesirable because of the additional costs 
associated with removing them, as well as their potential to damage the environment 88, 89.   
 Recently, a simple, inexpensive, organic solvent-free method has been developed to load 
curcumin into various types of colloidal delivery system, including micelles, liposomes, 
nanoemulsions, and protein nanoparticles 51, 92-94, 190. This pH-driven method is based on changes 
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in the hydrophobicity, and therefore water-solubility, of curcumin when the pH is changed.  At 
relatively low pH values (< pH 8), curcumin is a neutral non-polar molecule with a high oil-
water partition coefficient and low water-solubility 225.   As the pH is raised above this value, a 
number of the hydroxyl groups on curcumin become progressively deprotonated, resulting in an 
increase in negative charge, increase in hydrophilicity, decrease in oil-water partition coefficient, 
and rise in water-solubility.  This phenomenon can be used to load pre-existing colloidal 
particles using a two-step process: (i) curcumin crystals are dissolved in a strongly alkaline 
solution; (ii) this solution is mixed with an acidified colloidal suspension.  The final pH of the 
mixed system is around neutral or less, which causes the curcumin in the aqueous phase to 
become non-polar and move into the hydrophobic interior of the colloidal particles.  
 The objective of the current study was, therefore, to establish whether the pH-driven 
method could be used to successfully load curcumin into the soybean oil bodies within a 
commercial soymilk product.  Moreover, we examined the impact of environmental stresses, 
such as storage pH and temperature, on the physical and chemical study of the curcumin-loaded 
soymilks. Furthermore, the gastrointestinal fate of the soymilk before and after storage also 
investigated using an in-vitro model.  The results of this study should aid the design and 
formulation of more efficacious nutraceutical-enriched functional foods and beverages.  
6.2. Materials & Methods  
6.2.1 Materials 
 A commercial soy creamer, which contained 10% w/v fat, was purchased from a local 
supermarket (Silk, Whitewave Foods, Broomfield, Colorado).  Curcumin powder (C2302, purity 
95%) was produced by TCI Chemicals (Portland, OR). Sodium Hydroxide (SS266), hydrochloric 
acid (83.3 mM) and dimethyl sulfoxide (BP231) were obtained from Fisher Chemicals (Fair 
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Lawn, NJ). Nile Red (N3013), fluorescein isothiocyanate isomer I (FITC, F1250), and sodium 
azide (S2002) were purchased from the Sigma-Aldrich Chemical Company (St. Louis, MO).  
 The Nutrition Facts label on the soymilk used in this study reported that the product had 
the following attributes: serving size (15 mL); calories per serving, 20 kCal; total fat, 1.5 g; total 
carbohydrate, 2 g (1g sugar); and, protein, 0 g.  The ingredients reported on the product label 
were: soymilk (filtered water and soybean), cane sugar, palm oil maltodextrin, contains 2% or 
less of: soy lecithin, natural flavor, tapioca starch, locust bean gum, and dipotassium phosphate.  
It should be noted that soybeans do contain some protein, which was presumably below the 
threshold required to appear on the nutrition facts label.  
6.2.2 Preparation protocol  
Blank commercial soymilk 
 Initially, the effect of pH on the physiochemical properties of curcumin-free soymilks 
was examined by adjusting the pH from 2 to 10 using acid and base solutions. The particle 
characteristics of the soymilks were then measured using the methods described later. 
Curcumin-loaded soymilk 
 The effect of particle characteristics on the properties of curcumin-loaded soymilks 
prepared using the pH-driven method was then examined. A stock curcumin solution (10 mg/g) 
was prepared by dissolving a weighed amount of curcumin powder into a sodium hydroxide 
solution (0.2 N NaOH).  The alkaline curcumin stock solution was then added to a commercial 
soymilk (1:10 w/w) and the final system was rapidly adjusted to pH 6.5, 7.0 or 8.0 using the 
hydrochloric acid solution. The curcumin-loaded soymilks were then diluted with double 
distilled water to produce a final system containing 5 % oil, then stirred for 10 min at room 
temperature to ensure homogeneity. Finally, sodium azide (0.02%), which is a non-food grade 
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preservative, was added to the system to inhibit any microbial growth.  It should be noted that 
the pH-shift method would lead to the formation of some NaCl in the final samples due to the 
addition of NaOH to create an alkaline solution and then HCl to neutralize it. 
6.2.3 Storage study 
 The effect of pH on the chemical stability of curcumin within the soymilk was 
investigated when it was stored at 4 ºC for 36 days. Curcumin-loaded soymilks with three 
different pH values were prepared (pH 6.5, 7, and 8), poured into a series of glass test tubes (10 
mL), and then sealed with a cap and parafilm to avoid evaporation and contamination. All 
samples were then incubated in the dark at 4 ºC to avoid photodegradation.  Sealed samples were 
then taken and analyzed for each measurement throughout the storage period. 
 The impact of storage temperature (4, 20, 37 and 55 ºC) on the stability of the curcumin-
loaded soymilk was then investigated at pH 7.  A known volume of curcumin-loaded soymilk 
(10 mL) was placed within the glass test tubes and then stored in the dark.  Again, samples were 
selected periodically for analysis to determine the impact of storage temperature on product 
stability.  
6.2.3.1 Optical properties 
 The appearance and optical properties of the soymilks were determined using a digital 
camera and instrumental colorimeter (ColorFlex EZ 45/0-LAV, Hunter Associates Laboratory 
Inc., Virginia, USA), respectively. The colorimeter represented the optical properties of the 
samples using tristimulus color coordinates: L*, a* and b* values.  Here, L* represents lightness 
(0) to darkness (100); a* represents red (+) to green (-); and, b* represents yellow (+) to blue (-). 
Samples (10 mL) were poured into a Petri dish and then illuminated using D65-artificial daylight 
using a 10o standard angle and a black background.  
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6.2.3.2 Particle characterization 
 The particle size distribution (PSD) and mean particle diameter (D32) of each sample was 
measured using a laser diffraction particle size analyzer (Mastersizer 2000; Malvern Instruments, 
Worcestershire, UK).  The electrical characteristics (ζ -potential) of the particles in each sample 
were determined by measuring their electrophoretic mobility using a light scattering device 
(Nano-ZS, Malvern Instruments, Worcestershire, UK).  Each sample was diluted with double 
distilled water with the same pH as their aqueous phase prior to measurement.  
Microstructure analysis 
 A confocal scanning fluorescence microscopy (Nikon D-Eclipse C1 80i, Nikon, Melville, 
NY) was used to investigate the microstructure of the samples. Each sample was stained with 
Nile red (1 mg/ mL ethanol) and FITC (1 mg/mL DMSO) to highlight the lipid (stained red) and 
protein (stained green) regions, respectively. All images were acquired using 200 magnification 
(20 objective lens and 10 eyepiece lens).  
6.2.4 In-vitro study  
 A simulated gastrointestinal tract (GIT) was used to measure the bioaccessibility of the 
curcumin in the soymilks (pH 7) both before and after storage. This GIT model is based on one 
previously developed in our laboratory, which consists of simulated mouth, stomach and small 
intestinal conditions 243. The curcumin-loaded soymilk was passed through the full GIT model 
and then the amount of curcumin solubilized within the mixed micelle phase was measured. 
 To simulate the mouth phase, a fixed volume of pre-warmed (37 ºC) curcumin-loaded 
soymilk (15 mL) was transferred into a pre-warmed (37 ºC) simulated artificial saliva fluid (15 
mL), which was prepared by adding mucin (3mg/mL) to artificial saliva solution.  This mixture 
was then adjusted to pH 6.8 and placed within a temperature-controlled shaking incubator 
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operating at 100 rpm and 37 ºC for 30 seconds (Innova Incubator Shaker, Model 4080, 
New Brunswick Scientific, New Jersey, USA). The resulting sample was then incubated under 
simulated gastric conditions. Pre-heated (37 ºC) simulated gastric fluid (30 mL), which contained 
3.2 mg/ mL pepsin, was added to the same volume of the sample from the mouth phase (30 mL).  
The resulting mixture was then adjusted to pH 2.5 and incubated at 37 ºC for 2 hours with 100 
rpm shaking. After that, the sample (60 mL) arising from the stomach phase was transferred into 
the small intestinal phase. Pre-heated simulated intestinal fluid (3 mL) and bile salt solution (7 
mL) was added to the mixture and the pH was adjusted to neutral. Then, a freshly prepared 
pancreatic lipase solution (5 mL) was added to the mixture and the pH was adjusted back to 
neutral.  The bile salt solution was prepared by dissolving porcine bile extract (53.57 mg/mL) 
into phosphate buffer (5 mM, pH 7.0), and the pancreatic lipase solution was prepared by adding 
pancreatic lipase (0.16 mg/mL) into phosphate buffer (5 mM, pH 7.0).  Throughout the 2-hour 
small intestinal phase, an automatic titration unit (Metrohm, USA Inc.) was used to monitor and 
maintain the sample at pH 7.0.   
6.2.5 Curcumin concertation determination  
 The concentration of the curcumin within the soymilk was determined using a UV/visible 
spectrophotometry method.  First, the curcumin was extracted from the samples using acidified 
dimethyl sulfoxide (0.1% v/v 6N HCl) solution.  Acidification was used to enhance the chemical 
stability of the curcumin.  The absorbance of the curcumin solutions was measured using a UV-
visible-spectrometer (Genesys 150, Thermos Fisher Scientific, Madison, WI) at a wavelength of 
420 nm. The curcumin concentrations were then calculated from the measured absorbance values 
using a standard curve prepared using a series of samples of known curcumin level.  
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6.2.5.1 Encapsulation Efficiency  
 The encapsulation efficiency of the curcumin-loaded soymilks was calculated using the 
following equation: 
 Encapsulation Efficiency = 100  Cencapsulated / Cinitial    (1) 
Here, Cinitial is the total concentration of curcumin initially added to the soymilk and Cencapsulated is 
the concertation of curcumin present within the curcumin-loaded soymilk after preparation using 
the pH-driven method.  
6.2.6 Stability and Bioaccessibility 
 After passing through the full GIT model, the resulting fluid was collected and divided 
into two fractions.  One fraction, which was used without any further treatment, was taken to be 
the total digested phase.  The other fraction, which was the supernatant collected after 
centrifugation, was taken to be the mixed micelle phase. The mixed micelle phase was prepared 
by centrifugation of the total digest at 18,000 rpm at 25 ºC for 50 min (Thermo Scientific, 
Waltham, MA) and then collecting the clear supernatant from the samples. The curcumin 
concentrations within the total digested phase (𝐶𝑑𝑖𝑔𝑒𝑠𝑡) and with the mixed micelle phase 
(𝐶𝑚𝑖𝑐𝑒𝑙𝑙𝑒) were then determined using UV/visible spectrophotometry as described earlier.  
 The bioaccessibility and stability of the curcumin-loaded soymilk were then calculated 
using the Cmicelle, Cdigest and Cinitial values using the following expressions:  




     (2) 




      (3) 
Here, the Cmicelle is the concentration of curcumin within the mixed micelle phase; the 
Cdigest is the concentration of curcumin within the digest phase; the Cinitial is the concertation of 
curcumin within the soymilk system before digestion.  The Bioaccessibility represents the 
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fraction of curcumin solubilized in the mixed micelle phase, which is potentially available for 
absorption. The Stability represents the total amount of curcumin that survived after the soymilks 
were passed through the simulated GIT.  
6.2.7 Kinetic study 
 The kinetics of curcumin degradation within the soymilk samples during storage was 
calculated using the Arrhenius equation:  
  𝑘 = 𝐴 𝑒−𝐸𝑎/𝑅𝑇        (4) 
Here, k is the rate coefficient, A is the Arrhenius constant; Ea is the activation energy, R is the 
universal gas constant (8.314  10-3 kJ mol-1 K-1); and T is the temperature in Kelvin.  
6.2.8 Statistical analysis 
 All the data from this experimental study are displayed as the mean ± the standard 
deviation determined from measurements made on three freshly prepared samples. Statistical 
comparisons were carried out using dedicated mathematical software (SPSS version 6.0) and a 
significant difference was considered to occur when the p-value was lower than 0.05.    
6.3. Results and discussions 
6.3.1 Soymilk characteristics  
 The commercial soymilk used in this study consists of soybean oil bodies dispersed in an 
aqueous solution that contains various other ingredients, such as cane sugar, maltodextrin, soy 
lecithin, starch, locust bean gum, and dipotassium phosphate.  Visually, the soymilk had a 
homogenous appearance with a bright milky color (Fig. 1a).  Measurement of the pH of the 
soymilk showed that it was slightly basic (pH 7.5).  The mean particle diameter (D32) of the 
soymilk determined by laser diffraction analysis was 367 ± 2 nm.  Particle size distribution 
analysis showed that the majority of particles had diameters between about 0.1 and 4 m, but 
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that there was a small population of particles with larger dimensions (Fig 1b).   The original 
soymilk had a relatively high negative surface potential (ζ = -39.8 ± 2.6 mV), which can be 
attributed to the presence of anionic phospholipids and proteins at the oil body surfaces 235.   The 
magnitude of the negative charge on the oil bodies should be high enough to generate a strong 
electrostatic repulsion that prevents them from aggregating with each other 233, 254.  
Influence of pH on particle characteristics in soymilk 
 The impact of pH on the physicochemical properties and stability of the curcumin-free 
(blank) soymilk was characterized to establish whether it would remain stable during the pH-
driven method and to determine the range of pH conditions where it would remain stable in 
commercial applications.  The particle characteristics of these soymilks were measured after 
their aqueous phases had been adjusted to pH values ranging from 2 to 10 and then stored for 
several hours (Fig.1a).  From pH 6 to 10, the soymilks remained visibly stable, with no evidence 
of phase separation.  From pH 2 to 5, however, there was clear evidence of phase separation, 
with a curd-like whitish upper phase and a clear watery lower phase.  These results show that the 
soymilks were highly unstable to aggregation and creaming under moderately acidic conditions.  
 The impact of pH on the mean particle diameter and ζ-potential of the particles in the 
soymilks were investigated using laser diffraction and electrophoresis analysis, respectively 
(Figs. 1c & 1d).  From pH 10 to 7, the soybean oil bodies had a relatively high and constant 
negative surface potential (ζ  -42 mV) and had relatively small and constant particle dimensions 
(D32 < 380 nm).  When the pH was reduced to 6, the surface potential became slightly less 
negative (ζ  -35 mV) and the particle dimensions increased somewhat (D32  578 nm), which 
suggested that a limited amount of oil body aggregation had occurred.  When the pH was further 
reduced into the range from 5 to 2, there was a pronounced increase in the mean particle 
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diameter (D32 > 12 um), which indicated that extensive oil body aggregation occurred under 
these conditions.  The laser diffraction measurements were therefore consistent with the visual 
observations of phase separation in the samples over this pH range (Fig. 1a).  The origin of this 
effect can be attributed to the decrease in the magnitude of the surface potential on the oil bodies 
at lower pH values (Fig. 1c), which would have reduced the electrostatic repulsion between 
them.  Indeed, the ζ-potential went from negative at high pH values to positive at low pH values, 
with a net charge of zero around pH 3.6.   This effect can be attributed to progressive protonation 
of the carboxyl groups (-COO- → -COOH) and amino groups (-NH2 → -NH3
+) on the adsorbed 
proteins and phospholipids as the pH was reduced.  It should be noted, however, that the 
commercial soymilk contained other components that could also have attributed to its electrical 
characteristics, such as soy lecithin.  Presumably, this ingredient was added to improve the 













c.       d. 
 
Fig. 1. a) Impact of pH on appearance of blank soymilk; b) particle size distribution of blank soymilk (pH 7.5); 
c) Impact of pH on electrical characteristics (ζ-potential) of blank soymilk; and d) Impact of pH on mean 





































































6.3.2 Influence of pH-driven method on soymilk properties  
 The experiments described previously indicated that the soymilk remains physically 
stable at relatively high pH values.  In commercial products, the pH may vary somewhat 
depending on the ingredients used to formulate them, as well as any chemical changes that occur 
during storage.  For this reason, we carried out the following experiments using soymilk samples 
with three different final pH values: pH 6.5, 7.0 and 8.0.  Soymilk samples above pH 8 were not 
evaluated because food and beverage products rarely have such highly alkaline conditions.   
6.3.2.1 Appearance 
 Digital photography images and instrumental colorimetry measurements were used to 
characterize the appearance of the curcumin-loaded soymilks at the three different pH values 
(Figs. 3a and 4).  The photography images showed that the soymilk samples had a homogenous 
cloudy yellow appearance at pH 6.5 and 7, but were slightly more orange-colored at pH 8 (Fig 
3a). The tristimulus coordinates of the soymilks also indicated that there were appreciable 
differences in their color depending on pH (Table 1).  At pH 6.5 and 7, the soymilks had fairly 
similar color characteristics indicative of a creamy yellow appearance: L* ( 82), a* ( -8), and 
b* ( 81).  But, at pH 8, the soymilk had significantly lower L* ( 77) and b* ( 75) values and 
higher a* ( 0.6) values (Table 1).  This suggests that the soymilk at the highest pH was less 
light, less green, and less yellow than the ones at the lower pH values.  This effect can be 
attributed to the pH-dependent color of the curcumin molecule.  When the pH is increased to 
around the first pKa value of curcumin (around pH 7.5 to 8.5), one of its hydroxyl groups 
becomes deprotonated, which leads to a change in color from yellow to orange 1, 13, 255.  This 
phenomenon may be important when formulating curcumin-loaded soymilk products with 










231.6 ± 8.8 a 228.3 ± 7.4 a 235.4 ± 3.7 a 
Loading capacity (%) 92.6 ± 3.2 a 91.3 ± 2.7 a 94.2 ± 1.4 c 
L* 82.2 ± 0.2 b 82.4± 0.1 b 77.3  ± 0.5 a 
a* -8.44 ± 0.15 a -8.01 ± 0.09 a 0.64 ± 0.68 b 
b* 82.2 ± 0.5 c 80.3 ± 0.4 b 75.2 ± 0.7 a 
D32 (m) 0.47 ± 0.02 b 0.39 ± 0.01 a 0.38 ± 0.01 a 
ζ- potential (mV) 
-40.8 ± 1.3 b -42.1 ± 2.0 a -42.8 ± 0.9 a 
 
Table 1. Influence of pH on curcumin-loaded soymilk: initial curcumin concentration, loading capacity, 
tristimulus color value (L*, a*, and b*), mean particle diameter (D32) and electrical characteristics (ζ- 
potential). Different letters represent significant differences (Duncan, p< 0.05). 
 
 
6.3.2.2 Curcumin concentration 
 The impact of the pH-driven method on the encapsulation efficiency of the curcumin 
within the soymilks was determined.  A fixed amount of curcumin (250 μg/mL) was utilized to 
prepare all the nutraceutical-loaded soymilks using the pH-driven method. After loading, the 
encapsulation efficiencies of the curcumin in the soymilks were determined.  At all three pH 
values, a relatively high and fairly similar encapsulation efficiency was obtained, i.e., 91-94% 
(Table 1).  These results indicate that the pH-driven method was a successful approach for 
incorporating curcumin into pre-existing oil bodies.  
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6.3.2.3 Particle characteristics 
 The impact of using the pH-driven method for loading curcumin into the soybean oil 
bodies on the structural properties of the soymilk was also investigated.  The loading of the 
curcumin into the oil bodies had no significant impact on their surface potential (Fig. 2a) or 
mean particle diameter (Fig. 2b) at any of the pH values used.  There was little change in the 
surface potential and only a slight decrease in the mean particle diameter when the pH was 
increased from 6.5 to 8, which is consistent with the earlier experiments (Figs. 1a, c & d). 
Immediately after preparation, all the curcumin-loaded soymilks had a homogenous creamy 
yellow appearance (Fig. 3a), which suggests that they initially had good stability to aggregation 
and creaming. This was confirmed by measuring the microstructures of the soymilk using 
confocal microscopy (Fig. 3b), which showed that at all three pH values the soymilks contained 
relatively small oil bodies that were distributed evenly throughout the system.  Fluorescent 
staining indicated that the oil bodies (stained red) were dispersed in an aqueous medium that 













a         b 
 
Fig. 2. The a) electrical characteristics (ζ-potential) and b) mean particle diameter (D32) of the blank and curcumin-
loaded soymilks at various pH values. Different lowercase letters indicate significant differences (Duncan, p< 0.05) 
within the same type of soymilk; different capital letters indicate significant differences between two types of 


































































Fig 3. a) The appearances and b) microstructures of curcumin-loaded soymilks before and after storage at various 
pH values at 4 ºC for 36 days. The microstructure images were obtained using confocal fluorescence microscopy 




6.3.3 Effect of pH on storage stability of curcumin-loaded soymilk  
 For commercial applications, it is important that plant-based milks have a sufficiently 
long shelf life.  For this reason, we measured the physiochemical stability of curcumin-loaded 
soymilks (pH 6.5, 7, and 8) during storage at 4 ºC in the dark.  This temperature was selected 
because the milks would be expected to be stored in the refrigerator prior to utilization.   
6.3.3.1 Appearance 
 After 36 days storage, all of the soymilks still had a creamy yellow/orange color, but 
some phase separation was observed, with a watery serum layer being visible at the bottom of 
the test tubes (Fig 3a).  This effect was attributed to the upward movement of the oil bodies due 
to gravity. The thickness of the serum layer was greatest for the soymilk at pH 6.5, which was 
probably because it contained the largest particles (Fig. 2b), presumably because some of the oil 
bodies had aggregated.  Conversely, the soymilk at pH 8 was the most stable to gravitational 
separation, maintaining a uniform creamy yellow/orange appearance after storage.  There did, 
however, appear to be a slight reduction in the intensity of the color in this sample after storage, 
as well as the formation of thin orange sediment at the bottom of the test tube (Fig. 3a).  This 
orange sediment was assumed to be due to the formation and sedimentation of curcumin crystals 
within the soymilks.  The decrease in the color-intensity of the soymilk at pH 8 may, therefore, 
have been because some of the curcumin had moved to the bottom of the samples and therefore 
did not contribute to their overall appearance.  In addition, some of the curcumin may have 




Fig. 4  
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Fig. 4. Influence of pH on the a) mean particle diameters (D32) and b) electrical characteristics (ζ- potential) of 











Fig. 5  




















































Fig. 5 Influence of pH on a) the yellow color (b*) and b) curcumin concentration within the soymilks during 4 ºC 




The instrumental color coordinates of the curcumin-loaded soymilk were measured 
before and after storage (Fig. 5a, Table 1). The kinetics of color fading during storage is 
highlighted by plotting the normalized yellowness versus time because this was the dominant 
color coordinate: b*/b0*, where b0* is the color coordinate at zero time.  This value changed by 
less than 2% during storage, which suggests that there was little alteration in yellow color. There 
was also little change in the a*-value of the soymilks (Table 1). Indeed, a* increased from -8 to -
6 for the soymilks at pH 6.5 and 7, which indicates a slight decrease in their greenish hue.  
Conversely, the a* of the soymilk at pH 8 decreased slightly from 0 to -1, which indicates that it 













































6.3.3.2 Curcumin concentration 
 The concertation of curcumin remaining in the soymilk was also measured during storage 
to investigate the impact of pH on its chemical stability (Fig. 5b). After 36 days storage at 4 oC, 
the majority of curcumin was still present, with the precise amount depending on solution 
conditions (Table 1): pH 6.5 (91%), pH 7 (90%), and pH 8 (87%).  Overall, these results suggest 
that curcumin was relatively stable to degradation under these storage conditions, but that the 
rate of degradation increased as the pH was raised, which is consistent with previous results 256.   
6.3.3.3 Particle characteristics  
 Changes in the characteristics of the particles in the curcumin-loaded soymilks stored at 
different pH values were also determined (Fig. 4). The mean particle diameter of all the soymilks 
remained relatively constant during storage (Fig. 4a), suggesting that the oil bodies were stable to 
aggregation. The ζ-potentials of the particles in all the soymilks became slightly less negative 
(from around -40 to -35 mV) during storage (Fig. 4b), which suggests that there were some 
changes in the interfacial composition of the oil bodies during storage.  Even so, the negative 
surface potential should still have been large enough to generate a strong electrostatic repulsion 
that inhibited the aggregation of the oil bodies.  As mentioned earlier, we did see some phase 
separation (creaming) of the oil bodies after 36 days storage, particularly at the lower pH values.  
This result suggests that there may have been some weak flocs formed in the soymilk samples 
that promoted creaming due to the increase in particle size, but which were disrupted when the 
samples were diluted for the particle size measurements. 
Effect temperature on the soymilk containing curcumin  
 Many commercial food and beverage products experience changes in their temperature 
during their manufacture, storage, and utilization.  Consequently, it is important to establish the 
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impact of temperature on the physicochemical properties and stability of the curcumin-loaded 
soymilk samples.  For this reason, changes in the properties of the soymilk were measured when 
they were stored at 4, 20, 37, and 55 ºC for 14 days.  The soymilk at pH 7 was selected for these 
studies because it was more stable to creaming than the pH 6.5 sample and more stable to 

















Fig. 6 Influence of temperatures on the a) appearances of curcumin-loaded soymilk before and after 15-days storage. 
The impact of temperature on b) mean particle diameters (D32) and c) electrical characteristics (ζ- potential) of 
curcumin-loaded soymilks during 15-days storage. d) the microstructure of curcumin-loaded soymilks before and 




6.3.4 Effect of temperature on storage stability of curcumin-loaded soymilk  
6.3.4.1 Appearance 
 The storage temperature had a pronounced impact on the overall appearance of the 
curcumin-loaded soymilks (Fig. 6a).  The extent of color fading increased as the storage 
temperature increased.  At 4 and 20 ºC, the curcumin was relatively stable to fading, with the 
soymilks maintaining a strong yellowish color, but at 37 and 55 oC there was clear evidence of 
color fading.  In addition, the soymilks exhibited a greater degree of gravitational separation as 
the storage temperature was raised.  The samples stored at 4 and 20 ºC were relatively stable to 
creaming during storage, but those stored at 37 and 55 oC had a thick cream layer at their 
surfaces after storage, which was attributed to the upward movement of the oil bodies due to the 
gravitational forces acting upon them.    
 Instrumental colorimetry analysis of the curcumin-loaded soymilk during storage also 
showed that the rate of color fading increased with storage temperature.  The color stability of 
the soymilk samples was represented by plotting the relative change in their yellowness (b*/b0*) 
over time (Fig. 7a).  The L*, a* and b* values of the soymilks before and after storage is shown 
in Table 2.  Overall, color fading increased in the following order: 4 ºC ≈ 20 ºC < 37 ºC < 55 ºC 
(Fig. 7a).  The lightness (L*) of all the soymilks remained greater than 90 % even after 15-days 
storage. The greenness (a*) of the soymilks decreased by about 20% at 4 and 20 ºC, 30% at 37 
ºC, and 50% at 55 ºC after 15-days storage. The yellowness (b*) of the soymilks did not change 
appreciably (< 2%) at 4 and 20 ºC, but decreased by about 10% at 37 ºC, and 30% at 55 ºC.  
These results suggest that the curcumin should be stored at a relatively low temperature in order 
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  4 °C 20 °C 37 °C 55 °C 
Before 
Storage 
L* 82.41± 0.1 a 82.41± 0.1 a 82.41± 0.1 a 82.41± 0.1a 
a* -8.01 ± 0.09  a -8.01 ± 0.09  a -8.01 ± 0.09  a -8.01 ± 0.09  a 
b* 80.32 ± 0.40 a 80.32 ± 0.40 a 80.32 ± 0.40 a 80.32 ± 0.40 a 
After 
Storage 
L* 80.86 ± 0.08 c   80.82 ± 0.64 c 78.70 ± 0.12 76.30 ± 1.00 
a* -6.58 ± 0.03 c -6.53 ± 0.04 c -5.40 ± 0.16 b -3.74 ± 0.30 a 
b* 80.10 ± 0.27 d 78.94 ± 0.53 c 72.02 ± 0.26 b 51.66 ± 1.86 a 
 
Table 2. Influence of temperature on the tristimulus color coordinates (L*, a*, and b*) of samples before and after 
15-day incubation.  Different letters represent significant differences (Duncan, p< 0.05). 
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6.3.4.2 Curcumin concentration 
 The fading of the curcumin-loaded soymilks was most likely due to the chemical 
instability of the curcumin molecule at elevated temperatures.  We therefore measured the impact 
of temperature on the change in curcumin concentration during storage (Fig. 7b).  The rate of 
curcumin degradation clearly increased with increasing temperature.  After 15 days storage, less 
than 10% of the curcumin degraded at 4 and 20 ºC, around 35% at 37 ºC, and around 75 % at 55 
ºC.    The chemical transformation of the curcumin during storage would therefore account for 
the faster color fading observed at the higher temperatures. 
 A more detailed analysis of the reaction kinetics of curcumin degradation in the soymilks 
was obtained by applying the Arrhenius equation (Equation 4).  This equation can be rearranged 
to give: 
 ln(𝑘) = ln(𝐴) −
𝐸𝐴
𝑅𝑇
          (5) 
Thus, the activation energy can be determined by plotting the logarithm of the reaction rate (k) 
versus the reciprocal of the absolute temperature (1/T) (Fig. 8).  The reaction rate was 
determined at each temperature from plots of curcumin concentration versus time, assuming a 
first order reaction, i.e., C/C0 = A exp(-kt).  This analysis indicated that the activation energy for 









Fig. 8 Arrhenius equation graph of curcumin within soymilks, which represents the temperature dependence of the 
chemical reaction rate. 
 
 
6.3.4.5 Particle characteristics 
 The size and electrical characteristics of the particles in the soymilk samples were also 
measured during storage at the four different temperatures (Figs. 6b & 6c). Overall, the mean 
particle diameter remained relatively small (< 400 nm) and the ζ-potential remained highly 
negative ( –40 mV) throughout storage. These results suggest that the soymilk samples were 
relatively stable to coalescence or strong flocculation at all temperatures.  Conversely, the fact 
that we did observe appreciable creaming at the higher storage temperatures suggests that some 
weak flocculation of the oil bodies may have occurred.  However, the confocal microscopy 
images of the samples did not indicate that extensive oil body aggregation had occurred (Fig. 
6d).  An alternative explanation is that more rapid oil body creaming occurred at the higher 
storage temperatures because of the reduction in aqueous phase viscosity.  The dynamic shear 
viscosity of water has been reported to be 1.6, 1.0, 0.69, and 0.50 mPa s at 4, 20, 37, and 55 oC, 




















respectively (www.vaxasoftware.com).  Thus, there is more than a 3-fold decrease in the 
aqueous phase viscosity from the lowest to highest storage temperatures used.  According to 
Stoke’s law, the creaming velocity of a spherical particle due to gravity is inversely related to the 
viscosity of the surrounding fluid, so a decrease in aqueous phase viscosity should promote faster 
creaming 128.  Overall, these results suggest that the physical stability of the soymilks is also 
improved by storing them at relatively low temperatures. 
6.3.5 Bioaccessibility and stability  
 Finally, we examined the impact of encapsulation of curcumin within the soymilks on 
two of the main factors affecting nutraceutical bioavailability after ingestion: bioaccessibility and 
stability in the gastrointestinal tract (GIT) 257, 258.  The curcumin-loaded soymilk stored at pH 7 
and 4 ºC was used for these experiments because it had the best physical and chemical stability.  
The potential bioavailability of the curcumin was determined using a simulated GIT before and 
after storage of the soymilks (Table 3).  As expected, the total fraction of curcumin within both 
the total digest and the mixed micelle phases were slightly (but significantly) higher before 
storage than after storage, which can be attributed to some curcumin degradation.  The 
gastrointestinal stability and bioaccessibility of the curcumin were fairly similar before and after 
storage.  About 82-85% of the curcumin survived passage through the simulated mouth, 
stomach, and small intestine phases, but only about 55-59% of the curcumin was solubilized 
within the mixed micelle phase and therefore available for absorption.  It is possible that the 
remainder of the curcumin either formed crystals that precipitated or bound to insoluble protein 
complexes and was therefore not present in the mixed micelle phase.  Nevertheless, these 
measurements show that a substantial fraction of the ingested curcumin should still be in a from 
that would be bioavailable.  Having said this, it is important to note that the human gut contains 
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many types of metabolic enzymes that can transform curcumin into different forms 4, 68, which 
was not considered in the current study.  In future studies, it would therefore be useful to test the 
curcumin-loaded soymilks using animal or human feeding trials. 
 
Table 3. 
 CDigest (ug/mL) CMicelle (ug/mL) Stability (%) 
Bioaccessibility 
(%) 
Before Storage 186.80 ± 2.56  109.63 ± 18.13  81.87± 1.82  58.60 ± 9.08  
After Storage 177.67 ± 1.43  97.23 ± 10.06  85.39 ± 3.14  54.76 ± 6.04  
 
Table 3. Impact of storage at pH 7 on the gastrointestinal stability and bioaccessibility of curcumin in soymilks 




 In summary, this study has shown that the pH-driven method can be successfully used to 
load curcumin into commercial soymilks and that the storage stability of the resulting systems 
depends on pH and temperature.   The soymilks had good chemical stability when stored at 
refrigerator temperatures at pH 6.5, 7 and 8 for 36 days, but there was some change in the color 
of the curcumin-loaded soymilks at the highest pH.  The soymilks were susceptible to phase 
separation due to creaming when stored at pH 6.5, which was attributed to oil body aggregation.  
They also showed evidence of phase separation due to the formation and sedimentation of 
curcumin crystals when stored at pH 8.  The physical and chemical stability of the curcumin-
loaded soymilks (pH 7) was relatively high at 4 and 20 ºC, but decreased at higher temperatures 
of 37 and 55 ºC.  Overall, our results suggest that curcumin-loaded soymilks prepared using the 
pH driven method should be stored at neutral pH at relatively low temperatures.  We also 
showed that these samples had relatively good bioavailability in a simulated GIT model.   
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Nevertheless, further studies are needed to test their bioavailability using in vivo animal or 






















7. Fabrication of curcumin-loaded dairy milks using the pH-shift method: 
Formation, stability, and bioaccessibility 
7.1.1 Introduction  
 The creation of functional foods and beverages, which are products specifically designed 
to enhance human health and performance, is a rapidly growing area within the food and 
nutrition industry due to its potential economic and health benefits 259, 260.  Ideally, these products 
should contain bioactive substances that provide demonstrated health benefits beyond basic 
nutrition 261, 262, such as the prevention and treatment of specific diseases 262, 263, without posing a 
health risk to those consuming them 264. It has been reported that the global functional food 
market generated around $300 billion dollars of revenue in 2017, which has been predicted to 
rise to more than $440 billion by 2022 265. There is also a growing market for dietary 
supplements (such as pills and capsules) that may help prevent or treat certain kinds of chronic 
diseases 266. In this case, there is interest in developing alternative delivery formats that are more 
acceptable to consumers and that ensure a high bioavailability and bioactivity of the 
encapsulated bioactive substances. 
 Nutraceuticals are commonly used for their potential health benefits in functional food 
and supplement products 267. These bioactive molecules are typically natural food components 
derived from edible plants, animal, or microbial sources, including: phytochemicals from fruits, 
vegetables, cereals, and nuts; collagen, conjugated linolenic acid (CLA), and omega-3 fatty acids 
from meat and fish; and, probiotics from microbial cultures 2, 263. Many of these nutraceutical 
ingredients play multiple roles in foods.  For instance, in addition to their potential health 
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benefits, they may also function as natural colors, flavors, antioxidants, preservatives, stabilizers, 
and texture modifiers 268, 269.  
 In this article, we focus on the incorporation of a model hydrophobic nutraceutical 
(curcumin) into functional food products.  This nutraceutical is claimed to exhibit a broad 
spectrum of biological activities 270-272, but there are some challenges that have to be overcome 
before it can be successfully incorporated into functional foods 47, 63.  Curcumin is a bioactive 
polyphenol from turmeric that has strong antioxidant and anti-inflammatory activities 63, 272. It 
naturally has a bright yellow-orange appearance and a distinctive flavor, which means that it can 
be used as a natural colorant and flavoring in certain foods 1, 2. However, it is prone to chemical 
degradation during storage, has poor water-solubility, and has a low oral bioavailability 47, 273. It 
is, therefore, important to design functional food products with good storage stability and 
bioavailability 47, 63.   
 Previously, it has been shown that encapsulating curcumin within colloidal delivery 
systems that contain oily domains, such as micelles, liposomes, emulsions, and nanoemulsions, 
can improve its stability and bioavailability 92, 93, 96, 132. This effect has mainly been attributed to 
the higher chemical stability of curcumin in oily environments than in aqueous environments 256.  
Usually, curcumin has to be dissolved within the oil phase of an emulsion or nanoemulsion 
before homogenization is carried out 63.  Nevertheless, there are situations where it would be 
advantageous to load curcumin into the oil phase of pre-existing colloidal particles.  For instance, 
if one wanted to load curcumin into a naturally occurring colloidal dispersion (such as oil bodies 
from plants or animals) or if wanted to avoid chemical degradation during the homogenization 
process.  A number of studies have shown that this can be achieved using the pH-shift method 51, 
92, 93, 96. This method uses pH to control the water-solubility of curcumin92, 93. At relatively low 
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pH values (pH < 8), curcumin is a neutral hydrophobic molecule that has a relatively low water-
solubility.  Conversely, at relatively high pH values, the hydroxide groups on curcumin become 
deprotonated, which leads to an increase in its negative charge, polarity, and water-solubility. In 
the presence of a colloidal dispersion containing oily domains, curcumin can therefore be driven 
from the water phase to the oil phase by adjusting the pH from highly alkaline to slightly acidic.  
Previous studies have shown that this process is simple and rapid to carry out and does not lead 
to appreciable degradation of the curcumin 51, 94, 96.   
 The purpose of the current study was to determine whether the pH-shift method could be 
used to successfully load curcumin into dairy milk products, and then to establish the 
physicochemical stability and in vitro bioaccessibility of the resulting systems. Our motivation 
was that cow’s milk is already a widely and routinely consumed beverage and would therefore 
be a highly suitable delivery vehicle for incorporating beneficial nutraceuticals into consumers’ 
regular diets.  
7.2. Materials & Methods 
7.2.1 Materials  
 Powdered curcumin (C2302, purity 95%) was purchased from the TCI chemical company 
(Portland, OR). Ultra-pasteurized dairy creamer (10% w/v fat) was obtained from a local 
supermarket (HP Hood LLC, Lynnfield, MA). The following chemicals were purchased from 
Fisher Chemicals (Fair Lawn, NJ): sodium hydroxide (SS266), hydrochloric acid (83.3 mM) and 
dimethyl sulfoxide (BP231). Fluorescein isothiocyanate isomer I (FITC, F1250), Nile Red 
(N3013), and sodium azide (S2002) were purchased from the Sigma-Aldrich Chemical Company 
(St. Louis, MO). 
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 The Nutrition Facts label of the dairy creamer reported a serving size to be 30 mL, which 
contained: 30 kCal; 3 g total fat; 1 g total carbohydrate (1g sugar); < 1g protein, 2%DV for 
vitamin A; and 4% DV for calcium. The ingredients listed on the product label were: milk and 
cream with disodium phosphate.  
7.2.2 Preparation protocol  
Blank dairy milk 
 Initially, the original dairy milk sample was adjusted to a range of pH values (2 to 10) 
using HCl or NaOH solutions to examine its suitability for carrying out curcumin loading using 
the pH-shift method. After 3 hours, the particle characteristics of the milks were measured using 
the techniques described later. 
Curcumin-loaded dairy milk 
 Curcumin-loaded dairy milk was prepared using the pH-shift method, and the particle 
characteristics were measured before and after loading. Initially, curcumin powder was dissolved 
in an alkaline solution (0.2N NaOH) at room temperature for 1 min. This curcumin stock 
solution was then added into the dairy milk and the pH was quickly adjusted back to the target 
value (pH 6.5, 7 and 8). Double-distilled water was then added to the curcumin-loaded milks to 
reach a final oil content of 5% oil. A non-food grade preservative, sodium azide (0.02%), was 
added to the final samples to inhibit microbial growth. The curcumin-loaded milks were then 
stirred for 10 min at room temperature in the dark to ensure their homogeneity.  
7.2.3 Storage study 
 The impact of storage pH and temperature on the stability of the curcumin-loaded milk 
was investigated. The influence of pH (6.5, 7 and 8) on particle characteristics and curcumin 
stability within the milk was determined by storing the samples at 4 ºC for 60 days. This pH 
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range was selected to represent those typically found in commercial dairy milks.  The sample 
with the best stability was selected to determine the influence of storage temperature on the 
stability of the curcumin-loaded milk (4, 20, 37 and 55 ºC). To avoid evaporation, contamination, 
and photodegradation, an aliquot of each sample (10 mL) was transferred into a glass test tube, 
sealed with a cap and parafilm, and then stored in the dark. Finally, samples were collected and 
analyzed at selected periods throughout the storage period. 
7.2.3.1 Optical properties  
  The appearance of the curcumin-loaded milks was characterized using both a digital 
camera and an instrumental colorimeter (ColorFlex EZ 45/0-LAV, Hunter Associates Laboratory 
Inc., Virginia, USA). The colorimeter measures the color of the samples under standardized light 
conditions and then reports it using the CIE tristimulus system: L*, a*, and b*. Here, L* 
represents lightness (0) to darkness (100), a* represents red (+) to green (-), and, b* represents 
yellow (+) to blue (-).  An aliquot of each sample (10 mL) was transferred into a medium-size 
disposable petri dish, and then analyzed using D65 artificial daylight (10 standard angles) against 
a black background.   
7.2.3.2 Particle characterization 
 The particle characteristics of the samples were determined using a laser diffraction 
particle size analyzer (Mastersizer 2000; Malvern Instruments, Worcestershire, UK) and a 
particle electrophoresis device (Nano-ZS, Malvern Instruments, Worcestershire, UK). The laser 
diffraction instrument was used to measure the mean particle diameter (D32) of the samples, 
while the particle electrophoresis device was used to measure the surface potential (ζ-potential) 
of the samples.  All samples were diluted with double-distilled water (adjusted to the same pH as 
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the sample) prior to measurement to ensure light waves could pass through them and avoid 
multiple scattering. 
7.2.3.3 Microstructure analysis 
 The microstructures of the samples were investigated using confocal scanning 
fluorescence microscopy (Nikon D-Eclipse C1 80i, Nikon, Melville, NY). Samples were stained 
with Nile red (1mg / mL ethanol) and FITC (1 mg / mL DMSO) to highlight the location of 
lipids (red region) and proteins (green region). All images were obtained with a 10  eyepiece 
and a 20  objective lens, giving an overall 200 magnification.  
7.2.4 Simulated gastrointestinal study 
 A simulated gastrointestinal tract (GIT) model was used to evaluate the gastrointestinal 
fate (stability and bioaccessibility) of the curcumin within the milk samples. The GIT model 
consisted of simulated mouth, stomach, and small intestine phases, and was slightly modified 
from our previous study 243. 
 Initially, the curcumin-loaded milk entered the simulated mouth phase. Here, the sample 
(15 mL) was pre-warmed (37 ºC) and mixed with pre-warmed (37 ºC) simulated artificial saliva 
fluid (15 mL), which contained 3 mg/mL mucin. The mixture was then adjusted to pH 6.8 and 
incubated in a temperature-controlled shaking incubator (100 rpm, 37 ºC) for 30 seconds (Innova 
Incubator Shaker, Model 4080, New Brunswick Scientific, New Jersey, USA). The bolus sample 
resulting from the mouth phase was then exposed to simulated gastric conditions. A pre-heated 
(37 ºC) simulated gastric fluid (30 mL), which contained 3.2 mg/ mL pepsin, was added to the 
bolus sample and then the pH was adjusted to 2.5.  The resulting mixture was placed back into 
the same shaking incubator at the same settings for 2 hours. The chyme sample resulting from 
the stomach phase (60 mL) was then exposed to the small intestinal phase. Pre-heated (37 ºC) 
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simulated intestinal fluid (3 mL) and bile salt solution (7 mL) were added to the chyme sample 
with continuous stirring, and then the pH was adjusted to 7.0. Finally, freshly prepared 
pancreatic lipase solution (5 mL) was transferred into the sample and the pH was quickly 
adjusted back to 7.0. The bile salt solution was prepared by dissolving porcine bile extract (53.57 
mg/mL) into the phosphate buffer solution (5 mM, pH 7.0). The pancreatic lipase solution was 
prepared by adding pancreatic lipase (0.16 mg/mL) into phosphate buffer solution (5 mM, pH 
7.0). An automatic titration unit (Metrohm, USA Inc.) was used to monitor and maintain the 
sample at pH 7.0 by titrating NaOH (0.25 N) solution for 2 hours at 37 ºC. 
7.2.5 Curcumin concentration determination 
 The concentration of curcumin within the milk samples was determined using UV/visible 
spectrophotometry. An acidified dimethyl sulfoxide solution (0.1% v/v 6N HCl) was used to 
extract curcumin from the milk samples. A UV/Vis-spectrometer (Genesys 150, Thermos Fisher 
Scientific, Madison, WI) was utilized to measure the absorbance of the extracted curcumin 
solution at a wavelength of 420 nm. Finally, the curcumin concentration was determined by 
using the measured absorbance value and a standard curve prepared using curcumin solutions of 
known concentration.  
7.2.6 Encapsulation efficiency  
 The encapsulation efficiency of the curcumin-loaded milks was calculated using the 
following expression: 
 
 Encapsulation Efficiency = 100  CE / CI    (1) 
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Here, CI is the total curcumin concentration initially added to the milk and CE is the curcumin 
concentration remaining after preparation using the pH-shift method.  
7.2.7 Stability and bioaccessibility  
 The stability and bioaccessibility of the curcumin in the milk samples was measured after 
they had been passed through the simulated GIT model.  After the small intestine stage, the 
digest was collected and divided into two portions: (i) Digest portion: the curcumin 
concentration (CD) in one portion was measured directly using the UV/Vis spectrophotometry 
method; (ii) Micelle portion: the curcumin in the supernatant of the other portion (CM) was 
measured after it had been centrifuged at 18,000 rpm at 25 ºC for 50 min (Thermo Scientific, 
Waltham, MA). This latter portion was considered to represent the amount of curcumin that had 
been solubilized within the mixed micelles generated during digestion. The bioaccessibility and 
stability of the curcumin-loaded milk samples were then calculated using the following 
expressions: 




     (2) 




      (3) 
  The Bioaccessibility represents the fraction of curcumin solubilized in the mixed micelle 
phase, which is potentially available for absorption. The Stability represents the total amount of 
curcumin that survived after the milk was passed through the simulated GIT274.  
7.2.8 Kinetics of curcumin degradation 
 The kinetics of curcumin degradation within the milk samples during storage were 
modelled using the Arrhenius equation:  
  𝑘 = 𝐴 𝑒−𝐸𝑎/𝑅𝑇        (4) 
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Here, k is the rate coefficient, A is the Arrhenius constant, Ea is the activation energy, R is the 
universal gas constant (8.314  10-3 kJ mol-1 K-1); and T is the absolute temperature (K).  
7.2.9 Statistical analysis 
 The mean ± standard deviation was calculated from measurements made on at least three 
freshly prepared samples. Mathematical software (SPSS version 6.0) was used to calculate the 
statistical differences and considered as significantly different when the p-value was lower than 
0.05. 
7.3. Results and discussions 
7.3.1 Influence of pH on particle characteristics of blank dairy milk 
 Initially, the characteristics of the original dairy milk were analyzed. Visually, the milk 
had a light milky appearance, which can be attributed to light scattering by the milk fat globules 
and casein micelles it contained.  The milk had a pH value of 6.8. The particles in the milk had a 
relatively small mean diameter (D32 =396 ± 5 nm) and high negative surface potential (ζ = -40.1 
± 1.3 mV).  This high negative charge can be attributed to the adsorption of anionic surface-
active species, such as milk phospholipids and proteins above their isoelectric point (such as 
casein and whey proteins).   
 The influence of pH on the physical stability of the milk was evaluated to determine 
whether it was suitable for preparing curcumin-loaded milks using the pH-shift method, since 
this method requires that the fat globules remain stable to aggregation under both neutral and 
highly alkaline conditions. Samples of the milk were adjusted to different pH values (pH 3 to 
10), and then their physical stability was determined after they were stored at room temperature 
for several hours (Fig. 1).  The digital photography images showed that the milk samples 
exposed to different pH values all had a homogenously white appearance. At pH 3 to 5, however, 
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the milk samples were more likely to stick to the sides of the test tube walls than at higher pH 
values (Fig. 1a). This phenomenon can be attributed to changes in the aggregation state of the 
particles as the pH was varied. The laser diffraction measurements show that the mean particle 
diameter of the milk samples were relatively small from pH 10 to 6 (D32 < 1 m), but relatively 
large at lower pH values (D32 > 15 nm) (Fig. 1b).  These results indicate that extensive fat 
globule aggregation occurred in the milk particles under acidic conditions. The surface potential 
(ζ-potential) of the milk fat globules was relatively high and negative from pH 10 to 5 but then 
became positive when the pH was reduced further, with a point of zero charge around pH 4.3 
(Fig.1c).  This effect can be attributed to the presence of milk proteins (mainly casein and whey) 
at the surfaces of the fat globules, which have an isoelectric point between 4 and 5.  The high 
negative charge observed from pH 6 to 10 should be sufficient to generate a strong electrostatic 
repulsion, which inhibits droplet aggregation.  Presumably, the milk fat globules irreversibly 
aggregate when the pH is around the isoelectric point of the adsorbed protein layer because the 
electrostatic repulsion between the droplets is weakened.        
 Overall, these results show that the dairy milk should remain physically stable from pH 6 















 b.      c. 
 
Fig. 1 a) Impact of pH on appearance of blank dairy milks; b) Impact of pH on electrical characteristics (ζ-potential) 




 a       b 
 
Fig. 2 the a) electrical characteristic (ζ- potential) and b) mean particle diameter (D32) of the blank dairy milk with 
curcumin-loaded dairy milks under pH 6.5, 7 and 8. Different lowercase letters mean significant different (Duncan, 
p< 0.05) within the same type of dairy milks; different capital letter represents the significantly different between 
two types of sample (Duncan, p< 0.05). 
 
 
7.3.2 Influence of pH-shift method on milk properties  
 In this section, the suitability of the pH-shift method for loading curcumin into the milk 
samples was investigated.  Moreover, the impact of a limited range of pH values (pH 6.5, 7, and 
8) on the appearance, physical stability, and encapsulation efficiency of the milks was examined 
because commercial products may have aqueous phases that fall within this range.  
7.3.2.1 Appearance 
 Digital photography and instrumental colorimetry measurements were used to 
characterize the general appearance and overall color of the curcumin-loaded milk (Fig. 3a & 
Table 1). The photography images showed that the milk fat globules in all the curcumin-loaded 
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milk samples were homogenously distributed throughout the tubes, without any evidence of 
phase separation (Fig. 3a).  The milks had a cloudy yellow color at pH 6.5 and 7, but a more 
orangey color at pH 8. The instrumental colorimeter measurements also indicated that the color 
of the emulsions depended their pH (Table 1). At pH 6.5 and 7, the curcumin-loaded milks had 
similar color coordinates, which were indicative of a creamy yellow appearance: L* ( 87), a* ( 
-11), and b* ( +79). At pH 8, the milks had a lower whiteness (L*  83), greenness (a*  -4), 
and yellowness (b*  74) than at lower pH values. This color change can be attributed to pH-
dependent changes in the structural arrangement (and therefore absorption spectrum) of the 
curcumin molecules. When the pH of curcumin reaches its first pKa value (around 7.5 to 8.5), the 
color of the curcumin changes from yellow to orange due to deprotonation of one of the 
curcumin hydroxyl groups1, 13, 255.  Our results show that it is important to carefully control the 
pH of a milk sample to obtain a consistent color.  Alternatively, this phenomenon could be used 









230.8 ± 6.5a  233.0± 6.2 a 232 ± 11 a 
Loading capacity (%) 92.3 ± 2.4 a 93.2 ± 2.2 a 92.7 ± 4.0 a 
D32 (m) 0.39 ± 0.01 a 0.39 ± 0.01 a 0.45 ± 0.01 b 
ζ- potential (mV) 
-43.5 ± 1.3 b -45.30 ± 0.91 a -44.3 ± 1.0 ab 
Table 1. Influence of pH on the physical and chemical properties of curcumin-loaded dairy milk: the initial 
curcumin concentration, loading capacity, mean particle diameter (D32), and electrical characteristics (ζ- potential). 




7.3.2.2 Curcumin concentration  
 The encapsulation efficiency (EE) of curcumin within the milk after using the pH-shift 
method was also investigated using a fixed amount of curcumin (250 μg/mL). All the curcumin-
loaded milk samples had a relatively high and fairly similar amount of curcumin trapped within 
them, i.e., 92 to 93 % (Table 1). This result indicates that the pH-shift method can be used to 
successfully load curcumin into samples containing milk fat globules.  
7.3.2.3 Particle characteristics 
 The impact of loading the curcumin into the milk samples on their particle characteristics 
was also investigated. The pH-shift method did not have a significant impact on the surface 
potential of the milks (Fig. 2a). Surprisingly, the mean particle diameters of the curcumin-loaded 
milks were slightly smaller than the blank milks (Fig. 2b), which may have been because the pH-
shift method reduced the interfacial thickness or degree of aggregation of the milk fat globules. 
Photography images of the curcumin-loaded milks showed they all had a homogenous creamy 
yellow appearance, regardless of the pH value (Fig. 3a). These results indicate that the pH-shift 
method does not promote aggregation or phase separation of the milk fat globules during the 
curcumin loading process.  The microstructure images of the curcumin-loaded milks also 
confirmed this (Fig. 3b). All the milk samples contained relatively small milk fat globules 
(stained red) that were uniformly distributed throughout an aqueous medium containing protein 
(stained green).  
7.3.3 Effect of pH on storage stability of curcumin-loaded milk 
 Commercially, it is important that milk-based products have a shelf life that is 
sufficiently long. The physicochemical stability of the curcumin-loaded milks was therefore 
monitored during storage for 60 days at 4 ºC in the dark (pH 6.5, 7.0 and 8.0). This relatively low 
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temperature was selected because the milks would be expected to be stored in a commercial or 
domestic refrigerator prior to utilization.   
7.3.3.1 Appearance  
 Digital photography images were used to monitor changes in the appearance of the milk 
samples after storage (Fig. 3a). These images showed that the milks all remained evenly 
distributed through the test tubes after storage, indicating that aggregation and phase separation 
of the milk fat globules had not occurred during storage. At pH 6.5 and 7.0, the milks had 
creamy yellow colors that were very similar to the initial samples.  At pH 8.0, the orange color of 










Table 2. influence of pH and temperature on the tristimulus color value (L*, a*, and b*).  Left hand part of table: 
impact of pH on color values before and after 60 days’ incubation at 4 ºC; Right hand part of table: impact of 
temperature on color values before and after 15-day incubation at pH 7. The different lower-case letters represent 
significant differences between samples (between pHs or temperature) (Duncan, p< 0.05). The different capital-case 
letter represent significant difference before and after storage (Independent-Sample T-test, p< 0.05). 
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 The instrumental color coordinates of the curcumin-loaded milks were also measured to 
detect any changes in the appearance of the samples before and after storage (Table 2). The 
lightness (L*) values of the stored samples were similar to those of the fresh samples, which 
suggests there was little change in light scattering by the milk fat globules. The a*-values of all 
the milk samples became slightly less negative (less green) after storage, whereas the b*-values 
became slightly more positive (more yellow). Overall, our results suggest that the milk samples 
remained relatively stable to color fading during storage for two months under refrigeration 












Fig 3. a) The appearances and b) microstructures of curcumin-loaded dairy milks before and after storage at various 
pH values at 4 ºC for 60 days. The microstructure images were obtained using confocal fluorescence microscopy 
and the scale bars are 100 um.  
 
7.3.3.2 Curcumin concentration 
 The chemical stability of the curcumin in the milks was also investigated throughout 
storage under refrigeration conditions (Fig. 4b). After 60-day incubation at 4 ºC, the majority of 
the curcumin was still present in all the milk samples, regardless of storage pH: 88  3% at pH 
6.5; 88  2% at pH 7; and, 87  2% at pH 8. This result suggests that the encapsulated curcumin 
was relatively stable to chemical degradation at all pH values studied under refrigeration 
conditions.  
7.3.3.3 Particle characteristics 
 For commercial products, it is important that the milk fat globules do not aggregate and 
cream during storage.  For this reason, the influence of pH on the particle characteristics of the 
milks was also evaluated throughout refrigerated storage (Fig. 5). These results showed that the 
curcumin-loaded milks remained physically stable during storage, with little change in mean 
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particle diameter (Fig. 5a) or ζ-potential (Fig. 5b).  These results therefore support the visual 
observations discussed earlier (Fig. 3). Presumably, the high negative charge on the milk fat 
globules generated a strong electrostatic repulsion that inhibited their aggregation. As a result, 
the particles in the milk remained relatively small, which also inhibited their gravitational 
separation.  
 
Fig. 4  
a      b 
 
Fig. 4. Influence of pH on a) the yellow color (b*) and b) curcumin degradation of curcumin within the dairy milks 


















a.        b 
 
Fig. 5. Influence of pH on the a) mean particle diameters (D32) and b) electrical characteristics (ζ- potential) of 




7.3.4 Effect of storage temperature on the stability of curcumin-loaded milk 
 In principle, milk products may experience a range of different temperatures during their 
production, storage, and utilization.  For this reason, we examined the impact of storage 
temperature on the physical and chemical stability of the curcumin-loaded milk.  The milk 
samples (pH 7.0) were poured into sealed containers and then stored at 4, 20, 37, and 55 ºC for 
15-days in the dark.  
7.3.4.1 Appearance 
 There were noticeable changes in the appearance of the curcumin-loaded milks after 
storage, which depended on the storage temperature employed (Fig. 6a). In particular, there was 
evidence of color fading and gravitational separation in some of the samples.  The extent of color 
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fading increased as the storage temperature was raised, with the greatest degree of color fading 
being observed at 55 oC. The extent of gravitational separation also increased with increasing 
storage temperature. There was no visible evidence of phase separation during storage at 4 and 
20 ºC, but a thick cream layer was observed at the surface of the samples stored at 37 and 55 oC.  
This effect was attributed to the upward movement of aggregated milk fat globules due to the 
gravitational forces acting upon them.    
 Instrumental colorimetry measurements also indicated that there were temperature-
dependent differences in the color stability of the curcumin-loaded milks during storage. The L*, 
a* and b* values of the milks before and after storage are given in Table 2. The lightness (L*) 
and greenness (a*) of the milks remained fairly constant throughout storage at all temperatures, 
with only slight decreases being observed (Table 2). On the other hand, the yellowness (b*) of 
some of the milks decreased appreciably during storage, suggesting that there was some 
chemical degradation of the curcumin that led to color fading. For this reason, the change in the 
relative yellowness (b*/b0*) of the samples was plotted over time to provide an indication of the 
kinetics of color fading (Fig.7a). The rate of color fading increased with increasing storage 
temperature: 4 ºC ≈ 20 ºC > 37 ºC >> 55 ºC (Fig. 7a). After 15 days storage, there was no color 
fading in the milk samples stored at 4 and 20 ºC, about 4% in the samples stored at 37 ºC, and 
about 16% in the samples stored at 55 ºC. These results suggest that the curcumin-loaded milks 
will remain stable to color fading provided that they are stored at sufficiently low temperatures 

















Fig. 6 Influence of temperatures on the a) appearances of curcumin-loaded dairy milk before and after 15-days 
storage. The impact of temperature on b) mean particle diameters (D32) and c) electrical characteristics (ζ- potential) 
of curcumin-loaded dairy milks during 15-days storage. d) the microstructure of curcumin-loaded dairy milks before 
and after incubated under four different temperatures and a length of 100 um scale bars were applied. 
 
 
7.3.4.2 Curcumin concentration  
 Changes in the curcumin concentration of the milks during storage were also measured to 
investigate the impact of storage temperature on curcumin stability (Fig. 7b). The observed rate 
of curcumin degradation increased with increasing storage temperature.  For instance, after 15-
days storage, about 4%, 10%, 22% and 47% of the curcumin had degraded at 4, 20, 37, and 55 
ºC, respectively.  These results suggest that elevated storage temperatures accelerate the 
chemical degradation of curcumin, which is obviously undesirable for commercial applications 







Fig. 7  
a.          b. 
 
Fig. 7 Influence of temperature on the a) yellow color (b*) and b) curcumin content of curcumin within the dairy 
milk system were determined during 15-days storage. 
 
 
 More quantitative information about the kinetics of curcumin degradation in the milk 
samples were obtained by fitting the experimental data with the re-arranged Arrhenius equation: 
 ln(𝑘) = ln(𝐴) −
𝐸𝐴
𝑅𝑇
          (5) 
The activation energy (EA) was calculated by plotting the logarithm of the reaction rate constant 
(k) against the reciprocal of the absolute temperature (1/T) (Fig. 8). The reaction rate was 
determined at each temperature from plots of curcumin concentration versus time, assuming a 
first-order reaction, i.e., C/C0 = exp(-kt).  This analysis indicated that the activation energy for 
curcumin degradation was around +51.6 kJ/mol and the ln(A) value was around 15.6 (when time 
 171 
expressed in days).  The half-time was defined as the time required for the curcumin to degrade 
by 50%, which is given by the following expression: 
  𝑡1/2 = −
ln (0.5)
𝑘
           (6) 
Assuming the data can be extrapolated to higher temperatures, which needs to be verified 
experimentally, the calculated half-times for curcumin degradation are 184, 47, 14, 5.0 and 1.9 
days for 20, 40, 60, 80, and 100 oC, respectively.  This information may be useful for predicting 




Fig. 8 the Arrhenius equation graph of curcumin within the dairy milks system, which represents the temperature 





7.3.4.3 Particle characteristics 
 The impact of storage temperature on the characteristics of the particles in the milk 
samples were also evaluated (Fig. 6b & 6c). The measured mean particle diameter of the 
particles remained relatively small throughout storage (D32  400 nm) while the ζ-potential 
remained relatively high and negative (ζ  -45 mV). The confocal microscopy images suggested 
that the fat globules remained evenly spread throughout the samples at all temperatures (Fig. 6d).  
Taken together these results suggest that storage temperature did not have a major impact on the 
surface chemistry or aggregation stability of the milk samples.  However, this is somewhat 
inconsistent with the appearance of the milk samples held at the higher storage temperatures, 
which exhibited some creaming after storage (Fig. 6a).  This may have been an experimental 
artefact associated with sample preparation.  For the laser diffraction and confocal microscopy 
measurements, the samples were inverted a few times to ensure they were homogeneous prior to 
collecting an aliquot for analysis.  This process may have disrupted any weak flocs in the milk 
samples, thereby releasing the individual milk fat globules.   
 
7.3.5 Curcumin bioaccessibility and stability during simulated digestion 
 Finally, two of the main factors expected to impact curcumin bioavailability in the milk 
samples, namely bioaccessibility and stability, were investigated using a well-established 
simulated gastrointestinal tract (GIT) model 257, 258. The bioaccessibility and stability of the 
curcumin-loaded milk (pH 7.0) samples were measured before and after they were stored at 4 ºC 
for 60-days (Table 3). As mentioned earlier, the total concentration of curcumin in the milk 
samples was reduced by about 13% (from 233 to 205 ug/mL) after storage due to some chemical 
degradation of the polyphenol (Fig. 4b). This phenomenon accounts for the fact that the total 
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curcumin concentrations in the digest and mixed micelle fractions were higher before storage 
than after storage (Table 3). After exposure to simulated GIT conditions, the stability of the 
curcumin in the samples was higher before storage (89%) than after storage (71%), but the 
bioaccessibility was similar (around 40 %). The stability represents the amount of curcumin that 
survived after exposure to simulated mouth, stomach, and small intestinal conditions. Our results 
suggest that the aged curcumin was more susceptible to degradation than the fresh curcumin, 
although the origin of this effect is currently unknown. The bioaccessibility represents the 
fraction of curcumin in the small intestine phase that is solubilized within the mixed micelle 
phase, and thus available for absorption. The chemical stability of the curcumin should not 
therefore impact this value because it is a ratio of two curcumin concentrations in the small 
intestine.  Overall, our results suggest that the curcumin has a relatively high bioavailability both 
before and after storage. In future, it would be useful to test these systems using animal and 
human feeding studies to establish the overall bioavailability, which also depends on the 




 CDigest (ug/mL) CMicelle (ug/mL) Stability (%) 
Bioaccessibility 
(%) 
Before Storage 217 ± 19 B          89 ± 28 A 89.6 ± 3.0 B 41 ± 11 A 
After Storage 160 ± 4 A 61 ± 11 A 71.0 ± 1.9 A 38.0 ± 8.1 A 
 
Table 3. The curcumin concentration within the digest phase (CDigest), the curcumin concentration within the mixed 
micelle phase, the stability and bioaccessibility of curcumin-loaded dairy milk at pH7 that determined before and 
after storage using a stimulated gastrointestinal tract. The different letters represent significant differences before 





 In conclusion, we have shown that curcumin can be successfully loaded into pre-existing 
milk fat globules using the pH-shift method, and that the resulting curcumin-loaded milks have 
good chemical and physical stability under various storage conditions. For instance, around 88 % 
of the curcumin remained in the milk samples after storage under refrigerator temperatures for 60 
days. Moreover, there was no evidence of aggregation or creaming of the milk fat globules when 
they were stored under these conditions. A study of the impact of storage temperature on the 
stability of the curcumin-loaded milk samples showed that they were both chemically and 
physically stable at 4 and 20 ºC, but unstable at 37 and 55 ºC. We also showed that the curcumin-
loaded milks had relatively good bioaccessibility (40%) under simulated gastrointestinal 
conditions. The information obtained in this study may be useful for the rational design of a new 
range of curcumin-fortified functional food products based on dairy milk.  Future research, 
however, is still needed to establish the bioavailability of the curcumin in these products using 











8. Conclusions and Future Directions 
This research has shown that emulsion-based delivery systems can overcome the low 
solubility, poor chemical stability, and low bioaccessibility of curcumin in foods. It was 
demonstrated that a new organic solvent-free pH-driven method was particularly suitable at 
introducing curcumin into a variety of colloidal delivery systems, including nanoemulsions, 
soymilk, and dairy milk. This technique gave a high encapsulation efficiency and produced 
delivery systems that had a high bioaccessibility.  The delivery systems developed in this study 
may be used by the food, supplement, and pharmaceutical industries to incorporate curcumin 
into a diverse range of products designed to improve human health.   
Future work should focus on examining the efficacy of these delivery systems when used 
in real food applications such as different food matrices and storage/processing conditions.  For 
example, the poor light stability of curcumin is a major challenge in food products with 
transparent packaging, such as soft drinks and other beverages. Therefore, investigations of the 
photostability of curcumin-loaded colloidal delivery systems would be useful.  Moreover, 
examination of the factors affecting the bioavailability of curcumin using in vivo animal and 
human feeding studies would be advantageous.  In addition, the impact of these delivery systems 
on the sensory attributes of curcumin-fortified foods would be important, as it is critical that 
nutritionally fortified foods and beverages look and taste good, otherwise consumers will not 
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